Peplife 2.0 - Basic Search Results

Browsing by half-Life: Below 60 Seconds

Browse Results:

Filter by Year
From
Upto

ID	PMID	YEAR	Sequence	Name	Length	N-ter MOD	C-ter MOD	Linear/Cyclic	Chirality	Chem-MOD	Origin	Nature	Incubation Time	Concentration	Half Life	Protease	Assay	Test Sample	Vivo/Vitro	Reference	Patent No.	Activity
1049	10495424	1999	AAGIGILTV	MART-127 €“35	9	Free	Free	Linear	L	None	Synthetic	Immunogenic peptides	Not given	1 µM	22	Human plasma proteases and proteases of VMM5 cytotoxic T-lymphocyte	Not mentioned	VMM5 cytotoxic T-lymphocyte line incubated in human plasma	in vitro	None	None	IC50 for inhibition of binding of a standard peptide to HLA-A*0201 molecules is 0.5 µM
1050	10495424	1999	AAGIGILTV	PEG-MART-1	9	Free	Pegylation	Linear	L	None	Synthetic	Immunogenic peptides	Not given	Not given	Stability increased	Human plasma proteases and proteases of VMM5 cytotoxic T-lymphocyte	Not mentioned	VMM5 cytotoxic T-lymphocyte line incubated in human plasma	in vitro	None	None	IC50 for inhibition of binding of a standard peptide to HLA-A*0201 molecules is >35 µM
1051	10495424	1999	aAGIGILTv	D-MART-1	9	Free	Free	Linear	Mix	None	Synthetic	Immunogenic peptides	Not given	Not given	Stability increased	Human plasma proteases and proteases of VMM5 cytotoxic T-lymphocyte	Not mentioned	VMM5 cytotoxic T-lymphocyte line incubated in human plasma	in vitro	None	None	Not tested
1052	10495424	1999	AAGIGILTV	Glyco-MART-1	9	Asn(Î²-D-GlcNHAc)	Free	Linear	L	None	Synthetic	Immunogenic peptides	Not given	Not given	Stability increased	Human plasma proteases and proteases of VMM5 cytotoxic T-lymphocyte	Not mentioned	VMM5 cytotoxic T-lymphocyte line incubated in human plasma	in vitro	None	None	Not tested
1053	10495424	1999	AAGIGILTV	Cap-MART-1	9	Acetylation	Amidation	Linear	L	None	Synthetic	Immunogenic peptides	Not given	Not given	Stability increased	Human plasma proteases and proteases of VMM5 cytotoxic T-lymphocyte	Not mentioned	VMM5 cytotoxic T-lymphocyte line incubated in human plasma	in vitro	None	None	IC50 for inhibition of binding of a standard peptide to HLA-A*0201 molecules is 65 µM
1054	10495424	1999	AAGIGILTV	N-MART-1	9	Acetylation	Free	Linear	L	None	Synthetic	Immunogenic peptides	Not given	Not given	Stability increased	Human plasma proteases and proteases of VMM5 cytotoxic T-lymphocyte	Not mentioned	VMM5 cytotoxic T-lymphocyte line incubated in human plasma	in vitro	None	None	IC50 for inhibition of binding of a standard peptide to HLA-A*0201 molecules is 35 µM
1055	10495424	1999	AAGIGILTV	C-MART-1	9	Free	Amidation	Linear	L	None	Synthetic	Immunogenic peptides	Not given	Not given	Stability increased	Human plasma proteases and proteases of VMM5 cytotoxic T-lymphocyte	Not mentioned	VMM5 cytotoxic T-lymphocyte line incubated in human plasma	in vitro	None	None	IC50 for inhibition of binding of a standard peptide to HLA-A*0201 molecules is 7 µM
1075	15012592	2004	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR	N-acetyl-GLP-1	30	Acetylation	Free	Linear	L	None	Glucagon	Antihyperglycaemic, insulinotropic	Not reported	25 nM/kg body weight	Completely resistant to degradation	Adult obese diabetic (ob /ob ) mice blood protease	LC/MS equipped with a microbore C-18 HPLC	Intraperitoneally administered to adult obese diabetic (ob /ob ) mice	in vivo	None	None	IC50 = 32 ·9 of binding to a receptor
1076	15012592	2004	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR	N-pyroglutamyl-GLP-1	30	PyroGlutamic acid at 1st position	Free	Linear	L	None	Glucagon	Antihyperglycaemic, insulinotropic	Not reported	25 nM/kg body weight	Completely resistant to degradation	Adult obese diabetic (ob /ob ) mice blood protease	LC/MS equipped with a microbore C-18 HPLC	Intraperitoneally administered to adult obese diabetic (ob /ob ) mice	in vivo	None	None	IC50 = 6 ·7 nM of binding to a receptor
1269	19159331	2009	GSIGAASMEF	Peptide 1	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	2.7013	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1270	19159331	2009	IGAASMEFCF	Peptide 2	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0629	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1271	19159331	2009	AASMEFCFDV	Peptide 3	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0556	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1272	19159331	2009	SMEFCFDVFK	Peptide 4	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0103	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1273	19159331	2009	EFCFDVFKEL	Peptide 5	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0088	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1274	19159331	2009	CFDVFKELKV	Peptide 6	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0122	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1275	19159331	2009	DVFKELKVHH	Peptide 7	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0101	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1276	19159331	2009	FKELKVHHAN	Peptide 8	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0094	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1277	19159331	2009	ELKVHHANEN	Peptide 9	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1969	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1278	19159331	2009	KVHHANENIF	Peptide 10	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	1.2897	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1279	19159331	2009	HHANENIFYC	Peptide 11	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0485	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1280	19159331	2009	ANENIFYCPI	Peptide 12	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1557	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1281	19159331	2009	ENIFYCPIAI	Peptide 13	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.089	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1282	19159331	2009	IFYCPIAIMS	Peptide 14	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0469	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1283	19159331	2009	YCPIAIMSAL	Peptide 15	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.2911	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1284	19159331	2009	PIAIMSALAM	Peptide 16	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1596	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1285	19159331	2009	AIMSALAMVY	Peptide 17	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0512	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1286	19159331	2009	MSALAMVYLG	Peptide 18	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0132	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1287	19159331	2009	ALAMVYLGAK	Peptide 19	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0077	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1288	19159331	2009	AMVYLGAKDS	Peptide 20	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0111	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1289	19159331	2009	VYLGAKDSTR	Peptide 21	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0135	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1290	19159331	2009	LGAKDSTRTQ	Peptide 22	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0122	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1291	19159331	2009	AKDSTRTQIN	Peptide 23	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0092	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1292	19159331	2009	DSTRTQINKV	Peptide 24	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.021	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1293	19159331	2009	TRTQINKVVR	Peptide 25	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0027	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1294	19159331	2009	TQINKVVRFD	Peptide 26	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0094	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1295	19159331	2009	INKVVRFDKL	Peptide 27	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0069	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1296	19159331	2009	KVVRFDKLPG	Peptide 28	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0119	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1297	19159331	2009	VRFDKLPGFG	Peptide 29	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1526	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1298	19159331	2009	FDKLPGFGDS	Peptide 30	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	25.2445	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1299	19159331	2009	KLPGFGDSIE	Peptide 31	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	40.1296	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1300	19159331	2009	PGFGDSIEAQ	Peptide 32	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	17.8114	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1301	19159331	2009	FGDSIEAQCG	Peptide 33	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	7.122	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1302	19159331	2009	DSIEAQCGTS	Peptide 34	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	13.4815	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1303	19159331	2009	IEAQCGTSVN	Peptide 35	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	6.4814	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1304	19159331	2009	AQCGTSVNVH	Peptide 36	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	4.3435	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1305	19159331	2009	CGTSVNVHSS	Peptide 37	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	1.1378	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1306	19159331	2009	TSVNVHSSLR	Peptide 38	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1177	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1307	19159331	2009	VNVHSSLRDI	Peptide 39	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0148	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1308	19159331	2009	VHSSLRDILN	Peptide 40	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0527	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1309	19159331	2009	SSLRDILNQI	Peptide 41	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1504	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1310	19159331	2009	LRDILNQITK	Peptide 42	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0939	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1311	19159331	2009	DILNQITKPN	Peptide 43	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	4.1593	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1312	19159331	2009	LNQITKPNDV	Peptide 44	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	20.6999	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1313	19159331	2009	QITKPNDVYS	Peptide 45	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.2963	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1314	19159331	2009	TKPNDVYSFS	Peptide 46	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.012	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1315	19159331	2009	PNDVYSFSLA	Peptide 47	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0026	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1316	19159331	2009	DVYSFSLASR	Peptide 48	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0037	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1317	19159331	2009	YSFSLASRLY	Peptide 49	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0019	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1318	19159331	2009	FSLASRLYAE	Peptide 50	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0035	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1319	19159331	2009	LASRLYAEER	Peptide 51	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0031	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1320	19159331	2009	SRLYAEERYP	Peptide 52	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0052	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1321	19159331	2009	LYAEERYPIL	Peptide 53	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1052	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1322	19159331	2009	AEERYPILPE	Peptide 54	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	11.4998	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1323	19159331	2009	ERYPILPEYL	Peptide 55	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	1.466	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1324	19159331	2009	YPILPEYLQC	Peptide 56	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1016	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1325	19159331	2009	ILPEYLQCVK	Peptide 57	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.3817	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1326	19159331	2009	PEYLQCVKEL	Peptide 58	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1101	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1327	19159331	2009	YLQCVKELYR	Peptide 59	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0263	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1328	19159331	2009	QCVKELYRGG	Peptide 60	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0128	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1329	19159331	2009	VKELYRGGLE	Peptide 61	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0225	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1330	19159331	2009	ELYRGGLEPI	Peptide 62	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0244	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1331	19159331	2009	YRGGLEPINF	Peptide 63	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0238	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1332	19159331	2009	GGLEPINFQT	Peptide 64	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0336	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1333	19159331	2009	LEPINFQTAA	Peptide 65	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0242	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1334	19159331	2009	PINFQTAADQ	Peptide 66	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0812	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1335	19159331	2009	NFQTAADQAR	Peptide 67	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1293	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1336	19159331	2009	QTAADQAREL	Peptide 68	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0514	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1337	19159331	2009	AADQARELIN	Peptide 69	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0325	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1338	19159331	2009	DQARELINSW	Peptide 70	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0224	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1339	19159331	2009	ARELINSWVE	Peptide 71	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0156	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1340	19159331	2009	ELINSWVESQ	Peptide 72	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	1.2344	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1341	19159331	2009	INSWVESQTN	Peptide 73	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	3.3348	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1342	19159331	2009	SWVESQTNGI	Peptide 74	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.7564	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1343	19159331	2009	VESQTNGIIR	Peptide 75	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.3309	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1344	19159331	2009	SQTNGIIRNV	Peptide 76	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0066	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1345	19159331	2009	TNGIIRNVLQ	Peptide 77	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0072	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1346	19159331	2009	GIIRNVLQPS	Peptide 78	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0038	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1347	19159331	2009	IRNVLQPSSV	Peptide 79	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0049	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1348	19159331	2009	NVLQPSSVDS	Peptide 80	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.3384	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1349	19159331	2009	LQPSSVDSQT	Peptide 81	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1866	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1350	19159331	2009	PSSVDSQTAM	Peptide 82	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	4.5647	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1351	19159331	2009	SVDSQTAMVL	Peptide 83	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.2013	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1352	19159331	2009	DSQTAMVLVN	Peptide 84	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0195	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1353	19159331	2009	QTAMVLVNAI	Peptide 85	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0264	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1354	19159331	2009	AMVLVNAIVF	Peptide 86	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0165	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1355	19159331	2009	VLVNAIVFKG	Peptide 87	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0087	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1356	19159331	2009	VNAIVFKGLW	Peptide 88	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0051	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1357	19159331	2009	AIVFKGLWEK	Peptide 89	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0054	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1358	19159331	2009	VFKGLWEKAF	Peptide 90	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0039	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1359	19159331	2009	KGLWEKAFKD	Peptide 91	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0053	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1360	19159331	2009	LWEKAFKDED	Peptide 92	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0131	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1361	19159331	2009	EKAFKDEDTQ	Peptide 93	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0329	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1362	19159331	2009	AFKDEDTQAM	Peptide 94	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	7.6573	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1363	19159331	2009	KDEDTQAMPF	Peptide 95	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.6468	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1364	19159331	2009	EDTQAMPFRV	Peptide 96	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0033	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1365	19159331	2009	TQAMPFRVTE	Peptide 97	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0047	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1366	19159331	2009	AMPFRVTEQE	Peptide 98	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0063	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1367	19159331	2009	PFRVTEQESK	Peptide 99	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.131	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1368	19159331	2009	RVTEQESKPV	Peptide 100	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	2.1948	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1369	19159331	2009	TEQESKPVQM	Peptide 101	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	19.4782	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1370	19159331	2009	QESKPVQMMY	Peptide 102	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	3.8079	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1371	19159331	2009	SKPVQMMYQI	Peptide 103	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.124	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1372	19159331	2009	PVQMMYQIGL	Peptide 104	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.088	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1373	19159331	2009	QMMYQIGLFR	Peptide 105	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.006	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1374	19159331	2009	MYQIGLFRVA	Peptide 106	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0025	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1375	19159331	2009	QIGLFRVASM	Peptide 107	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0015	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1376	19159331	2009	GLFRVASMAS	Peptide 108	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.006	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1377	19159331	2009	FRVASMASEK	Peptide 109	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0082	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1378	19159331	2009	VASMASEKMK	Peptide 110	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1745	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1379	19159331	2009	SMASEKMKIL	Peptide 111	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0072	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1380	19159331	2009	ASEKMKILEL	Peptide 112	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0103	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1381	19159331	2009	EKMKILELPF	Peptide 113	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0135	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1382	19159331	2009	MKILELPFAS	Peptide 114	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0183	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1383	19159331	2009	ILELPFASGT	Peptide 115	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0767	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1384	19159331	2009	ELPFASGTMS	Peptide 116	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0648	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1385	19159331	2009	PFASGTMSML	Peptide 117	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	3.844	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1386	19159331	2009	ASGTMSMLVL	Peptide 118	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1692	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1387	19159331	2009	GTMSMLVLLP	Peptide 119	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0949	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1388	19159331	2009	MSMLVLLPDE	Peptide 120	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0317	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1389	19159331	2009	MLVLLPDEVS	Peptide 121	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.323	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1390	19159331	2009	VLLPDEVSGL	Peptide 122	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	8.3587	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1391	19159331	2009	LPDEVSGLEQ	Peptide 123	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.3722	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1392	19159331	2009	DEVSGLEQLE	Peptide 124	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1719	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1393	19159331	2009	VSGLEQLESI	Peptide 125	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	1.0014	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1394	19159331	2009	GLEQLESIIN	Peptide 126	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.5162	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1395	19159331	2009	EQLESIINFE	Peptide 127	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0686	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1396	19159331	2009	LESIINFEKL	Peptide 128	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0663	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1397	19159331	2009	SIINFEKLTE	Peptide 129	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0667	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1398	19159331	2009	INFEKLTEWT	Peptide 130	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0541	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1399	19159331	2009	FEKLTEWTSS	Peptide 131	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0563	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1400	19159331	2009	KLTEWTSSNV	Peptide 132	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.4176	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1401	19159331	2009	TEWTSSNVME	Peptide 133	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.5842	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1402	19159331	2009	WTSSNVMEER	Peptide 134	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.9286	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1403	19159331	2009	SSNVMEERKI	Peptide 135	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0399	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1404	19159331	2009	NVMEERKIKV	Peptide 136	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0072	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1405	19159331	2009	MEERKIKVYL	Peptide 137	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0037	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1406	19159331	2009	ERKIKVYLPR	Peptide 138	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0008	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1407	19159331	2009	KIKVYLPRMK	Peptide 139	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0017	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1408	19159331	2009	KVYLPRMKME	Peptide 140	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0044	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1409	19159331	2009	YLPRMKMEEK	Peptide 141	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0088	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1410	19159331	2009	PRMKMEEKYN	Peptide 142	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0056	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1411	19159331	2009	MKMEEKYNLT	Peptide 143	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0367	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1412	19159331	2009	MEEKYNLTSV	Peptide 144	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0093	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1413	19159331	2009	EKYNLTSVLM	Peptide 145	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0124	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1414	19159331	2009	YNLTSVLMAM	Peptide 146	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0294	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1415	19159331	2009	LTSVLMAMGI	Peptide 147	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0787	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1416	19159331	2009	SVLMAMGITD	Peptide 148	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1194	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1417	19159331	2009	LMAMGITDVF	Peptide 149	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.8333	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1418	19159331	2009	AMGITDVFSS	Peptide 150	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0154	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1419	19159331	2009	GITDVFSSSA	Peptide 151	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0178	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1420	19159331	2009	TDVFSSSANL	Peptide 152	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.019	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1421	19159331	2009	VFSSSANLSG	Peptide 153	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1849	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1422	19159331	2009	SSSANLSGIS	Peptide 154	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.7012	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1423	19159331	2009	SANLSGISSA	Peptide 155	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.6149	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1424	19159331	2009	NLSGISSAES	Peptide 156	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	1.5216	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1425	19159331	2009	SGISSAESLK	Peptide 157	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.5455	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1426	19159331	2009	ISSAESLKIS	Peptide 158	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0401	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1427	19159331	2009	SAESLKISQA	Peptide 159	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0451	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1428	19159331	2009	ESLKISQAVH	Peptide 160	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0465	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1429	19159331	2009	LKISQAVHAA	Peptide 161	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0192	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1430	19159331	2009	ISQAVHAAHA	Peptide 162	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1691	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1431	19159331	2009	QAVHAAHAEI	Peptide 163	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1777	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1432	19159331	2009	VHAAHAEINE	Peptide 164	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1356	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1433	19159331	2009	AAHAEINEAG	Peptide 165	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.7772	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1434	19159331	2009	HAEINEAGRE	Peptide 166	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1388	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1435	19159331	2009	EINEAGREVV	Peptide 167	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1025	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1436	19159331	2009	NEAGREVVGS	Peptide 168	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1284	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1437	19159331	2009	AGREVVGSAE	Peptide 169	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0967	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1438	19159331	2009	REVVGSAEAG	Peptide 170	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	1.7169	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1439	19159331	2009	VVGSAEAGVD	Peptide 171	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	4.0618	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1440	19159331	2009	GSAEAGVDAA	Peptide 172	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	3.1271	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1441	19159331	2009	AEAGVDAASV	Peptide 173	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0711	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1442	19159331	2009	AGVDAASVSE	Peptide 174	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0548	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1443	19159331	2009	VDAASVSEEF	Peptide 175	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0426	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1444	19159331	2009	AASVSEEFRA	Peptide 176	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0246	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1445	19159331	2009	SVSEEFRADH	Peptide 177	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0788	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1446	19159331	2009	SEEFRADHPF	Peptide 178	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0759	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1447	19159331	2009	EFRADHPFLF	Peptide 179	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0569	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1448	19159331	2009	RADHPFLFCI	Peptide 180	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0056	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1449	19159331	2009	DHPFLFCIKH	Peptide 181	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0042	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1450	19159331	2009	PFLFCIKHIA	Peptide 182	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0046	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1451	19159331	2009	LFCIKHIATN	Peptide 183	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0185	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1452	19159331	2009	CIKHIATNAV	Peptide 184	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0929	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1453	19159331	2009	KHIATNAVLF	Peptide 185	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0719	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1454	19159331	2009	IATNAVLFFG	Peptide 186	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0048	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1455	19159331	2009	TNAVLFFGRC	Peptide 187	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0015	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1456	19159331	2009	AVLFFGRCVS	Peptide 188	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0012	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1457	19159331	2009	VLFFGRCVSP	Peptide 189	10	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0014	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1458	19159331	2009	GSIGAASMEFCFDVFK	Peptide 190	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0097	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1459	19159331	2009	IGAASMEFCFDVFKEL	Peptide 191	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0084	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1460	19159331	2009	AASMEFCFDVFKELKV	Peptide 192	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0068	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1461	19159331	2009	SMEFCFDVFKELKVHH	Peptide 193	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0084	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1462	19159331	2009	EFCFDVFKELKVHHAN	Peptide 194	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0098	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1463	19159331	2009	CFDVFKELKVHHANEN	Peptide 195	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0103	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1464	19159331	2009	DVFKELKVHHANENIF	Peptide 196	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0201	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1465	19159331	2009	FKELKVHHANENIFYC	Peptide 197	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0074	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1466	19159331	2009	ELKVHHANENIFYCPI	Peptide 198	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0851	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1467	19159331	2009	KVHHANENIFYCPIAI	Peptide 199	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0892	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1468	19159331	2009	HHANENIFYCPIAIMS	Peptide 200	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0575	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1469	19159331	2009	ANENIFYCPIAIMSAL	Peptide 201	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0425	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1470	19159331	2009	ENIFYCPIAIMSALAM	Peptide 202	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0327	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1471	19159331	2009	IFYCPIAIMSALAMVY	Peptide 203	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0167	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1472	19159331	2009	YCPIAIMSALAMVYLG	Peptide 204	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0125	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1473	19159331	2009	PIAIMSALAMVYLGAK	Peptide 205	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0077	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1474	19159331	2009	AIMSALAMVYLGAKDS	Peptide 206	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0088	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1475	19159331	2009	MSALAMVYLGAKDSTR	Peptide 207	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0063	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1476	19159331	2009	ALAMVYLGAKDSTRTQ	Peptide 208	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0045	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1477	19159331	2009	AMVYLGAKDSTRTQIN	Peptide 209	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0037	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1478	19159331	2009	VYLGAKDSTRTQINKV	Peptide 210	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.004	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1479	19159331	2009	LGAKDSTRTQINKVVR	Peptide 211	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0033	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1480	19159331	2009	AKDSTRTQINKVVRFD	Peptide 212	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0038	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1481	19159331	2009	DSTRTQINKVVRFDKL	Peptide 213	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0044	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1482	19159331	2009	TRTQINKVVRFDKLPG	Peptide 214	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0045	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1483	19159331	2009	TQINKVVRFDKLPGFG	Peptide 215	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0085	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1484	19159331	2009	INKVVRFDKLPGFGDS	Peptide 216	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0111	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1485	19159331	2009	KVVRFDKLPGFGDSIE	Peptide 217	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0131	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1486	19159331	2009	VRFDKLPGFGDSIEAQ	Peptide 218	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1209	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1487	19159331	2009	FDKLPGFGDSIEAQCG	Peptide 219	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	5.693	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1488	19159331	2009	KLPGFGDSIEAQCGTS	Peptide 220	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	6.4211	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1489	19159331	2009	PGFGDSIEAQCGTSVN	Peptide 221	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	5.0348	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1490	19159331	2009	FGDSIEAQCGTSVNVH	Peptide 222	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	1.3951	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1491	19159331	2009	DSIEAQCGTSVNVHSS	Peptide 223	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.4688	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1492	19159331	2009	IEAQCGTSVNVHSSLR	Peptide 224	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.193	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1493	19159331	2009	AQCGTSVNVHSSLRDI	Peptide 225	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0267	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1494	19159331	2009	CGTSVNVHSSLRDILN	Peptide 226	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0499	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1495	19159331	2009	TSVNVHSSLRDILNQI	Peptide 227	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1029	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1496	19159331	2009	VNVHSSLRDILNQITK	Peptide 228	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0614	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1497	19159331	2009	VHSSLRDILNQITKPN	Peptide 229	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1104	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1498	19159331	2009	SSLRDILNQITKPNDV	Peptide 230	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1963	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1499	19159331	2009	LRDILNQITKPNDVYS	Peptide 231	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0514	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1500	19159331	2009	DILNQITKPNDVYSFS	Peptide 232	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0223	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1501	19159331	2009	LNQITKPNDVYSFSLA	Peptide 233	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0054	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1502	19159331	2009	QITKPNDVYSFSLASR	Peptide 234	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0025	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1503	19159331	2009	TKPNDVYSFSLASRLY	Peptide 235	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0011	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1504	19159331	2009	PNDVYSFSLASRLYAE	Peptide 236	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0014	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1505	19159331	2009	DVYSFSLASRLYAEER	Peptide 237	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0011	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1506	19159331	2009	YSFSLASRLYAEERYP	Peptide 238	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0032	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1507	19159331	2009	FSLASRLYAEERYPIL	Peptide 239	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0031	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1508	19159331	2009	LASRLYAEERYPILPE	Peptide 240	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0023	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1509	19159331	2009	SRLYAEERYPILPEYL	Peptide 241	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0028	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1510	19159331	2009	LYAEERYPILPEYLQC	Peptide 242	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0281	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1511	19159331	2009	AEERYPILPEYLQCVK	Peptide 243	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.2682	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1512	19159331	2009	ERYPILPEYLQCVKEL	Peptide 244	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1018	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1513	19159331	2009	YPILPEYLQCVKELYR	Peptide 245	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0298	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1514	19159331	2009	ILPEYLQCVKELYRGG	Peptide 246	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0143	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1515	19159331	2009	PEYLQCVKELYRGGLE	Peptide 247	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0152	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1516	19159331	2009	YLQCVKELYRGGLEPI	Peptide 248	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0093	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1517	19159331	2009	QCVKELYRGGLEPINF	Peptide 249	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0085	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1518	19159331	2009	VKELYRGGLEPINFQT	Peptide 250	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0052	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1519	19159331	2009	ELYRGGLEPINFQTAA	Peptide 251	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0085	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1520	19159331	2009	YRGGLEPINFQTAADQ	Peptide 252	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.011	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1521	19159331	2009	GGLEPINFQTAADQAR	Peptide 253	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0207	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1522	19159331	2009	LEPINFQTAADQAREL	Peptide 254	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0155	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1523	19159331	2009	PINFQTAADQARELIN	Peptide 255	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0183	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1524	19159331	2009	NFQTAADQARELINSW	Peptide 256	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0247	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1525	19159331	2009	QTAADQARELINSWVE	Peptide 257	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0297	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1526	19159331	2009	AADQARELINSWVESQ	Peptide 258	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0322	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1527	19159331	2009	DQARELINSWVESQTN	Peptide 259	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0223	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1528	19159331	2009	ARELINSWVESQTNGI	Peptide 260	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0078	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1529	19159331	2009	ELINSWVESQTNGIIR	Peptide 261	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1455	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1530	19159331	2009	INSWVESQTNGIIRNV	Peptide 262	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0095	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1531	19159331	2009	SWVESQTNGIIRNVLQ	Peptide 263	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0099	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1532	19159331	2009	VESQTNGIIRNVLQPS	Peptide 264	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0085	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1533	19159331	2009	SQTNGIIRNVLQPSSV	Peptide 265	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0032	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1534	19159331	2009	TNGIIRNVLQPSSVDS	Peptide 266	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0033	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1535	19159331	2009	GIIRNVLQPSSVDSQT	Peptide 267	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.005	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1536	19159331	2009	IRNVLQPSSVDSQTAM	Peptide 268	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0069	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1537	19159331	2009	NVLQPSSVDSQTAMVL	Peptide 269	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1618	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1538	19159331	2009	LQPSSVDSQTAMVLVN	Peptide 270	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0332	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1539	19159331	2009	PSSVDSQTAMVLVNAI	Peptide 271	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0371	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1540	19159331	2009	SVDSQTAMVLVNAIVF	Peptide 272	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0236	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1541	19159331	2009	DSQTAMVLVNAIVFKG	Peptide 273	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.008	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1542	19159331	2009	QTAMVLVNAIVFKGLW	Peptide 274	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0051	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1543	19159331	2009	AMVLVNAIVFKGLWEK	Peptide 275	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0061	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1544	19159331	2009	VLVNAIVFKGLWEKAF	Peptide 276	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.003	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1545	19159331	2009	VNAIVFKGLWEKAFKD	Peptide 277	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0028	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1546	19159331	2009	AIVFKGLWEKAFKDED	Peptide 278	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0037	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1547	19159331	2009	VFKGLWEKAFKDEDTQ	Peptide 279	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0057	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1548	19159331	2009	KGLWEKAFKDEDTQAM	Peptide 280	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0084	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1549	19159331	2009	LWEKAFKDEDTQAMPF	Peptide 281	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0101	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1550	19159331	2009	EKAFKDEDTQAMPFRV	Peptide 282	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0037	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1551	19159331	2009	AFKDEDTQAMPFRVTE	Peptide 283	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0047	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1552	19159331	2009	KDEDTQAMPFRVTEQE	Peptide 284	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0049	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1553	19159331	2009	EDTQAMPFRVTEQESK	Peptide 285	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0041	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1554	19159331	2009	TQAMPFRVTEQESKPV	Peptide 286	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0076	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1555	19159331	2009	AMPFRVTEQESKPVQM	Peptide 287	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.005	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1556	19159331	2009	PFRVTEQESKPVQMMY	Peptide 288	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1097	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1557	19159331	2009	RVTEQESKPVQMMYQI	Peptide 289	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1086	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1558	19159331	2009	TEQESKPVQMMYQIGL	Peptide 290	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0696	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1559	19159331	2009	QESKPVQMMYQIGLFR	Peptide 291	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0055	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1560	19159331	2009	SKPVQMMYQIGLFRVA	Peptide 292	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.002	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1561	19159331	2009	PVQMMYQIGLFRVASM	Peptide 293	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0022	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1562	19159331	2009	QMMYQIGLFRVASMAS	Peptide 294	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0021	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1563	19159331	2009	MYQIGLFRVASMASEK	Peptide 295	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0025	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1564	19159331	2009	QIGLFRVASMASEKMK	Peptide 296	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0021	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1565	19159331	2009	GLFRVASMASEKMKIL	Peptide 297	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0047	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1566	19159331	2009	FRVASMASEKMKILEL	Peptide 298	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0026	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1567	19159331	2009	VASMASEKMKILELPF	Peptide 299	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0075	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1568	19159331	2009	SMASEKMKILELPFAS	Peptide 300	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0073	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1569	19159331	2009	ASEKMKILELPFASGT	Peptide 301	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0034	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1570	19159331	2009	EKMKILELPFASGTMS	Peptide 302	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0134	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1571	19159331	2009	MKILELPFASGTMSML	Peptide 303	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.022	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1572	19159331	2009	ILELPFASGTMSMLVL	Peptide 304	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0507	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1573	19159331	2009	ELPFASGTMSMLVLLP	Peptide 305	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.041	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1574	19159331	2009	PFASGTMSMLVLLPDE	Peptide 306	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0444	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1575	19159331	2009	ASGTMSMLVLLPDEVS	Peptide 307	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0325	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1576	19159331	2009	GTMSMLVLLPDEVSGL	Peptide 308	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0306	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1577	19159331	2009	MSMLVLLPDEVSGLEQ	Peptide 309	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0139	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1578	19159331	2009	MLVLLPDEVSGLEQLE	Peptide 310	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1049	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1579	19159331	2009	VLLPDEVSGLEQLESI	Peptide 311	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.2344	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1580	19159331	2009	LPDEVSGLEQLESIIN	Peptide 312	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1597	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1581	19159331	2009	DEVSGLEQLESIINFE	Peptide 313	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0265	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1582	19159331	2009	VSGLEQLESIINFEKL	Peptide 314	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0393	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1583	19159331	2009	GLEQLESIINFEKLTE	Peptide 315	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0228	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1584	19159331	2009	EQLESIINFEKLTEWT	Peptide 316	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0345	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1585	19159331	2009	LESIINFEKLTEWTSS	Peptide 317	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0424	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1586	19159331	2009	SIINFEKLTEWTSSNV	Peptide 318	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0653	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1587	19159331	2009	INFEKLTEWTSSNVME	Peptide 319	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0497	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1588	19159331	2009	FEKLTEWTSSNVMEER	Peptide 320	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0286	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1589	19159331	2009	KLTEWTSSNVMEERKI	Peptide 321	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0414	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1590	19159331	2009	TEWTSSNVMEERKIKV	Peptide 322	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0139	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1591	19159331	2009	WTSSNVMEERKIKVYL	Peptide 323	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.006	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1592	19159331	2009	SSNVMEERKIKVYLPR	Peptide 324	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0021	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1593	19159331	2009	NVMEERKIKVYLPRMK	Peptide 325	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0021	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1594	19159331	2009	MEERKIKVYLPRMKME	Peptide 326	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0014	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1595	19159331	2009	ERKIKVYLPRMKMEEK	Peptide 327	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0012	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1596	19159331	2009	KIKVYLPRMKMEEKYN	Peptide 328	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0016	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1597	19159331	2009	KVYLPRMKMEEKYNLT	Peptide 329	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.003	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1598	19159331	2009	YLPRMKMEEKYNLTSV	Peptide 330	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0054	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1599	19159331	2009	PRMKMEEKYNLTSVLM	Peptide 331	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0051	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1600	19159331	2009	MKMEEKYNLTSVLMAM	Peptide 332	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0321	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1601	19159331	2009	MEEKYNLTSVLMAMGI	Peptide 333	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0225	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1602	19159331	2009	EKYNLTSVLMAMGITD	Peptide 334	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0211	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1603	19159331	2009	YNLTSVLMAMGITDVF	Peptide 335	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0298	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1604	19159331	2009	LTSVLMAMGITDVFSS	Peptide 336	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.017	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1605	19159331	2009	SVLMAMGITDVFSSSA	Peptide 337	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0276	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1606	19159331	2009	LMAMGITDVFSSSANL	Peptide 338	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0241	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1607	19159331	2009	AMGITDVFSSSANLSG	Peptide 339	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0262	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1608	19159331	2009	GITDVFSSSANLSGIS	Peptide 340	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.024	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1609	19159331	2009	TDVFSSSANLSGISSA	Peptide 341	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0361	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1610	19159331	2009	VFSSSANLSGISSAES	Peptide 342	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.2471	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1611	19159331	2009	SSSANLSGISSAESLK	Peptide 343	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.3682	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1612	19159331	2009	SANLSGISSAESLKIS	Peptide 344	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0601	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1613	19159331	2009	NLSGISSAESLKISQA	Peptide 345	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0601	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1614	19159331	2009	SGISSAESLKISQAVH	Peptide 346	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0526	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1615	19159331	2009	ISSAESLKISQAVHAA	Peptide 347	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0502	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1616	19159331	2009	SAESLKISQAVHAAHA	Peptide 348	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0475	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1617	19159331	2009	ESLKISQAVHAAHAEI	Peptide 349	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0463	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1618	19159331	2009	LKISQAVHAAHAEINE	Peptide 350	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0154	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1619	19159331	2009	ISQAVHAAHAEINEAG	Peptide 351	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1789	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1620	19159331	2009	QAVHAAHAEINEAGRE	Peptide 352	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0901	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1621	19159331	2009	VHAAHAEINEAGREVV	Peptide 353	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0783	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1622	19159331	2009	AAHAEINEAGREVVGS	Peptide 354	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1269	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1623	19159331	2009	HAEINEAGREVVGSAE	Peptide 355	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1531	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1624	19159331	2009	EINEAGREVVGSAEAG	Peptide 356	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.195	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1625	19159331	2009	NEAGREVVGSAEAGVD	Peptide 357	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1676	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1626	19159331	2009	AGREVVGSAEAGVDAA	Peptide 358	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.1212	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1627	19159331	2009	REVVGSAEAGVDAASV	Peptide 359	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0694	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1628	19159331	2009	VVGSAEAGVDAASVSE	Peptide 360	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0475	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1629	19159331	2009	GSAEAGVDAASVSEEF	Peptide 361	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0261	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1630	19159331	2009	AEAGVDAASVSEEFRA	Peptide 362	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0214	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1631	19159331	2009	AGVDAASVSEEFRADH	Peptide 363	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0322	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1632	19159331	2009	VDAASVSEEFRADHPF	Peptide 364	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0389	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1633	19159331	2009	AASVSEEFRADHPFLF	Peptide 365	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0233	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1634	19159331	2009	SVSEEFRADHPFLFCI	Peptide 366	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0029	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1635	19159331	2009	SEEFRADHPFLFCIKH	Peptide 367	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0038	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1636	19159331	2009	EFRADHPFLFCIKHIA	Peptide 368	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0031	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1637	19159331	2009	RADHPFLFCIKHIATN	Peptide 369	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0038	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1638	19159331	2009	DHPFLFCIKHIATNAV	Peptide 370	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0046	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1639	19159331	2009	PFLFCIKHIATNAVLF	Peptide 371	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0055	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1640	19159331	2009	LFCIKHIATNAVLFFG	Peptide 372	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0038	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1641	19159331	2009	CIKHIATNAVLFFGRC	Peptide 373	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0025	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1642	19159331	2009	KHIATNAVLFFGRCVS	Peptide 374	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0008	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1643	19159331	2009	HIATNAVLFFGRCVSP	Peptide 375	16	2,4-dichlorophenoxyacetic acid with (CH2)n-spacers	Biotinylation with PEG spacer	Linear	L	None	Synthetic	Not mentioned	120 minutes	67 pico molar	0.0009	Murine crude intestinal proteases	Proteolysis assay	Murine crude intestinal protease preparetion	in vitro	None	None	Not reported
1645	17904340	2008	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR	GLP-1	30	Free	Amidation	Linear	L	None	GLP-1	Regulates blood glucose levels	Not reported	200 µg/ml	0.51 ±0.02	Proteases in rat intestinal fluid	RP-HPLC	Rat intestinal fluid	in vitro	None	None	Oral hypoglycemic efficacy in db/db mice was 2.7 ±12.1%
1646	17904340	2008	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR	GLP-1	30	Free	Amidation	Linear	L	None	GLP-1	Regulates blood glucose levels	Not reported	200 µg/ml	0.79 ±0.01	Proteases in rat intestinal homogenate	RP-HPLC	Rat intestinal homogenate	in vitro	None	None	Oral hypoglycemic efficacy in db/db mice was 2.7 ±12.1%
1651	17904340	2008	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR	GLP-1	30	Free	Amidation	Linear	L	None	GLP-1	Regulates blood glucose levels	Not reported	200 µg/ml	0.51 ±0.02	Proteases in rat intestinal fluid	RP-HPLC	Rat intestinal fluid	in vitro	None	None	EC50=3.64 ±0.25nM insulinotropic activity
1652	17904340	2008	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR	GLP-1	30	Free	Amidation	Linear	L	None	GLP-1	Regulates blood glucose levels	Not reported	200 µg/ml	0.79 ±0.01	Proteases in rat intestinal homogenate	RP-HPLC	Rat intestinal homogenate	in vitro	None	None	EC50=3.64 ±0.25nM insulinotropic activity
1670	9740616	1998	DRVYIHP	Ang-(1-7)	7	Free	Free	Linear	L	None	Angiotensinogen	Antihypertensive	30 min	Not mentioned	10 ±1	Angiotensin-converting enzyme	Radioimmunoassay and HPLC	Blood sample of normotensive Sprague-Dawley rat	in vivo	None	None	Not mentioned
1671	9740616	1998	DRVYIHP	Ang-(1-7)	7	Free	Free	Linear	L	None	Angiotensinogen	Antihypertensive	30 min	10 µg	10 ±1	Angiotensin-converting enzyme	Radioimmunoassay and HPLC	Blood sample of anesthetized spontaneously hypertensive rat	in vivo	None	None	Not mentioned
1672	9740616	1998	DRVYIHP	Ang-(1-7)	7	Free	Free	Linear	L	None	Angiotensinogen	Antihypertensive	30 min	10 µg	9 ±1	Angiotensin-converting enzyme	Radioimmunoassay and HPLC	Blood sample of mRen-2 transgenic rat	in vivo	None	None	Not mentioned
1673	9740616	1998	DRVYIHP	Ang-(1-7)	7	Free	Free	Linear	L	None	Angiotensinogen	Antihypertensive	30 min	10 µg	~11 ±1	Angiotensin-converting enzyme and losartan(AT1 antagonist)	Radioimmunoassay and HPLC	Blood sample of normotensive Sprague-Dawley rat	in vivo	None	None	Not mentioned
1674	9740616	1998	DRVYIHP	Ang-(1-7)	7	Free	Free	Linear	L	None	Angiotensinogen	Antihypertensive	30 min	10 µg	~11 ±1	Angiotensin-converting enzyme and losartan(AT1 antagonist)	Radioimmunoassay and HPLC	Blood sample of anesthetized spontaneously hypertensive rat	in vivo	None	None	Not mentioned
1675	9740616	1998	DRVYIHP	Ang-(1-7)	7	Free	Free	Linear	L	None	Angiotensinogen	Antihypertensive	30 min	10 µg	~14 ±1	Angiotensin-converting enzyme and losartan(AT1 antagonist)	Radioimmunoassay and HPLC	Blood sample of mRen-2 transgenic rat	in vivo	None	None	Not mentioned
1677	9740616	1998	DRVYIHP	Ang-(1-7)	7	Free	Free	Linear	L	None	Angiotensinogen	Antihypertensive	30 min	10 µg	~44 ±1	Angiotensin-converting enzyme and lisinopril(inhibitor)	Radioimmunoassay and HPLC	Blood sample of anesthetized spontaneously hypertensive rat	in vivo	None	None	Not mentioned
1678	9740616	1998	DRVYIHP	Ang-(1-7)	7	Free	Free	Linear	L	None	Angiotensinogen	Antihypertensive	30 min	10 µg	~29 ±1	Angiotensin-converting enzyme and lisinopril(inhibitor)	Radioimmunoassay and HPLC	Blood sample of mRen-2 transgenic rat	in vivo	None	None	Not mentioned
1679	9740616	1998	DRVYIHP	Ang-(1-7)	7	Free	Free	Linear	L	None	Angiotensinogen	Antihypertensive	30 min	10 µg	~45 ±1	Angiotensin-converting enzyme,losartan(AT1 antagonist)and lisinopril(inhibitor)	Radioimmunoassay and HPLC	Blood sample of normotensive Sprague-Dawley rat	in vivo	None	None	Not mentioned
1680	9740616	1998	DRVYIHP	Ang-(1-7)	7	Free	Free	Linear	L	None	Angiotensinogen	Antihypertensive	30 min	10 µg	~49 ±1	Angiotensin-converting enzyme,losartan(AT1 antagonist)and lisinopril(inhibitor)	Radioimmunoassay and HPLC	Blood sample of anesthetized spontaneously hypertensive rat	in vivo	None	None	Not mentioned
1681	9740616	1998	DRVYIHP	Ang-(1-7)	7	Free	Free	Linear	L	None	Angiotensinogen	Antihypertensive	30 min	10 µg	~40 ±1	Angiotensin-converting enzyme,losartan(AT1 antagonist)and lisinopril(inhibitor)	Radioimmunoassay and HPLC	Blood sample of mRen-2 transgenic rat	in vivo	None	None	Not mentioned
1708	10871321	2000	RPPGFSPFR	Bradykinin	9	Free	Free	Linear	L	None	Human blood plasma	Cardioprotective effects	Not reported	106 cpm/200Î¼l/mouse	Not measured as peptide degraded rapidly<30 approx.	Aminopeptidase P,Dipeptidyl-peptidaseIV,KininaseII,KininaseI and neutral endopeptidase	HPLC-ESI-MS	Human blood sample	in vivo	None	None	Not mentioned
1723	1697165	1990	SLRRSSCFGGRIDRIGAQSGLGCNSFRY	Atrial natriuretic peptide (ANP)	28	Free	Free	Cyclic (C7-C23)	L	None	Atrial natriuretic peptide	Natriuretic, diuretic and vasorelaxant	Not reported	0.17-0.25 MBq	0.42 ±0.03	Rat blood proteases	Radioimmunoassay and RP-HPLC	Rat blood plasma (infused into fumoral vein and right carotid artery)	in vivo	None	None	Not given
1738	1939259	1991	FYSL	Î±-BCP(6-9)	4	Free	Free	Linear	L	None	Bag cells in the abdominal ganglion of the marine snail Aplysia	Neurotransmitter	Not reported	10-5 M conc. of peptide	0.65	Aplysia haemolymph proteases	HPLC	Heamolymph of Aplysia	in vitro	None	None	Not given
1742	1939259	1991	FYS	Î±-BCP(6-8)	3	Free	Free	Linear	L	None	Bag cells in the abdominal ganglion of the marine snail Aplysia	Neurotransmitter	Not reported	10-5 M conc. of peptide	0.48	Aplysia haemolymph proteases	HPLC	Heamolymph of Aplysia	in vitro	None	None	Not given
1879	18307313	2007	R-X-R	CAP 4	2	Free	NHBn	Linear	L	X= structure given in paper	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 47 µM for S.aureus
1880	18307313	2007	R-X-R	CAP 4	2	Free	NHBn	Linear	L	X= structure given in paper	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 6 µM for Methicillin- resistant S.aureus
1881	18307313	2007	R-X-R	CAP 4	2	Free	NHBn	Linear	L	X= structure given in paper	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 11 µM for Methicillin- resistant S.epidermis
1906	18307313	2007	R-Bip-R	CAP 13	2	Free	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 12 µM for S.aureus
1907	18307313	2007	R-Bip-R	CAP 13	2	Free	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 12 µM for Methicillin- resistant S.aureus
1908	18307313	2007	R-Bip-R	CAP 13	2	Free	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 8 µM for Methicillin- resistant S.epidermis
1909	18307313	2007	R-Bip-R	CAP 14	2	Free	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 10 µM for S.aureus
1910	18307313	2007	R-Bip-R	CAP 14	2	Free	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 9 µM for Methicillin- resistant S.aureus
1911	18307313	2007	R-Bip-R	CAP 14	2	Free	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 6 µM for Methicillin- resistant S.epidermis
1912	18307313	2007	R-Bip-R	CAP 15	2	Free	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 8 µM for S.aureus
1913	18307313	2007	R-Bip-R	CAP 15	2	Free	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 5 µM for Methicillin- resistant S.aureus
1914	18307313	2007	R-Bip-R	CAP 15	2	Free	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 4 µM for Methicillin- resistant S.epidermis
1921	18307313	2007	R-X-R	CAP 17	2	Free	CH2CH2Ph	Linear	L	X= structure given in paper	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 5 µM for S.aureus
1922	18307313	2007	R-X-R	CAP 17	2	Free	CH2CH2Ph	Linear	L	X= structure given in paper	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 4 µM for Methicillin- resistant S.aureus
1923	18307313	2007	R-X-R	CAP 17	2	Free	CH2CH2Ph	Linear	L	X= structure given in paper	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 4 µM for Methicillin- resistant S.epidermis
1924	18307313	2007	R-Bip-R	CAP 17	2	Acetylation	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 5 µM for S.aureus
1925	18307313	2007	R-Bip-R	CAP 17	2	Acetylation	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 4 µM for Methicillin- resistant S.aureus
1926	18307313	2007	R-Bip-R	CAP 17	2	Acetylation	Y= structure given in paper	Linear	L	Bip	Synthetic peptide	Antimicrobial	Not reported	1 mg/mL	Stable	Trypsin	RP-HPLC	Trypsin	in vitro	None	None	MIC= 4 µM for Methicillin- resistant S.epidermis
1991	19602537	2009	HSEGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIA	GLPAG	37	Free	Cholesterol moiety	Linear	L	None	Proglucagon molecule	Antidiabetic	Not reported	3mg/kg	Stable	Mouse blood proteases	RP-HPLC and ESI-MS	Mouse plasma (Subcutaneous injection)	in vivo	None	None	EC 50, cAMP=180nM for mGCGR
2274	4070016	1985	GGFMTSEKSQTPLVTL	DTÎ³E( Des-Tyr1-Î³-Endorphin) (Î²-endorphin-(2-17))	16	Free	Free	Linear	L	None	CNS and piyuitary gland of Humans	Neuropeptide, non-opioid y-type endorphins	Not given	3.1-7.1 µg	0.7 (distribution phase)	Rat blood proteases	RP-HPLC	Male wistar Rats (intravenously)	in vivo	None	None	Not reported
2276	4070016	1985	TSEKSQTPLVTL	DEÎ³E (Des-Enkephalin-Î³-Endorphin) (Î²-endorphin-(6--17))	12	Free	Free	Linear	L	None	CNS and piyuitary gland of Humans	Neuropeptide, non-opioid y-type endorphins	Not given	1.0-1.15 µg	0.6 (distribution phase)	Rat blood proteases	RP-HPLC	Male wistar Rats (intravenously)	in vivo	None	None	Not reported
2310	6658706	1983	ADSGEGDFLAEGGGVR	125I-labeled desamino-tyrosyl (DAT-FPA) FPA	16	Free	Free	Linear	L	DAT-FPA was labeled with 125-iodine or with 123-iodine by chloramine-T	Desaminotyrosine Fibrinopeptide derivative	Blood clotting	5 sec and at 10 sec intervals upto 2 mins, then after 6,10,20,30,40,60,90,120,150,210 and 240 min	Labeled 125-I-FPA (0.1 mCi) in 1 ml of 1 µg of FPA	30 (radioactivity)	Normal rabbit blood proteases	Gel filtration chromatography of blood plasma at different time interval show that rapid clearence of peptide from blood plasma.	Intravenous injection in lateral vein of normal rabbit	in vivo	http://search.anaspec.com/?keywords=fibrinopeptide	None	Not reported
2314	6658706	1983	ADSGEGDFLAEGGGVR	Human Fibrinopeptide A (FPA)	16	Free	Free	Linear	L	None	N terminal end of the A-alpha chain of fibrinogen	Blood clotting	9 sec and at 10 sec intervals upto 2 mins, then after 6,10,20,30,40,60,90,120,150,210 and 240 min	Labeled 125-I-FPA (0.1 mCi) in 1 ml of 1 µg of FPA	30	Normal rabbit blood proteases	Gel filtration chromatography of blood plasma at different time interval show that rapid clearence of peptide from blood plasma.	Intravenous injection in lateral vein of normal rabbit	in vivo	None	None	Not reported
2318	6658706	1983	ADSGEGDFLAEGGGVR	125I-labeled desamino-tyrosyl (DAT-FPA) FPA	16	Free	Free	Linear	L	DAT-FPA was labeled with 125-iodine or with 123-iodine by chloramine-T	Desaminotyrosine Fibrinopeptide derivative	Blood clotting	2 sec and at 10 sec intervals upto 2 mins, then after 6,10,20,30,40,60,90,120 min	Labeled 125-I-FPA (0.1 mCi) in 1 ml of 1 µg of FPA	30 (radioactivity)	Nephrectomized rabbits blood proteases	Gel filtration chromatography of blood plasma at different time interval show that rapid clearence of peptide from blood plasma.	Intravenous injection in lateral vein of nephrectomized rabbits	in vivo	None	None	Not reported
2320	6658706	1983	ADSGEGDFLAEGGGVR	Human Fibrinopeptide A (FPA)	16	Free	Free	Linear	L	None	N terminal end of the A-alpha chain of fibrinogen	Blood clotting	4 sec and at 10 sec intervals upto 2 mins, then after 6,10,20,30,40,60,90,120 min	Labeled 125-I-FPA (0.1 mCi) in 1 ml of 1 µg of FPA	30	Nephrectomized rabbits blood proteases	Gel filtration chromatography of blood plasma at different time interval show that rapid clearence of peptide from blood plasma.	Intravenous injection in lateral vein of nephrectomized rabbits	in vivo	None	None	Not reported
2364	9421401	1998	SLRRSSCFGGRMDRIGAQSGLGCNSFRY	Atrial Natriuretic peptide	28	Free	Free	Linear	L	None	Human Heart muscle cells	Antihypertensive	0.5, 1, 1.5, 2, 3, 5, 8, 15, and 25 min	2 Î¼g	0.8 ±0.1 (t1/2 fast phase)	Rat plasma proteases	Radioimmunoassay	Exogenously administered to Male SHR-SP/Izm rats treated with carvedilol	in vivo	None	None	ANP role in antihypertension and blood pressure is determined by injecting ANP peptide(8mg/kg of body weight) in carvedilol and control group. The systolic blood pressure was decreased after 1 week of treatment in carvedilol treated group.
2365	9421401	1998	SLRRSSCFGGRMDRIGAQSGLGCNSFRY	Atrial Natriuretic peptide	28	Free	Free	Linear	L	None	Human Heart muscle cells	Antihypertensive	0.5, 1, 1.5, 2, 3, 5, 8, 15, and 25 min	2 Î¼g	0.9 ±0.1 (t1/2 fast phase)	Rat plasma proteases	Radioimmunoassay	Exogenously administered to Male SHR-SP/Izm rats	in vivo	None	None	ANP role in antihypertension and blood pressure is determined by injecting ANP peptide(8mg/kg of body weight) in carvedilol and control group. The systolic blood pressure was decreased after 1 week of treatment in carvedilol treated group.
2387	10708307	1999	HSDAVFTDNYTRLRKQMAVKKYLNSILN	Vasoactive intestinal peptide	28	Free	Free	Linear	L	I125 radiolabeling	Porcine intestine	Relaxation of the airway smooth muscle, attenuation of acute inflammation, regulation of mucus secretion	1.5, 2.5, 5, 10, 15, 20, 30, 40, and 60 min	0.33 nM	0.62 ±0.05 (t1/2 elimination)	Rat plasma proteases	Not mentioned	Intravenously administration to rat plasma	in vivo	PMID 5450698	None	Not tested
2402	2147684	1990	AQDFVQWLMNT	Glucagon(19-29)	11	Free	Free	Linear	L	None	Glucagon derivative	Growth Hormone	Not mentioned	200pmol/2.5ml	<10	Hepatic plasma membrane proteases	Radioimmunoassay and HPLC	Hepatic plasma membrane	in vitro	None	None	Inhibit calcium pump at 20% concentration
2403	2182027	1990	CSCSSLMDKECVYFCHLDIIW	Endothelin 1 (ET-l)	21	Free	Free	Linear	L	Labelled with I125	Synthetic peptide with the sequence of human and porcine Endothelin 1	Vasoconstrictiong peptide	15sec-6min	0.2pmol	40	Wistar rats blood protease	HPLC	Wistar rats	in vivo	None	None	Causes vasoconstriction
2494	9234336	1993	HSDAVFTDNYTRLRKQMAVKKYLNSILN	Vasoactive intestinal peptide (VIP)	28	Free	Free	Linear	L	None	Small intestinal mucosa	Vasoactive peptide	2,3,6,10,20,40,60 minutes	250 Î¼g	0.45 ±0.05	Rat blood proteases	Radioimmunoassay	Intravenous injection to Rat blood	in vivo	http://www.sigmaaldrich.com/catalog/product/sigma/	None	Regulate of blood flow and smooth muscle relaxation in specific mammalian organs
2506	12489813	2002	RPPGF	Bradykinin	5	Free	Free	Linear	L	None	Kininogen	Vasodilating peptide	Not mentioned	100 ng/ml	15	Rat blood proteases	Radioimmunoassay using new radioionated analogue RPPG(125I)F	Cultured rat aortic smooth muscle cells	in vitro	None	None	Not reported
2568	8218482	1993	YRGDS	RGD containing peptide	5	Free	Free	Linear	L	None	Extra Cellular Matrix proteins	Antitumor peptide	Not mentioned	0.2 mL	30 (t1/2 first phase)	Mice blood proteases	Radioimmunoassay	Intravenously injected to C57BL6 mice	in vivo	None	None	Less effective in in blocking peptide-mediated attachment of B16-FlO melanoma cells to a surface.
2794	21903490	2011	RKEVY	TP5(Thymopentin)	5	Free	Free	Linear	L	None	Thymopentin	Immunomodulatory drug	Not mentioned	Not mentioned	30	Human plasma proteases	Not mentioned	Human plasma	in vivo	None	None	Not reported
2798	24874704	2014	YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY	AM(adrenomedullin)	52	Free	Amidation	Cyclic (Ringed structure formed by C16-C21)	L	None	Isolated from Human pheochromocytoma	Vasodilator and cardiovascular protection	Not mentioned	3nmol/kg Dose	0.62 ±0.02 (1st plasma half life)	Rat plasma proteases	ELISA	Male Wistar rats plasma	in vivo	http://www.genscript.com/peptide/RP11288-Adrenomed	None	Native human AM peptide elevated intracellular cAMP levels in a dose-dependent manner with pEC50 and Emax values of 8.59 ± 0.90 and9.30 ± 0.26 nmol/well
2837	1646465	1991	SQDSAERIQERLRNSKMAHSSSCFGQKIDRIGAVSRLGCDGLRQF	iso-rANP(1-45) (Recombinant atrial natriuretic peptide)	45	Free	Free	Cyclic (C23-C39)	L	None	Derived from ANP (Atrial natriuretic peptide)	Natriuretic and vasodilator	Blood samples collected at 5-1800 seconds after peptide injecteion	1 x 106 cpm	23.7 + 1.7 (Î±- t1/2)	Rat plasma proteases	Radioimmunoassay	Male Wistar rats plasma (Dose i/p injected)	in vivo	None	None	Not reported
2839	1646465	1991	SLRRSSCFGGRMDRIGAQSGLGCNSFRY	125I-rANP(1-45) (Recombinant atrial natriuretic peptide)	28	Free	Free	Cyclic (C7-C23)	L	Iodinated at Tyr	Derived from ANP (Atrial natriuretic peptide)	Natriuretic and vasodilator	Blood samples collected at 5-1800 seconds after peptide injecteion	1 x 106 cpm	20.2 ±5.3 (Î±- t1/2)	Rat plasma proteases	Radioimmunoassay	Male Wistar rats plasma (Dose i/p injected)	in vivo	None	None	Not reported
2840	1649728	1991	HSDAVFTDNYTRLRKQMAVKKYLNSILN	VIP(Vasoactive intestinal peptide)	28	Free	Amidation	Linear	L	None	Peptide hormone secreted by Intestine	Stimulates the secretion of electrolytes and water	Sample collected at 40-50 minutes	10pmol min-1 kg -1 peptide infused	0.50 ±0.11	Rabbit plasma proteases	Radioimmunoassay	New Zealand White rabbits plasma(have low sodium diet i.e. 29.35 k 4.02 pmol/l)	in vivo	None	None	Not reported
2863	2162275	1990	HSDAVFTDNYTRLRKQMAVKKYLNSILN	VIP (Vasoactive intestinal peptide)	28	Acetylation	Amidation	Linear	L	None	Neuropeptide derived from Prepro-VIP	Vasodilator	Not mentioned	5 pmol min-1 kg-1	0.8	Human plasma proteases	Radioimmunoassay	Human plasma	in vivo	None	None	It increase heart rate
2874	2942845	1986	SLRRSSCFGGRMDRIGAQSGLGCNSFRY	ANF (Ser99-Tyr126) (Atrial natriuretic factor )	28	Free	Free	Cyclic (C7-C23)	L	Radioiodinated peptide at Tyr	Atrial natriuretic factor derivative	Natriuretic, diuretic and vasorelaxant peptide	Blood collected 5second-5 minutes after peptide injected	60mg/kg	16.8 ±0.9	Rat plasma proteases	RP-HPLC	Male Sprague-Dawley rats plasma (Dose i/p injected)	in vivo	None	None	IC50=59pM, Inhibition of aldosterone production
2875	2942845	1986	RRSSCFGGRMDRIGAQSGLGCNSFRY	ANF (Arg101-Tyr126) (Atrial natriuretic factor )	26	Free	Free	Cyclic (C5-C21)	L	Radioiodinated peptide at Tyr	Atrial natriuretic factor derivative	Natriuretic, diuretic and vasorelaxant peptide	Blood collected 5second-5 minutes after peptide injected	60mg/kg	17.1 ±1.5	Rat plasma proteases	RP-HPLC	Male Sprague-Dawley rats plasma (Dose i/p injected)	in vivo	None	None	IC50=204pM, Inhibition of aldosterone production
2876	2942845	1986	SSCFGGRMDRIGAQSGLGCNSFRY	ANF (Ser103-Tyr126) (Atrial natriuretic factor )	24	Free	Free	Cyclic (C3-C19)	L	Radioiodinated peptide at Tyr	Atrial natriuretic factor derivative	Natriuretic, diuretic and vasorelaxant peptide	Blood collected 5second-5 minutes after peptide injected	60mg/kg	22.0 ±4.5	Rat plasma proteases	RP-HPLC	Male Sprague-Dawley rats plasma (Dose i/p injected)	in vivo	None	None	IC50=276pM, Inhibition of aldosterone production
2877	2942845	1986	SLRRSSCFGGRMDRIGAQSGLGCNSFRY	ANF (Ser99-Tyr126) (Atrial natriuretic factor )	28	Free	Free	Cyclic (C7-C23)	L	Radioiodinated peptide at Tyr	Atrial natriuretic factor derivative	Natriuretic, diuretic and vasorelaxant peptide	Blood collected 5second-5 minutes after peptide injected	60mg/kg	25.2 ±6.1	Rat plasma proteases	RP-HPLC	Male Sprague-Dawley rats (nephrectomized rat) plasma (Dose i/p injected)	in vivo	None	None	Not reported
2878	2942845	1986	SLRRSSCFGGRMDRIGAQSGLGCNSFRY	ANF (Ser99-Tyr126) (Atrial natriuretic factor )	28	Free	Free	Cyclic (C7-C23)	L	Radioiodinated peptide at Tyr	Atrial natriuretic factor derivative	Natriuretic, diuretic and vasorelaxant peptide	Blood collected 5second-5 minutes after peptide injected	60mg/kg	16.3 ±1.2	Rat plasma proteases	RP-HPLC	Male Sprague-Dawley rats (hepatectomized rat) plasma (Dose i/p injected)	in vivo	None	None	Not reported
2879	2942845	1986	SLRRSSCFGGRMDRIGAQSGLGCNSFRY	ANF (Ser99-Tyr126) (Atrial natriuretic factor )	28	Free	Free	Cyclic (C7-C23)	L	Radioiodinated peptide at Tyr	Atrial natriuretic factor derivative	Natriuretic, diuretic and vasorelaxant peptide	Blood collected 5second-5 minutes after peptide injected	60mg/kg	19.4 ±3.5	Rat plasma proteases	RP-HPLC	Male Sprague-Dawley rats (both nephrectomized & hepatectomized rat) plasma (Dose i/p injected)	in vivo	None	None	Not reported
2923	1882091	1991	PGlu-HWSYGLRPG	GnRH (Gonadotropin releasing hormone)	10	Free	Amidation	Linear	L	pGlu= Pyro-glutamate	Hormone secreted by Hypothalamus	Stimulates the release of the gonadotropins from the pituitary.	Blood collected 30-300 minutes after peptide injection	24 µg/kg	0.69 (t1/2 alpha)	Rat plasma proteases	Radioimmunoassay	(Dose i/m injected)Rat plasma	in vivo	1631133	None	Not reported
2925	1882091	1991	PGlu-HWSYfLRPG	D-Phe-6-GnRH (Gonadotropin releasing hormone)	10	Free	Amidation	Linear	Mix	None	GnRH derivative	Stimulates the release of the gonadotropins from the pituitary.	Blood collected 30-300 minutes after peptide injection	24 µg/kg	0.83	Rat plasma proteases	Radioimmunoassay	(Dose i/v injected)Rat plasma	in vivo	1631133	None	Not reported
2945	2521208	1989	CYFQNCPRG	VP (Vasopressin)	9	Free	Amidation	Cyclic (C1-C6)	L	None	Anti-diuretic hormone secreted by pitutiary gland	Anti-diuretic and regulates retention of water	Not mentioned	Exogenously administered	0.9(fast component)	Proteases from Rabbit plasma	Radioimmunoassay	Rabbit plasma	in vivo	None	None	Not mentioned
2956	1664804	1991	SQDSAFRIQERLRNSKMAHSSSCFGQKIDRIGAVSRLGCDGLRLF	Rat BNP-45 ( Brain natriuretic peptide-45)	45	Free	Free	Cyclic (C23-C39)	L	None	Isolated from rat heart and shown to be a circulating form of rat BNP	Cardiac Natriuretic Peptide	Blood samples collected at 0.5-10 minutes post peptide injection	2 µg/150ul saline	45 (t1/2 alpha or initial phase t1/2)	Proteases from Mice (WKY)plasma	Radioimmunoassay	(Dose i/v injected)Mice (WKY) plasma	in vivo	None	None	Urinary sodi µM excretion (uEq/min per kg)= 0.43 ± 0.13, mean arterial pressure (mmHg) = 129 ± 1, Urinary cGMP excretion (pmol/min) = 27.0 ± 3.1
2958	1664804	1991	SLRRSSCFGGRIDRIGAQSGLGCNSFRY	Rat alpha-ANP (Atrial natriuretic peptide)	28	Free	Free	Cyclic (C7-C23)	L	None	Atrial natriuretic peptide	Natriuretic and vasodilator	Blood samples collected at 0.5-10 minutes post peptide injection	2 µg/150ul saline	55 (t1/2 alpha or initial phase t1/2)	Proteases from Mice (WKY)plasma	Radioimmunoassay	(Dose i/v injected)Mice (WKY) plasma	in vivo	None	None	Urinary sodi µM excretion (uEq/min per kg)= 0.45 ± 0.10, mean arterial pressure (mmHg) = 129 ± 2, Urinary cGMP excretion (pmol/min) = 28.0 ±2.6
2991	8218482	1993	YRGDS	Pentapeptide	5	Free	Free	Linear	L	None	Synthetic RGD containing peptide	Cell attachment property	Not mentioned	Not mentioned	30 (Half life of 1st phase)	Proteases from mouse bood	HPLC	Mouse blood	in vivo	None	None	Not reported
3010	9234336	1994	HSDAVFTDNYTRLRKQMAVKKYLNSILN	131I-VIP (Vasoactive intestinal peptide)	28	Free	Amidation	Linear	L	Iodinated at Tyr	Neuropeptide	Anti-inflammatory neuropeptide	Blood sample collected after 2-60 minutes of peptide administeration	250 µg (6MBq in 0.2mL)	0.44 ±0.05 (elimination half life)	Proteases from rat blood	HPLC	(Dose i/v injected)Rat blood	in vivo	None	None	Not reported
3180	8035644	1994	RPPGFSPFR	Bradykinin	9	Free	Free	Linear	L	None	Not mentioned	A potent endothelium-dependent vasodilator which leads to drop in blood pressure	Not reported	Intraarterial doses of 0.01-0.3 nmol	20 to 45	Cat blood proteases	HPLC	Hind limb vascular bed of the cat	in vivo	http://www.drugbank.ca/drugs/DB00199	None	Not reported
4039	38554247	2024	CKGKGAKCSRLMYDCCTGSCRSGKC	K2-MVIIA	25	Free	Amidation	Cyclic (C1-C16,C8-C20, C15-C25)	L	Alkyl chain conjugated with Lys2 side chain	Derived from the venom of cone snails (genus Conus)	Treatment of Refractory Chronic Pain	At 0, 1, 2, 4, 8, and 24 h, aliquots of peptides MVIIA at 37 celsisus	100 µM	Remained intact for 78.68% after 24 Hours	Human serum protease	HPLC	Human serum	In Vitro	None	None	N.A.
4040	38554247	2024	CKGKGAKCSRLMYDCCTGSCRSGKC	K2-K4-MVIIA	25	Free	Amidation	Cyclic (C1-C16,C8-C20, C15-C25)	L	Alkyl chain conjugated with Lys2, Lys4 side chain	Derived from the venom of cone snails (genus Conus)	Treatment of Refractory Chronic Pain	At 0, 1, 2, 4, 8, and 24 h, aliquots of peptides MVIIA at 37 celsisus	100 µM	Remained intact for 75.61% after 24 Hours	Human serum protease	HPLC	Human serum	In Vitro	None	None	N.A.
4047	38486997	2024	HsQGTFTSDKSKYLE-Aib-KAAQDFVEWLKAGGPSSGAPPPS	1907-B	40	Free	Replacing the amide bond with a C-terminal acid	Cyclic (Lactam Bridge K17 & D21)	Mix	At position 10 of the peptide sequence, modifications involving octadecanedioic acid (C18) and a glycine/serine-based linker "GGSGSG" were introduced, Aib modification,D-serine	GLP-1 analogs	Antidiabetes	N.A.	25.0 μg/kg	N.A.	Cynomolgus monkeys plasma protease	HPLC-MS/MS	Cynomolgus monkeys plasma	In Vivo	None	None	GLP-1R EC50 (nmol/L) = 0.088 (for 1907-B)
4109	N.A.	2024	AMVSEFLKQAWFIENEEQEYVQTLKSSKGGPGSAVSPYPTFNPSSDV	Peptide 1	47	Free	Amidation	Linear	L	V24L modifications	Annexin A1 Derivative	Antiinflammatory	Blood Samples Were Collected At The Following Time Points: Pre-Dose, Then, 10 Min,20 Min,30Min,0.75,1,1.5,2,2.5,3,4,6,8,12,16 And 24 H After Infusion Start	25 μg/kg	0.79 (Elimination Half Life)	Human plasma protease	LC-MS/MS	Human plasma	In Vivo	None	EP 2023067975 W	N.A.
4110	N.A.	2024	AMVSEFLKQAWFIENEEQEYVQTLKSSKGGPGSAVSPYPTFNPSSDV	Peptide 1	47	Free	Amidation	Linear	L	V24L modifications	Annexin A1 Derivative	Antiinflammatory	Blood Samples Were Collected At The Following Time Points: Pre-Dose, Then, 10 Min,20 Min,30Min,0.75,1,1.5,2,2.5,3,4,6,8,12,16 And 24 H After Infusion Start	50 μg/kg	0.92 (Elimination Half Life)	Human plasma protease	LC-MS/MS	Human plasma	In Vivo	None	EP 2023067975 W	N.A.
4120	38697423	2024	N.A.	DAE Rum55	N.A.	N.A.	N.A.	N.A.	D	N.A.	Ruminococcus sp. CAG55	Epimerase	50 °C	N.A.	4.5 (Activity Half Life)	N.A.	N.A.	N.A.	In Vitro	None	None	D-allulose/D-psicose 3-epimerase (DAE/DPE, EC 5.1.3.30) and D-tagatose 3-epimerase (DTE, EC 5.1.3.31), of which DAE usually exhibits higher catalytic activity
4121	38697423	2024	N.A.	E268R-EKL16	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	Ruminococcus sp. CAG55 derivative	Epimerase	50 °C	N.A.	135.3 (Activity Half Life)	N.A.	N.A.	N.A.	In Vitro	None	None	D-allulose/D-psicose 3-epimerase (DAE/DPE, EC 5.1.3.30) and D-tagatose 3-epimerase (DTE, EC 5.1.3.31), of which DAE usually exhibits higher catalytic activity
4122	38753095	2024	N.A.	Xyn10-HB	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	GH10 xylanase from Halalkalibacterium halodurans C-125	GH10 xylanase	pH 8.5 and 60 °C	N.A.	3 (Activity Half Life)	N.A.	N.A.	N.A.	In Vitro	None	None	Xyn10-HB produced active XOS with antioxidant activity determined by the DPPH radical scavenging method (IC50 of 0.54 mg/mL after 4 h)
4123	38115231	2024	N.A.	Trx1P	N.A.	N.A.	N.A.	Linear	L	N.A.	Derived from E. coli thioredoxin (Trx).	N.A.	N.A.	N.A.	124 ± 15 (T1/2 Cis-Trans Isomerizations)	N.A.	N.A.	N.A.	N.A.	None	None	N.A.
4124	38115231	2024	N.A.	Trx1Thp	N.A.	N.A.	N.A.	Linear	L	Incorporation of 4-thiaproline (Thp) at position cisPro76	Derived from E. coli thioredoxin (Trx).	N.A.	N.A.	N.A.	33 ± 3 (T1/2 Cis-Trans Isomerizations)	N.A.	N.A.	N.A.	N.A.	None	None	N.A.
4125	37827496	2024	N.A.	TTRA81V heterozygous	508	N.A.	N.A.	Linear	L	Alanine (Ala) is substituted with valine (Val) at position 81	Derived from missense mutation in the TTR gene	Causes mild transthyretin amyloid cardiomyopathy	N.A.	3.6 μM	21	Urea between 0.5 and 9 M in phosphate buffer (1 mM of EDTA, 10 mM of sodium phosphate, and 100 mM of potassium chloride, pH = 7.4	UPLC	Human serum	In Vitro	None	None	N.A.
4126	37827496	2024	N.A.	TTRA81V homozygous	508	N.A.	N.A.	Linear	L	Alanine (Ala) is substituted with valine (Val) at position 81	Derived from missense mutation in the TTR gene	Causes mild transthyretin amyloid cardiomyopathy	N.A.	3.6 μM	17.5	Urea between 0.5 and 9 M in phosphate buffer (1 mM of EDTA, 10 mM of sodium phosphate, and 100 mM of potassium chloride, pH = 7.4	UPLC	Human serum	In Vitro	None	None	N.A.
4127	37827496	2024	N.A.	TTRWT (wild-type transthyretin)	508	N.A.	N.A.	Linear	L	None	Liver‐secreted plasma protein	Causes mild transthyretin amyloid cardiomyopathy	N.A.	3.6 μM	44	Urea between 0.5 and 9 M in phosphate buffer (1 mM of EDTA, 10 mM of sodium phosphate, and 100 mM of potassium chloride, pH = 7.4	UPLC	Human serum	In Vitro	None	None	N.A.
4128	37827496	2024	N.A.	TTRL55P mutation	508	N.A.	N.A.	Linear	L	leucine (Leu) is substituted with proline (Pro) at position 55	Derived from missense mutation in the TTR gene (L55P)	Causes mild transthyretin amyloid cardiomyopathy	N.A.	3.6 μM	4.4	Urea between 0.5 and 9 M in phosphate buffer (1 mM of EDTA, 10 mM of sodium phosphate, and 100 mM of potassium chloride, pH = 7.4	UPLC	Human serum	In Vitro	None	None	N.A.
4191	37390979	2023	HSDGTFTSELSRLREEARLKRLLQGLV	Stapled secretin	27	Free	Amidation	Cyclic (E16-K20 Lactam Bridge)	L	E16, K20 modification	Human secretin modified analog	Secretin receptor agonist	N.A.	30 nmol/kg	N.A.	Male NMRI mice plasma protease	Mass spectrometry	Male NMRI mice plasma (Non fasted)	In Vivo	None	None	EC50 = 1172 nM for native secretin on murine adipocytes
4249	36719326	2023	RGDfK	68Ga(AAZ3A-endoHB)-c(RGD)	5	Ga labelling, conjugation of AAZ3A-endoHB-NCS to c(RGD)(cyclo(Arg-Gly-Asp-D-Phe-Lys) peptide at N terminus	Free	Cyclic (RGDfK)	Mix	None	Synthetic	Positron Emission Tomography (PET) imaging	37 °C	N.A.	Stable upto 4 hour	Human serum protease	UPLC-UV-RA	Human serum	In Vitro	None	None	N.A.
4303	N.A.	2023	Y-Aib-EGTFISDLSI-Aib-KEEIHQ-Aib-EFIEWLLAQGPSSGAPPPS	SEQ ID NO 19	39	Free	Amidation	Linear	L	Aib = α-aminoisobutyric acid	Exendin-4 analogs	Antidiabetes	Blood samples were collected at 0 H and after 0.25, 0.5, 1 , 2, 4, 8, 24, 32, 48, 56, 72, 80, and 96 H post S.C. application	0.1 mg/kg	N.A.	Minipigs plasma protease	LC-MS	Minipigs plasma	In Vivo	None	EP 2022074607 W	IC50 hGIPR (nM) = 2
4365	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Exendin	39	Fluorescently labelled	Amidation	Linear	L	None	Derived from Gila monster	Antidiabetes	Ten μl of blood was collected from a tiny incision on the tail vein into tubes containing 90 μl of 1,000 U ml-1 heparin (Sigma) at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h.	1000 nmol/kg	0.65 ± 0.04 (T1/2 Absorption)	Naïve mice plasma protease	Fluorescence assay	Naïve mice plasma	In Vivo	PDB id: 7MLL	None	EC50 (nM) = 0.04 ± 0.01
4366	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Ex-PEGRh	39	Fluorescently labelled	PEG Rh(27.7Kda)	Linear	L	None	Exendin-4 analogs	Antidiabetes	Ten μl of blood was collected from a tiny incision on the tail vein into tubes containing 90 μl of 1,000 U ml-1 heparin (Sigma) at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h.	1000 nmol/kg	6.59 ± 0.27 (T1/2 Absorption)	Naïve mice plasma protease	Fluorescence assay	Naïve mice plasma	In Vivo	PDB id: 7MLL	None	EC50 (nM) = 1.3 ± 0.2
4367	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Ex-PEGMw	39	Fluorescently labelled	PEG MW(46.3 Kda)	Linear	L	None	Exendin-4 analogs	Antidiabetes	Ten μl of blood was collected from a tiny incision on the tail vein into tubes containing 90 μl of 1,000 U ml-1 heparin (Sigma) at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h.	1000 nmol/kg	6.6 ± 0.9 (T1/2 Absorption)	Naïve mice plasma protease	Fluorescence assay	Naïve mice plasma	In Vivo	PDB id: 7MLL	None	EC50 (nM) = 2.7 ± 0.5
4368	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Ex-POEGMAopt	39	Fluorescently labelled	PEGMAopt(54.7Kda)	Linear	L	None	Exendin-4 analogs	Antidiabetes	Ten μl of blood was collected from a tiny incision on the tail vein into tubes containing 90 μl of 1,000 U ml-1 heparin (Sigma) at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h.	1000 nmol/kg	9.1 ± 0.9 (T1/2 Absorption)	Naïve mice plasma protease	Fluorescence assay	Naïve mice plasma	In Vivo	PDB id: 7MLL	None	EC50 (nM) = 2.8 ± 0.7
4369	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Exendin	39	Fluorescently labelled	Amidation	Linear	L	None	Derived from Gila monster	Antidiabetes	Ten μl of blood was collected from a tiny incision on the tail vein into tubes containing 90 μl of 1,000 U ml-1 heparin (Sigma) at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h.	1000 nmol/kg	0.77 ± 0.07 (T1/2 Absorption)	Naïve mice plasma protease	Fluorescence assay	Naïve mice plasma	In Vivo	PDB id: 7MLL	None	EC50 (nM) = 0.04 ± 0.01
4370	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Ex-PEGRh	39	Fluorescently labelled	PEG RH(27.7KDa)	Linear	L	None	Exendin-4 analogs	Antidiabetes	Ten μl of blood was collected from a tiny incision on the tail vein into tubes containing 90 μl of 1,000 U ml-1 heparin (Sigma) at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h.	1000 nmol/kg	N.A.	Immunized mice plasma protease	Fluorescence assay	Immunized mice plasma	In Vivo	PDB id: 7MLL	None	EC50 (nM) = 1.3 ± 0.2
4371	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Ex-POEGMAopt	39	Fluorescently labelled	POEGMAopt(54.7Kda)	Linear	L	None	Exendin-4 analogs	Antidiabetes	Ten μl of blood was collected from a tiny incision on the tail vein into tubes containing 90 μl of 1,000 U ml-1 heparin (Sigma) at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h.	1000 nmol/kg	12.1 ± 1.0 (T1/2 Absorption)	Immunized mice plasma protease	Fluorescence assay	Immunized mice plasma	In Vivo	PDB id: 7MLL	None	EC50 (nM) = 2.8 ± 0.7
4372	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Exendin	39	Free	Amidation	Linear	L	Fluorescently labeled	Isolated from the saliva of the Gila monster lizard (Heloderma suspectum)	Antidiabetes	Blood collection at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h	1000 nmol/kg	0.65 ± 0.04 (T1/2 Absorption)	Naïve mice plasma protease	Fluorescence assay	Naïve mice plasma	In Vivo	PDB id: 1JRJ	None	EC50 = 0.04 ± 0.01 nM for exendin
4373	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Ex-PEGRh	39	Free	PEGylation	Linear	L	Fluorescently labeled	Synthetic	Antidiabetes	Blood collection at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h	1000 nmol/kg	6.59 ± 0.27 (T1/2 Absorption)	Naïve mice plasma protease	Fluorescence assay	Naïve mice plasma	In Vivo	PDB id: 1JRJ	None	EC50 = 1.3 ± 0.2 nM
4374	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Ex-PEGMw	39	Free	PEGylation	Linear	L	Fluorescently labeled	Synthetic	Antidiabetes	Blood collection at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h	1000 nmol/kg	6.6 ± 0.9 (T1/2 Absorption)	Naïve mice plasma protease	Fluorescence assay	Naïve mice plasma	In Vivo	PDB id: 1JRJ	None	EC50 = 2.7 ± 0.5 nM
4375	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Ex-POEGMAopt	39	Free	POEGMA conjugation	N.A.	L	Fluorescently labeled	Synthetic	Antidiabetes	Blood collection at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h	1000 nmol/kg	9.1 ± 0.9 (T1/2 Absorption)	Naïve mice plasma protease	Fluorescence assay	Naïve mice plasma	In Vivo	PDB id: 1JRJ	None	EC50 = 2.8 ± 0.7 nM
4376	36630826	2023	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Exendin	39	Free	Amidation	Linear	L	Fluorescently labeled	Isolated from the saliva of the Gila monster lizard (Heloderma suspectum)	Antidiabetes	Blood collection at 5-min, 1-, 2-, 4-, 8-, 24-, 48-, 72-, 96-, 120-, 144- and 168-h	1000 nmol/kg	0.77 ± 0.07 (T1/2 Absorption)	Naïve mice plasma protease	Fluorescence assay	Naïve mice plasma	In Vivo	PDB id: 1JRJ	None	EC50 = 0.04 ± 0.01 nM for exendin
4377	38092894	2023	N.A.	tag-free rhMFG-E8	387	Cystatin S	Free	Linear	L	Glycosylation	Derived from Expi293F Human cells	antiinflammatory	Blood samples (100 μl per time point) were collected at 0, 3, 6, 9, 12 and 15 min, then every 15 min for the first 60 min till 2 hours	50 µg	11.55 (Distribution Half Life)	SD rats plasma protease	ELISA	SD rats plasma	In Vivo	None	None	LD50/30 (lethal dose, 50% at 30 days) falls between 14.5 Gy and 15 Gy after partial body irradiation (PBI) in mice treated with vehicle (normal saline),
4387	37242650	2023	RPVNLTMRRKLRKHNCLQRRCMPLHRSVPFP	ELA	32	pGlu = Pyroglutamate	Free	Cyclic (C17-C22 disulfide bond)	L	None	Human derived	Endogenous Ligand of APJ	Incubated at 37°C for 2, 5 and 10 min	1 mM	Almost completely degraded after 2 min	Rats plasma protease	HPLC-MS	Rats plasma	In Vitro	https://pubmed.ncbi.nlm.nih.gov/26986036/	None	Gαi1 EC50 (nM) = 5.3 ± 2.5
4420	36499357	2022	IVRWSKKVPCVS	WSC02	12	Free	Free	Linear	L	Cysteine was introduced in the sequence of both peptides at position 10	Synthetic	Anticancer, Antiinflammatory	Five microliter aliquots were separated after 0, 5, 10, 20, 30, 45, 60, 90, and 120 min	7 µM	0.7	Human plasma protease	Flow cytometry-based functional assay and mass spectrometry	Human plasma	In Vitro	None	None	N.A.
4602	35659720	2022	LPLTPLP	DTX-P7	7	DTX	Free	Linear	L	None	Docetaxel (DTX) and heptapeptide (P7) Fusion protein	Anticancer (Treatment Of Non-Small Cell Lung Cancer)	1, 2, 4, 12, 24, 48 and 72 h after injection, the mice were anesthetized, and approximately 0.5 ml of blood was collected	60 mg/kg	Longer Half Life	BALB/c mice plasma protease	HPLC	BALB/c mice bearing A549 tumors plasma	In Vivo	None	None	IC50 = 11.4 nM for DTX-P7 in A549 cells
4603	35659720	2022	LPLTPLP	DTX-P7	7	DTX	Free	Linear	L	None	Docetaxel (DTX) and heptapeptide (P7) Fusion protein	Anticancer (Treatment Of Non-Small Cell Lung Cancer)	1, 2, 4, 12, 24, 48 and 72 h after injection, the mice were anesthetized, and approximately 0.5 ml of blood was collected	60 mg/kg	Longer Half Life	BALB/c mice plasma protease	HPLC	BALB/c mice bearing A549 tumors plasma	In Vivo	None	None	IC50 = 0.62 nM for DTX-P7 in H1975 cells
4621	35430336	2022	KPSSPPEE	A6 peptide	8	Acetylation	Amidation	Linear	L	None	Synthetic	Antitumor	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	None	None	N.A.
4622	35414877	2022	MCFQYFHILWPFCGSGSDYKDDDDK	B_3.1	25	C18 diacid-gGlu-2xOEG	Amidation, FLAG tag	Cyclic	L	None	Synthetic	Targets GIP receptor	At selected time points samples were taken: 5, 15, 30, 60, 120, 210, 300 mins	1 μM	Stable	Human plasma protease	LC-MS	80% pooled human Li-heparin plasma	In Vitro	None	None	IC50(nM) = 347
4625	35414877	2022	MCFTHFHMLWPFCGSGSDYKDDDDK	B_1275.1	25	C18 diacid-gGlu-2xOEG	Amidation, FLAG tag	Cyclic	L	None	Synthetic	Targets GIP receptor	At selected time points samples were taken: 5, 15, 30, 60, 120, 210, 300 mins	1 μM	Stable	Human plasma protease	LC-MS	80% pooled human Li-heparin plasma	In Vitro	None	None	IC50(nM) = 1209
4627	35414877	2022	MCFTHFHMLWPFC	B_1275.3	14	C18 diacid-gGlu-2xOEG	Amidation, FLAG tag	Cyclic	L	None	Synthetic	Targets GIP receptor	At selected time points samples were taken: 5, 15, 30, 60, 120, 210, 300 mins	1 μM	Stable	Human plasma protease	LC-MS	80% pooled human Li-heparin plasma	In Vitro	None	None	IC50(nM) = 159
4628	35414877	2022	ACFTHFDLLWPFCGSGSDYKDDDDK	B_1275.4	25	Acetylation	Amidation, FLAG tag	Cyclic	L	None	Synthetic	Targets GIP receptor	At selected time points samples were taken: 5, 15, 30, 60, 120, 210, 300 mins	1 μM	Stable	Human plasma protease	LC-MS	80% pooled human Li-heparin plasma	In Vitro	None	None	IC50(nM) = 826
4629	35414877	2022	ACFTHFDLLWPFC	B_1275.5	14	Acetylation	Free	Cyclic	L	None	Synthetic	Targets GIP receptor	At selected time points samples were taken: 5, 15, 30, 60, 120, 210, 300 mins	1 μM	Stable	Human plasma protease	LC-MS	80% pooled human Li-heparin plasma	In Vitro	None	None	IC50(nM) = 2300
4630	35414877	2022	ACFTHFDLLWPFC	B_1275.6	14	C18 diacid-gGlu-2xOEG	Free	Cyclic	L	None	Synthetic	Targets GIP receptor	At selected time points samples were taken: 5, 15, 30, 60, 120, 210, 300 mins	1 μM	Stable	Human plasma protease	LC-MS	80% pooled human Li-heparin plasma	In Vitro	None	None	IC50(nM) = 860
4651	35174698	2022	MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK	eGFP	239	Free	Free	Linear	L	None	Enhanced GFP	Tagging	N.A.	N.A.	No Degradation	E. Coli Bl21(De3) star strain lysate protease	Fluorescence assay	E. coli BL21 (DE3) star strain lysate in which RNase E has been knocked out	In Vivo	PDB id: 4EUL	None	N.A.
4661	35113575	2022	ETVTLLVALKVRYRERIT-Ahx-CKRGARSTC	TT1-IP peptide	27	Free	Amidation	Cyclic (C-C Disulfide Bond)	L	Conjugation of TT1 and IP proteins which is linked by Ahx	TT1 and IP fusion protein	Antitumor (Effect on TPP-IPs on Cll xenograft models)	periods of time (0, 1, 6, and 24 h)	5 mg/kg	40% of the peptide was recovered after 6 hours incubation	Human serum protease	MS using MALDI-TOF	Human serum	In Vitro	None	None	The average survival for TT1-IP and LinTT1-IP treated groups was 19 days (the survival range for TT1-IP group was 17-23 days and for LinTT1-IP group was 13-25 days) and for the control group 16 days (range of 14-20 days)
4679	34910492	2022	SETSKSF	68Ga-DOTA-SETSKSF	7	68Ga labelled	Free	Cyclic	L	None	Synthetic	Used For Positron Emission Tomography imaging of PD-L1 expression in tumors	N.A.	5.29 ± 0.21 (%ID/g)	N.A.	N.A.	N.A.	H1975 tumor model	In Vitro	None	None	N.A.
4680	34910492	2022	SETSKSF	68Ga-DOTA-SETSKSF	7	68Ga labelled	Free	Cyclic	L	None	Synthetic	Used For Positron Emission Tomography imaging of PD-L1 expression in tumors	N.A.	0.89 ± 0.10 (%ID/g)	N.A.	N.A.	N.A.	A549 tumor model	In Vitro	None	None	N.A.
4687	34431071	2022	PGQEHPNARKYKGANKKGLSKGCFGLKLDRIGSMSGLGC	vosoritide	39	Free	Free	Cyclic (Cysteine (23->39)-Disulfide)	L	None	Analog of C-type natriuretic peptide	Treatment of Achondroplasia	In a phase II study, full PK sampling was performed at days 1, 10, 29, 85 and 183, during which plasma samples were collected predose and at 5 (± 2 min), 15 (± 2 min), 30 (± 5 min), 60 (± 5 min), 90 (± 5 min), 120 (± 5 min) and 180 (± 5 min) min postdose	2.5 µg/kg	N.A.	Human plasma protease	ELISA	Human plasma	In Vivo	https://pubchem.ncbi.nlm.nih.gov/compound/119058036#section=2D-Structure	None	N.A.
4688	34431071	2022	PGQEHPNARKYKGANKKGLSKGCFGLKLDRIGSMSGLGC	vosoritide	39	Free	Free	Cyclic (Cysteine (23->39)-Disulfide)	L	None	Analog of C-type natriuretic peptide	Treatment of Achondroplasia	In a phase II study, full PK sampling was performed at days 1, 10, 29, 85 and 183, during which plasma samples were collected predose and at 5 (± 2 min), 15 (± 2 min), 30 (± 5 min), 60 (± 5 min), 90 (± 5 min), 120 (± 5 min) and 180 (± 5 min) min postdose	7.5 µg/kg	N.A.	Human plasma protease	ELISA	Human plasma	In Vivo	https://pubchem.ncbi.nlm.nih.gov/compound/119058036#section=2D-Structure	None	N.A.
4752	35910276	2022	MRKSIVRYFVMAFILLFALSTFLTGVQATSVPDKKSPELEKAEIYGDIDVTSDKQTTVIVELKEKSLAEAKADGEKQTKASLKTARSKAKSKALKTLKKAKVNREYDRVFSGFSMKLPASEIPKLLAVKEVKAVYPNATYKPDSVKGKDVTLAADAIYPQMDKSAPFIGADQAWKSGYTGKGIKVAVIDTGVDYTHPDLKNNFGPYKGYDFVDNDYDPQETPTGDPRGGATDHGTHVAGTIAANGQIKGVAPEATLLAYRVLGPGGSGTTENVIAGIEKAVADGAKVMNLSLGNSLNSPDYATSIALDWAMAEGVVAVTSNGNSGPENWTVGSPGTSRVAISVGASQLPYNEYSVTLPSYSSAKVMGYQEEKDLEALNGQEVELVEAGLGQADDFSGKDVKGKVAVIQRGVIPFVDKAENAKNAGAIGAVIYNNATGEIEANVMGMAVPTVKLSKEEGEKLVQQIKEGKHSVVFSFKLDKKLGETIASFSSRGPVMDTWMIKPDVSAPGVNIVSTIPTHDPKNPYGYGSKQGTSMASPHVAGTAAILKQAKPDWTPEQIKGVLMNTAEKLTDENGKPLPHNTQGAGSIRIMEALKASSIVTPGSHSYGTFLKDKGKQTKKQAFTIENLSSHRKAYQLEYSFKGTGITVSGTERVVVPANQTGKAAAKVTVNSAKTKAGTYEGTVYIREDGRKVAEIPLLLIVKEPDYPRVTSVTVEPGAKQGAYTIEAYLPGGAEELAFLVYDENLNLLGQAGVYKNQGKGYQSYQWNGKINDAASLKSGKYYMLAYASAKGKSSYVLTEDPFIVE	KB-SP	806	Free	Free	Linear	L	None	Derived from Bacillus sp. KB111 strain	Haloprotease	50°C	N.A.	90 (Enzyme Activity)	N.A.	Zymography	EDTA + Tris-HCl + 0.5 M NaCl+ azocasein	In Vitro	GenBank id: KUL11341.1	None	KB-SP exhibited more than 50% of the highest activity at pH=6.5–10
4753	35910276	2022	MRKSIVRYFVMAFILLFALSTFLTGVQATSVPDKKSPELEKAEIYGDIDVTSDKQTTVIVELKEKSLAEAKADGEKQTKASLKTARSKAKSKALKTLKKAKVNREYDRVFSGFSMKLPASEIPKLLAVKEVKAVYPNATYKPDSVKGKDVTLAADAIYPQMDKSAPFIGADQAWKSGYTGKGIKVAVIDTGVDYTHPDLKNNFGPYKGYDFVDNDYDPQETPTGDPRGGATDHGTHVAGTIAANGQIKGVAPEATLLAYRVLGPGGSGTTENVIAGIEKAVADGAKVMNLSLGNSLNSPDYATSIALDWAMAEGVVAVTSNGNSGPENWTVGSPGTSRVAISVGASQLPYNEYSVTLPSYSSAKVMGYQEEKDLEALNGQEVELVEAGLGQADDFSGKDVKGKVAVIQRGVIPFVDKAENAKNAGAIGAVIYNNATGEIEANVMGMAVPTVKLSKEEGEKLVQQIKEGKHSVVFSFKLDKKLGETIASFSSRGPVMDTWMIKPDVSAPGVNIVSTIPTHDPKNPYGYGSKQGTSMASPHVAGTAAILKQAKPDWTPEQIKGVLMNTAEKLTDENGKPLPHNTQGAGSIRIMEALKASSIVTPGSHSYGTFLKDKGKQTKKQAFTIENLSSHRKAYQLEYSFKGTGITVSGTERVVVPANQTGKAAAKVTVNSAKTKAGTYEGTVYIREDGRKVAEIPLLLIVKEPDYPRVTSVTVEPGAKQGAYTIEAYLPGGAEELAFLVYDENLNLLGQAGVYKNQGKGYQSYQWNGKINDAASLKSGKYYMLAYASAKGKSSYVLTEDPFIVE	KB-SP	806	Free	Free	Linear	L	None	Derived from Bacillus sp. KB111 strain	Haloprotease	60 °C	N.A.	10 (Enzyme Activity)	N.A.	Zymography	EDTA + Tris-HCl + 0.5 M NaCl+ azocasein	In Vitro	GenBank id: KUL11341.1	None	KB-SP exhibited more than 50% of the highest activity at pH=6.5–10
4754	35910276	2022	MRKSIVRYFVMAFILLFALSTFLTGVQATSVPDKKSPELEKAEIYGDIDVTSDKQTTVIVELKEKSLAEAKADGEKQTKASLKTARSKAKSKALKTLKKAKVNREYDRVFSGFSMKLPASEIPKLLAVKEVKAVYPNATYKPDSVKGKDVTLAADAIYPQMDKSAPFIGADQAWKSGYTGKGIKVAVIDTGVDYTHPDLKNNFGPYKGYDFVDNDYDPQETPTGDPRGGATDHGTHVAGTIAANGQIKGVAPEATLLAYRVLGPGGSGTTENVIAGIEKAVADGAKVMNLSLGNSLNSPDYATSIALDWAMAEGVVAVTSNGNSGPENWTVGSPGTSRVAISVGASQLPYNEYSVTLPSYSSAKVMGYQEEKDLEALNGQEVELVEAGLGQADDFSGKDVKGKVAVIQRGVIPFVDKAENAKNAGAIGAVIYNNATGEIEANVMGMAVPTVKLSKEEGEKLVQQIKEGKHSVVFSFKLDKKLGETIASFSSRGPVMDTWMIKPDVSAPGVNIVSTIPTHDPKNPYGYGSKQGTSMASPHVAGTAAILKQAKPDWTPEQIKGVLMNTAEKLTDENGKPLPHNTQGAGSIRIMEALKASSIVTPGSHSYGTFLKDKGKQTKKQAFTIENLSSHRKAYQLEYSFKGTGITVSGTERVVVPANQTGKAAAKVTVNSAKTKAGTYEGTVYIREDGRKVAEIPLLLIVKEPDYPRVTSVTVEPGAKQGAYTIEAYLPGGAEELAFLVYDENLNLLGQAGVYKNQGKGYQSYQWNGKINDAASLKSGKYYMLAYASAKGKSSYVLTEDPFIVE	KB-SP	806	Free	Free	Linear	L	None	Derived from Bacillus sp. KB111 strain	Haloprotease	50°C	N.A.	5 (Enzyme Activity)	N.A.	Zymography	EDTA + Tris-HCl + 0.5 M NaCl+ azocasein	In Vitro	GenBank id: KUL11341.1	None	KB-SP exhibited more than 50% of the highest activity at pH=6.5–10
4755	35910276	2022	N.A.	BA17	N.A.	Free	Free	Linear	L	None	Isolated from B. licheniformis	Serine protease	50°C	N.A.	90 (Enzyme Activity)	N.A.	Zymography	N.A.	In Vitro	None	None	N.A.
4756	35910276	2022	N.A.	BA17	N.A.	Free	Free	Linear	L	None	Isolated from B. licheniformis	Serine protease	60 °C	N.A.	12 (Enzyme Activity)	N.A.	Zymography	N.A.	In Vitro	None	None	N.A.
4757	35858423	2022	LQEHPQARKYKGAQKKGLSKGCFGLKLDRIGSMSGLGC	MS-[Gln6,14]CNP-38 (4A)	38	Free	Free	Linear	N.A.	Mod = (CH3)2CHSO2-MS-BCN microsphere conjugation	Synthetic	Treatment of achondroplasia	pH 9.4, 37 °C	N.A.	6 (Release Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	N.A.
4758	35858423	2022	LQEHPQARKYKGAQKKGLSKGCFGLKLDRIGSMSGLGC	MS-[Gln6,14]CNP-38(4B)	38	Free	Free	Linear	N.A.	Mod = (CH3)2NSO2-MS-BCN microsphere conjugation	Synthetic	Treatment of achondroplasia	pH 9.4, 37 °C	N.A.	15.8 (Release Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	N.A.
4759	35858423	2022	LQEHPQARKYKGAQKKGLSKGCFGLKLDRIGSMSGLGC	MS-[Gln6,14]CNP-38 (4A)	38	Free	Free	Linear	N.A.	Mod = (CH3)2CHSO2-MS-BCN microsphere conjugation	Synthetic	Treatment of achondroplasia	pH 7.4, 37 °C,	N.A.	600 (Release Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	N.A.
4760	35858423	2022	LQEHPQARKYKGAQKKGLSKGCFGLKLDRIGSMSGLGC	MS-[Gln6,14]CNP-38(4B)	38	Free	Free	Linear	N.A.	Mod = (CH3)2NSO2-MS-BCN microsphere conjugation	Synthetic	Treatment of achondroplasia	pH 7.4, 37 °C,	N.A.	1580 (Release Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	N.A.
4761	35711755	2022	N.A.	R13 Fae	393	N.A.	N.A.	N.A.	N.A.	N.A.	Synthetic	Xylanase	pH 6.0 25 Celsius	N.A.	23 (Half Life Activty)	N.A.	N.A.	Phosphate buffer	In Vitro	None	None	N.A.
4762	35711755	2022	N.A.	R13 Fae	393	N.A.	N.A.	N.A.	N.A.	N.A.	Synthetic	Xylanase	pH 6.0 ,35°C	N.A.	16 (Half Life Activity)	N.A.	N.A.	Phosphate buffer	In Vitro	None	None	N.A.
4763	35488338	2022	N.A.	FRAP-smTG	N.A.	Frap (A Fusion Tag)	Free	Linear	L	None	TGm1 variant	Used to generate protein crosslinking or attachment of small molecules	60 ℃	0.4 mg/mL	< 2 (Activity Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	N.A.
4764	35488338	2022	N.A.	FRAP-TGm1	N.A.	Frap (A Fusion Tag)	Free	Linear	L	None	TGm1 variant	Used to generate protein crosslinking or attachment of small molecules	60 ℃	0.4 mg/mL	11.31 (Activity Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	N.A.
4765	35488338	2022	N.A.	FRAPD-TGm1	N.A.	Frap (A Fusion Tag)	Free	Linear	L	additional modification (Asp residue)	TGm1 variant	Used to generate protein crosslinking or attachment of small molecules	60 ℃	0.4 mg/mL	21.97 (Activity Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	N.A.
4766	35133860	2022	NDRAAAIIRADDLASTGYTGEGQIVGVADSGLDTGDLDRIHPDFEGRVKELYAIGRKGDASDPDGHGTHVAGSIVGTGKASDGOYKGMAPDAKLVFHSMLDEYGYLAGDVSDILEEAYADGARIHSDSWGVDDDGEYGLDSFLFDQFLWEHPDMTALVAAGNAGIYGYETIGTPATAKNVIAVGASENDRPELDEDEADDPDEVAAFSSRGTTADGRLKPDLVAPGSYILSTRSSLAPDENFHGLFNAFYAYLSGTSMATPVLAGGVAQVRQFLQENGVDNPSGALIKAMLISGADDLNEDMRVQGFGRANLRRAIETGFVDEKKGLKTGDVATYRLNVTDDSQPLAITLAWTDYPASLAAERTLVNNLNLRVVTPSGETLNGNDFFHYPYDDEVDNLNNVEQVWIKHPEEGVYTVTVEGYNVPMGPQPYALAANG	mTSS	436	Free	Free	Linear	L	None	Derived from preTSS	Collagenolytic protease	75°C	N.A.	1.5 (Activity Half Life)	N.A.	N.A.	10 mM CaCl2 at pH 9.0	In Viro Study	None	None	In the presence of 10 mM CaCl2 at pH 9.0, mTSS retained more than 80% or 70% of the original activity after 8 h of incubation at 60°C or 70°C
4767	35133860	2022	NDRAAAIIRADDLASTGYTGEGQIVGVADSGLDTGDLDRIHPDFEGRVKELYAIGRKGDASDPDGHGTHVAGSIVGTGKASDGOYKGMAPDAKLVFHSMLDEYGYLAGDVSDILEEAYADGARIHSDSWGVDDDGEYGLDSFLFDQFLWEHPDMTALVAAGNAGIYGYETIGTPATAKNVIAVGASENDRPELDEDEADDPDEVAAFSSRGTTADGRLKPDLVAPGSYILSTRSSLAPDENFHGLFNAFYAYLSGTSMATPVLAGGVAQVRQFLQENGVDNPSGALIKAMLISGADDLNEDMRVQGFGRANLRRAIETGFVDEKKGLKTGDVATYRLNVTDDSQPLAITLAWTDYPASLAAERTLVNNLNLRVVTPSGETLNGNDFFHYPYDDEVDNLNNVEQVWIKHPEEGVYTVTVEGYNVPMGPQPYALAANG	mTSS	436	Free	Free	Linear	L	None	Derived from preTSS	Collagenolytic protease	60°C	N.A.	2 (Activity Half Life)	N.A.	N.A.	10 mM CaCl2 at pH 11.0	In Viro Study	None	None	In the presence of 10 mM CaCl2 at pH 9.0, mTSS retained more than 80% or 70% of the original activity after 8 h of incubation at 60°C or 70°C
4768	35133860	2022	NDRAAAIIRADDLASTGYTGEGQIVGVADSGLDTGDLDRIHPDFEGRVKELYAIGRKGDASDPDGHGTHVAGSIVGTGKASDGOYKGMAPDAKLVFHSMLDEYGYLAGDVSDILEEAYADGARIHSDSWGVDDDGEYGLDSFLFDQFLWEHPDMTALVAAGNAGIYGYETIGTPATAKNVIAVGASENDRPELDEDEADDPDEVAAFSSRGTTADGRLKPDLVAPGSYILSTRSSLAPDENFHGLFNAFYAYLSGTSMATPVLAGGVAQVRQFLQENGVDNPSGALIKAMLISGADDLNEDMRVQGFGRANLRRAIETGFVDEKKGLKTGDVATYRLNVTDDSQPLAITLAWTDYPASLAAERTLVNNLNLRVVTPSGETLNGNDFFHYPYDDEVDNLNNVEQVWIKHPEEGVYTVTVEGYNVPMGPQPYALAANG	mTSS	436	Free	Free	Linear	L	None	Derived from preTSS	Collagenolytic protease	N.A.	N.A.	>12 (Activity Half Life)	N.A.	N.A.	10 mM CaCl2 at pH 7.5	In Viro Study	None	None	In the presence of 10 mM CaCl2 at pH 9.0, mTSS retained more than 80% or 70% of the original activity after 8 h of incubation at 60°C or 70°C
4769	35133860	2022	NDRAAAIIRADDLASTGYTGEGQIVGVADSGLDTGDLDRIHPDFEGRVKELYAIGRKGDASDPDGHGTHVAGSIVGTGKASDGOYKGMAPDAKLVFHSMLDEYGYLAGDVSDILEEAYADGARIHSDSWGVDDDGEYGLDSFLFDQFLWEHPDMTALVAAGNAGIYGYETIGTPATAKNVIAVGASENDRPELDEDEADDPDEVAAFSSRGTTADGRLKPDLVAPGSYILSTRSSLAPDENFHGLFNAFYAYLSGTSMATPVLAGGVAQVRQFLQENGVDNPSGALIKAMLISGADDLNEDMRVQGFGRANLRRAIETGFVDEKKGLKTGDVATYRLNVTDDSQPLAITLAWTDYPASLAAERTLVNNLNLRVVTPSGETLNGNDFFHYPYDDEVDNLNNVEQVWIKHPEEGVYTVTVEGYNVPMGPQPYALAANG	mTSS	436	Free	Free	Linear	L	None	Derived from preTSS	Collagenolytic protease	70°C	N.A.	6 (Activity Half Life)	N.A.	N.A.	pH 9	In Viro Study	None	None	In the presence of 10 mM CaCl2 at pH 9.0, mTSS retained more than 80% or 70% of the original activity after 8 h of incubation at 60°C or 70°C
4770	35133860	2022	N.A.	E187A	N.A.	Free	Free	Linear	L	Residue Glu187 of the Ca1 site in the catalytic domain was replaced by Ala	Derived from preTSS	Collagenolytic protease	70°C	N.A.	N.A.	N.A.	N.A.	N.A.	In Viro Study	None	None	When the residue Glu187 of the Ca1 site in the catalytic domain was replaced by Ala, the resulting variant E187A was completely inactivated after incubation at 70°C for 3 h
4847	35036703	2021	CWRLRWHSPLKGM	[64Cu]CM-1	13	64Cu labeling	Free	Linear	L	None	Synthetic	PET Radiotracer For Cd133	1 hour	∼100 μCi	22.4 Of Intact [64Cu]Cm-1 Remained	Mouse serum protease	radio-HPLC	mouse serum	In Vitro	None	None	CM1 shows high binding affinity for CD133 (KD = 7.37 nM), 64Cu]CM-2 showed a binding affinity (IC50) of 44.95 nM, which is similar to that of [64Cu]CM-1 (IC50 = 52.55 nM)
4848	35036703	2021	CWRLRWHSPLKGM	[64Cu]CM-1	13	64Cu labeling	Free	Linear	L	None	Synthetic	PET Radiotracer For Cd133	2 hour	∼100 μCi	20.1% Of Intact [64Cu]Cm-1 Remained	Mouse serum protease	radio-HPLC	mouse serum	In Vitro	None	None	CM1 shows high binding affinity for CD133 (KD = 7.37 nM), 64Cu]CM-2 showed a binding affinity (IC50) of 44.95 nM, which is similar to that of [64Cu]CM-1 (IC50 = 52.55 nM)
4849	35036703	2021	CWRLRWHSPLKGM	[64Cu]CM-2	14	6-aminohexanoic acid (Ahx) linker is anchored between the N terminus of the peptide and the (DOTA) 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid , 64Cu labeling	Free	Linear	L	None	Synthetic	PET Radiotracer For Cd133	1 hour	∼100 μCi	94.9 of intact tracers remained	Mouse serum protease	radio-HPLC	mouse serum	In Vitro	None	None	64Cu]CM-2 showed a binding affinity (IC50) of 44.95 nM, which is similar to that of [64Cu]CM-1 (IC50 = 52.55 nM)
4850	35036703	2021	CWRLRWHSPLKGM	[64Cu]CM-2	14	6-aminohexanoic acid (Ahx) linker is anchored between the N terminus of the peptide and the (DOTA) 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid , 64Cu labeling	Free	Linear	L	None	Synthetic	PET Radiotracer For Cd133	2 hour	∼100 μCi	91.9% of intact tracers remained	Mouse serum protease	radio-HPLC	mouse serum	In Vitro	None	None	64Cu]CM-2 showed a binding affinity (IC50) of 44.95 nM, which is similar to that of [64Cu]CM-1 (IC50 = 52.55 nM)
4855	34859381	2021	pGlu-WNLNAAGYLLATHACG	M89b	17	pGlu = Pyroglutamate at position 1	Free	Linear	L	None	galanin analog	Interacts With Different G Protein-Coupled Receptors	>23 hours	10 µM	40% Of M89B Had Been Degraded	Rats serum protease	HPLC	Rats serum	In Vitro	None	None	EC50 ratios to Gal-(1-15)(n) = NA(3) (in GAL1R) (B-Arrestin), EC50 ratios to Gal-(1-15)(n) = NA(3) (in GAL1R) (Ca-efflux)
4856	34859381	2021	GWTLNSAGYLLGPHL	GAL-(1–15)	15	Free	Free	Linear	L	None	isolated from the porcine intestine	Interacts With Different G Protein-Coupled Receptors	>30 minutes	10 µM	80% Of Gal-(1–15) Was Degraded	Rats serum protease	HPLC	Rats serum	In Vitro	None	None	EC50 ratios to Gal-(1-15)(n) = 1.7(3) (in GAL2R) (B-Arrestin), EC50 ratios to Gal-(1-15)(n) = 1.4(3) (in GAL2R) (Ca-efflux)
4890	34661390	2021	KKK-Mal-CVVGSPSAQDEASPLS	Gd4-TESMA	19	Gd4	Free	Linear	L	Mal links KKK and other peptide	Synthetic	For imaging Atherosclerotic Plaque vulnerability	2 hours	0.6 mM which is diluted in water at a final concentration of 0.06 mM when aliquoting	No Degradation	Pooled serum protease from human male AB plasma	RP-HPLC	50% pooled serum from human male AB plasma	In Vitro	None	None	KD (μM) = 41 ± 12 ( Interaction between Immobilized Human Recombinant Tropoelastin and Gd4TESMA)
4897	34459035	2021	PFSTQDTDLDLEMLAPYIPMDDDFQLRSFDQLSP	FLAGHIF1α	34	Free	Free	Linear	L	FLAG tag	Hypoxia-Inducible Factor 1-alpha	Role in survival, metabolism, and angiogenesis	N.A.	N.A.	~50% Increase	Cells lysate protease	CHX assay, Western blotting	HEK293 Flp‐In T‐REx cell lysate after pevonedistat treatment	In Vitro	PDB id: 1LQB	None	N.A.
4898	34459035	2021	EFKLELVEKLFAEDTEAKNPFSTQDTDLDLEMLAPYIPMDDDFQLRSFDQLSPLESSSASPESASPQSTVTVFQQTQIQEPTANATTTTATTDELKTVTKDRMEDIKILIASPSPTHIHKETT	CODD	120	Free	Free	Linear	L	FLAG tag	C-Terminal oxygen-dependent degradation domain	Regulates gene expression	N.A.	N.A.	5.8‐Fold Increase	Cells lysate protease	CHX assay, Western blotting	HEK293 Flp‐In T‐REx cells lysate after neddylation inhibition	In Vitro	None	None	N.A.
4900	34455010	2021	pGlu-RPVNLTMRRKLRKHNCLQRRCMPLHSRVPFP	ELA-32	32	pGlu = Pyroglutamate	Free	Cyclic (Cys-Cys Disulfide Bond)	L	None	Derived from Zebrafish	Anticancer, Treatment of Cardiovascular Disease	Blood sample were withdrawn at time points: 0, 2, 5, 10, 15, 30, 60, 120 min	5 μg/mL	44.2 ± 3	Human kidney homogenate protease	LC–MS/MS	Human kidney homogenate	In Vitro	None	None	N.A.
4908	34393794	2021	KFRRQRPRLSHLGPMPF	K17F	17	Free	Free	Linear	L	None	Apelin-17 Analog	Treatment of Hypertension	N.A.	250 nmol/kg	50	Rats plasma protease	RIA	Rats plasma	In Vivo	Pubchem CID Apelin: 56841713	None	IC50: 0.11 ± 0.01 nmol/l for K17F
4914	34206631	2021	YGGFL	KK 103	6	N terminal of Tyr linked with NH bond with R1 = Structure given in paper	Free	Linear	L	None	Synthetic	Analgesic	Aliquot (95 µL) was taken at 0, 5, 15, 60, and 300 min	315 µmol/L	>95% Remained	CSF Protease	UPLC	Pooled human cerebrospinal fluid	In Vitro	None	None	N.A.
4915	34206631	2021	YGGFL	Leu-ENK	5	Free	Free	Linear	L	None	Opioid peptide	Analgesic	Aliquot (95 µL) was taken at 0, 5, 15, 60, and 300 min	315 µmol/L	>80% Remained	CSF Protease	UPLC	Pooled human cerebrospinal fluid	In Vitro	None	None	N.A.
4926	36133017	2021	KGSGSGCPRILMRCKQDSDCLAGCVCGPNGFCG	Fab–CKP-NLP	30	Free	Free	Linear	L	Fab conjugation, Lys1 fatty acid conjugation (Palm)	Synthetic	Platform for potential delivery of peptide like drug candidates	37 °C for 24 hour	N.A.	75% Remained Intact	N.A.	SEC	N.A.	In Vitro	None	None	N.A.
4971	33665501	2021	Poly(L-glutamic acid)	PEG-pHe-PLG-Pt (pH 6.5)	n	PEG-CDM	Cisplatin (CDDP) is complexed with the carboxyl groups of the L-glutamic acid	Linear	L	Poly(L-glutamic acid) is grafted with methoxy poly(ethylene glycol) (PEG) using a pH-sensitive linker, CDM = 2-propionic-3-methylmaleic anhydride	Synthetic	Anticancer	At predefined time points 5, 15, and 30 min, and 1, 3, 6, 12, and 24 h, 200.0 μL of blood samples were collected from the orbital cavities of rats	3 mg/kg	N.A.	Rats plasma protease	ICP-MS	Rats plasma	In Vivo	None	None	IC50 (μg mL−1) = 5.8 in SKOV3 cells
4988	33607165	2021	RRPYIL	NT(8:13)	6	Free	Free	Linear	L	None	Neuropeptide	Analgesic	Plasma collected at 0, 1, 2, 5, 10, 30 and 60 min	0.156 mM	0.98 ± 0.08	Rats plasma protease	UPLC-MS	Rats plasma	In Vivo	None	None	(Binding) Ki (nM) = 1.65 ± 0.06 for hNTS1
5003	33555858	2021	LEGREKVRA-X19-I-Aib-Aib-EG-X25-STWS-Aib-RKKK	Cpd 67(B10-33 )	24	Acetylation	Amidation	Linear	L	Lys24 conjugated with (-(PEG2)3-(γE)3-C16-OH), PEGylation,Aib,Nle,acetylation at Lys10 and Lys23	Synthetic	Treatment of Cardiovascular Diseases	N.A.	1 mg/kg	N.A.	Rats plasma protease	LCHRMS	Rats plasma	In Vivo	None	None	EC50 nM = 809 ± 20 (70%) in OVCAR5 cells
5004	33555858	2021	LEGREKVRAKI-Aib-Aib-EG-Nle-STWS-Aib-RKKK	Cpd 68(B10-33 )	24	Acetylation	Amidation	Linear	L	Lys24 conjugated with (-(PEG2)3-(γE)3-C18-OH), PEGylation,Aib,Nle,acetylation at Lys10 and Lys23	Synthetic	Treatment of Cardiovascular Diseases	N.A.	1 mg/kg	N.A.	Rats plasma protease	LCHRMS	Rats plasma	In Vivo	None	None	EC50 nM = 368 ± 76 (75%) in OVCAR5 cells
5021	32778037	2021	RRWVRRVRRWVRRVVRVVRRWVRR	[14C]-WLBU2	24	C14 labeling	Free	Linear	L	None	Synthetic	Antimicrobial	N.A.	15 mg/kg	22 (Radioactivity Half Life)	CD1 female mice plasma protease	Radiochromatography	CD1 female mice plasma	In Vivo	None	None	N.A.
5022	33822591	2021	MKIILWLCVFGLFLATLFPISWQMPVESGLSSEDSASSESFASKIKRHGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSG	MS−[Gln28]exenatide	87	Free	Free	Linear	L	Conventional unsubstituted β-eliminative linker, linked by a GDM linker and Mod = (CH3)2NSO2−	Exendin-4 analogs	Antidiabetes	pH 7.4, 37 °C	N.A.	~2020 (Release Half Life)	N.A.	N.A.	N.A.	In Vitro	PDB id: 7MLL	None	N.A.
5023	33822591	2021	MKIILWLCVFGLFLATLFPISWQMPVESGLSSEDSASSESFASKIKRHGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSG	MS−[Gln28]exenatide	87	Free	Free	Linear	L	Conventional unsubstituted β-eliminative linker	Exendin-4 analogs	Antidiabetes	pH 7.4, 37 °C	N.A.	900 (Release Half Life)	Rats	N.A.	Rats	In Vivo	PDB id: 7MLL	None	N.A.
5024	33822591	2021	MKIILWLCVFGLFLATLFPISWQMPVESGLSSEDSASSESFASKIKRHGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSG	MS−[Gln28]exenatide	87	Free	Free	Linear	L	with GDM linker and Mod = (CH3)2NSO2−	Exendin-4 analogs	Antidiabetes	pH 7.4, 37 °C	N.A.	~1800 (Release Half Life)	N.A.	N.A.	N.A.	In Vitro	PDB id: 7MLL	None	N.A.
5025	33822591	2021	MKIILWLCVFGLFLATLFPISWQMPVESGLSSEDSASSESFASKIKRHGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSG	MS−[Gln28]exenatide	87	Free	Free	Linear	L	Conventional unsubstituted β-eliminative linker	Exendin-4 analogs	Antidiabetes	pH 7.4, 37 °C	N.A.	750 (Release Half Life)	Rats	N.A.	Rats	In Vivo	PDB id: 7MLL	None	N.A.
5026	33801382	2021	fQWAVGH	[177Lu]Lu-NeoB	7	Acetylation, 177Lu Labelling	Aminoethylamide -NH-CH(CH2-CH(CH3)2)2	Linear	Mix	None	Derived from the antagonist GRPR peptide SB3	Antitumor (Treatment of Gastrointestinal Stromal Tumors)	N.A.	N.A.	40.2 (Distribution Half Life)	N.A.	N.A.	N.A.	N.A.	https://pmc.ncbi.nlm.nih.gov/articles/PMC6150197/	None	[177Lu]Lu-NeoB tumor uptake in 400 pmol group mice (~11% ID/g) was found to be higher than that observed in 800 pmol group mice (~7% ID/g)
5073	32888078	2020	QHTQITKV	Human Myr-PTEN-PDZ	8	N-myristoyl	Free	Linear	L	Lipidation	Synthetic	Treatment of Alzheimer's diseases	Samples (80 μL) were taken at 0, 3, 6,9, 15, 30, 45, 60, 90, 120, 180, 240, 360 and 1440 min	Peptide stock solutions (120 μL) were added to pre-warmed diluted plasma (50% v/v, 1080 μL)	N.A.	Simulated intestinal fluid protease	HPLC	Simulated intestinal fluid	In Vitro	None	None	N.A.
5101	32844654	2020	IKPEAPGCDASPEECNRYYASLRHYLNLVTRQRY	Peptide 4	34	Free	Amidation	Cyclic (Cys-Cys Disulfide Bond)	L	Cysteine substiution at 10, 17	PYY analog	Antiobesity	Blood samples were collected at 0.25, 0.5, 0.75, 1, 1.17, 1.33, 1.5, 2, 4, 6, 8, 24, 30, and 48 h after the start of infusion	0.033 mg/kg	N.A.	Mouse plasma protease	UPLC-MS/MS	Mouse plasma	In Vivo	None	None	EC50 (nM) = 2.3 ± 0.3 for hNPY2R (cAMP)
5102	32844654	2020	IKPEAPGEDASPEELNRYYACLRHYLNCVTRQRY	Peptide 8	34	Free	Amidation	Cyclic (Cys-Cys Disulfide Bond)	L	Cysteine substiution at 23, 30	PYY analog	Antiobesity	Blood samples were collected at 0.25, 0.5, 0.75, 1, 1.17, 1.33, 1.5, 2, 4, 6, 8, 24, 30, and 48 h after the start of infusion	0.033 mg/kg	N.A.	Mouse plasma protease	UPLC-MS/MS	Mouse plasma	In Vivo	None	None	EC50 (nM) = 1.2 ± 0.1 for hNPY2R (cAMP)
5104	32844654	2020	PKPEAPGCDASPEECNRYYADLRHYLNWLTRQRY	Peptide 13	34	Free	Amidation	Cyclic (Cys-Cys Disulfide Bond)	L	Cysteine substiution at 10, 17	PYY analog	Antiobesity	Blood samples were collected at 0.25, 0.5, 0.75, 1, 1.17, 1.33, 1.5, 2, 4, 6, 8, 24, 30, and 48 h after the start of infusion	0.033 mg/kg	N.A.	Mouse plasma protease	UPLC-MS/MS	Mouse plasma	In Vivo	None	None	EC50 (nM) = 0.62 ± 0.09 for hNPY2R (cAMP)
5117	32781586	2020	AKRLKKLAKKIWKWK	TAMRA-HPA3NT3-A2	15	Free	Free	Linear	L	TAMRA labeled	HPA3NT3 analogue	Antimicrobial	Incubation times (0, 60, 120 min) at 37 °C	128, 64, 32, 16, 8, 4, 2, 1, and 0.5 µM	Degradation occured initially after 10 min	Human serum protease	HPLC	Human serum	In Vitro	None	None	Hemolysis % =0.3 for 250 micromolar (Toxicity of HPA3NT3 analogue peptide against RBCs)
5184	32235388	2020	GCCSDPPCRNKHPDLC	TxIB	16	Free	Free	Linear	L	None	α-conotoxin derived from the venom of the cone snail species Conus textile	Blocks the Α6/Α3Β2Β3 Nicotinic Acetylcholine Receptors	Aliquots of each peptide were taken out at 0, 12, 24, 36, and 48 h.	100 μM	Stable	Male AB human serum protease	RP-UPLC	Male AB human serum	In Vitro	None	None	42% inhibition of α6β2* nAChRs by TxIB
5185	32235388	2020	GAAGGCCSDPPCRNKHPDLC	cTxIB-4	20	Linker	Free	Cyclic (C2-C8, C3-C16 Disulfide Bond And Linker-C16 Bond)	L	None	α-conotoxin TxIB analogue	Blocks the Α6/Α3Β2Β3 Nicotinic Acetylcholine Receptors	Aliquots of each peptide were taken out at 0, 12, 24, 36, and 48 h.	100 μM	Slightly lower stability than TXIB	Male AB human serum protease	RP-UPLC	Male AB human serum	In Vitro	None	None	Inhibition of cTxIB-4 is 35%
5186	32235388	2020	GGAAGGCCSDPPCRNKHPDLC	cTxIB-5	21	Linker (GGAAG)	Free	Cyclic (C2-C8, C3-C16 Disulfide Bond And Linker-C16 Bond)	L	None	α-conotoxin TxIB analogue	Blocks the Α6/Α3Β2Β3 Nicotinic Acetylcholine Receptors	Aliquots of each peptide were taken out at 0, 12, 24, 36, and 48 h.	100 μM	Slightly lower stability than TXIB	Male AB human serum protease	RP-UPLC	Male AB human serum	In Vitro	None	None	Inhibition of cTxIB-5 is 42%
5187	32235388	2020	GCCSDPPCRNKHPDLC	cTxIB-6	22	Linker (GAGAAG)	Free	Cyclic (C2-C8, C3-C16 Disulfide Bond And Linker-C16 Bond)	L	None	α-conotoxin TxIB analogue	Blocks the Α6/Α3Β2Β3 Nicotinic Acetylcholine Receptors	Aliquots of each peptide were taken out at 0, 12, 24, 36, and 48 h.	100 μM	Slightly lower stability than TXIB	Male AB human serum protease	RP-UPLC	Male AB human serum	In Vitro	None	None	Inhibition of cTxIB-6 is 48%
5252	31765157	2020	XFLFRPRN	CPN-116	7	X = Struture given in paper (6b)	Amidation	Linear	L	None	Synthetic	Antiobesity	At 30 min	50 mg/mL	20% of the initial concentration	Rats serum protease	LC-MS	Rats serum after i.p. pentobarbital sodium	In Vitro	https://sci-hub.se/10.1021/jm500599s	None	CPN exhibits a selective agonistic activity to mouse NMUR2 with an EC50 value of 28 ± 2 nM
5253	31765157	2020	XFLFRPRN	CPN-116	7	X = Struture given in paper (6b)	Amidation	Linear	L	None	Synthetic	Antiobesity	at 30 min	50 mg/mL	90% of initial concentration	Rats CSF protease	LC-MS	Rats CSF after i.p. pentobarbital sodium	In Vitro	https://sci-hub.se/10.1021/jm500599s	None	CPN exhibits a selective agonistic activity to mouse NMUR2 with an EC50 value of 28 ± 2 nM
5254	31765157	2020	XFLFRPRN	CPN-116	7	X = Struture given in paper (6b)	Amidation	Linear	L	None	Synthetic	Antiobesity	4 hours	50 mg/mL	20% of the initial concentration	Rats CSF protease	LC-MS	Rats CSF after i.p. pentobarbital sodium	In Vitro	https://sci-hub.se/10.1021/jm500599s	None	CPN exhibits a selective agonistic activity to mouse NMUR2 with an EC50 value of 28 ± 2 nM
5271	N.A.	2020	CSW-Aze-A-hArg-CLHQDLC	Ac-(06-34-18) Aze3 (HomoArg5)	12	Acetylation	Free	Linear	L	Aze replaces Pro (P)at position 4 , HomoArg6 replaces Arg (R)	Synthetic	Targets plasma kallikrein	N.A.	5 uM	N.A.	Rats plasma protease	Waters Xevo TQ-MS	Rats plasma	In Vitro	None	US 201214350192 A	IC50(nM)(rat kallikrein) = NA
5272	N.A.	2020	CSW-Aze-A-4GuanPhe-CLHQDLC	Ac-(06-34-18) Aze3 (4GuanPhe5)	12	Acetylation	Free	Linear	L	Aze replaces Pro (P)at position 4 , 4GuanPhe6 replaces Arg (R)	Synthetic	Targets plasma kallikrein	N.A.	5 uM	N.A.	Rats plasma protease	Waters Xevo TQ-MS	Rats plasma	In Vitro	None	US 201214350192 A	IC50(nM)(rat kallikrein) = NA
5273	N.A.	2020	CSW-Aze-A-NMeArg-CLHQDLC	Ac-(06-34-18) Aze3 (NMeArg5)	12	Acetylation	Free	Linear	L	Aze replaces Pro (P)at position 4, NMeArg replaces Arg (R) at position 6	Synthetic	Targets plasma kallikrein	N.A.	5 uM	N.A.	Rats plasma protease	Waters Xevo TQ-MS	Rats plasma	In Vitro	None	US 201214350192 A	IC50(nM)(rat kallikrein) = NA
5278	N.A.	2020	CSF-Aze-Y-hArg-CLHQDLC	Ac-(06-34-18) Phe2 Aze3 Tyr4 HomoArg5	12	Acetylation	Free	Linear	L	HomoArg replaces Arg (R) at position 6,Tryptophan (W) at position 3 is replaced with Phe, alanine (A) at position 5 is replaced with Tyr, Aze substituitons at position 4	Synthetic	Targets plasma kallikrein	N.A.	5 uM	N.A.	Rats plasma protease	Waters Xevo TQ-MS	Rats plasma	In Vitro	None	US 201214350192 A	IC50(nM)(rat kallikrein) = NA
5279	N.A.	2020	CSF-Aze-Y-4GuanPhe-CLHQDLC	Ac-(06-34-18) Phe2 Aze3Tyr4 4GuanPhe5	12	Acetylation	Free	Linear	L	4GuanPhe replaces Arg (R) at position 6,Tryptophan (W) at position 3 is replaced with Phe, alanine (A) at position 5 is replaced with Tyr, Aze substituitions at position 4	Synthetic	Targets plasma kallikrein	N.A.	5 uM	N.A.	Rats plasma protease	Waters Xevo TQ-MS	Rats plasma	In Vitro	None	US 201214350192 A	IC50(nM)(rat kallikrein) = NA
5280	N.A.	2020	CSF-Aze-Y-NMeArg-CLHQDLC	Ac-(06-34-18) Phe2 Aze3Tyr4 NMeArg5	12	Acetylation	Free	Linear	L	NMeArg replaces Arg (R) at position 6,Tryptophan (W) at position 3 is replaced with Phe, alanine (A) at position 5 is replaced with Tyr, Aze substituitions at position 4	Synthetic	Targets plasma kallikrein	N.A.	5 uM	N.A.	Rats plasma protease	Waters Xevo TQ-MS	Rats plasma	In Vitro	None	US 201214350192 A	IC50(nM)(rat kallikrein) = NA
5282	32454120	2020	N.A.	Uox-WT	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	Synthetic	Treatment of hyperuricemia	Incubated for 4 h at room temperature	28 μM	1.1 (Enzymatic Activity Half Life)	Mice serum protease	Uric acid degradation assay	Mice serum	In Vivo	None	None	N.A.
5283	32454120	2020	N.A.	Uox-HSA	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	Synthetic	Treatment of hyperuricemia	Incubated for 4 h at room temperature	28 μM	17.4 (Enzymatic Activity Half Life)	Mice serum protease	Uric acid degradation assay	Mice serum	In Vivo	None	None	N.A.
5284	32454120	2020	N.A.	PEG-PAEU + Uox-HSA	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	Synthetic	Treatment of hyperuricemia	Incubated for 4 h at room temperature	28 μM	43.6 (Enzymatic Activity Half Life)	Mice serum protease	Uric acid degradation assay	Mice serum	In Vivo	None	None	N.A.
5285	32454120	2020	N.A.	PEG-PAEU-ABP + Uox-HSA	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	Synthetic	Treatment of hyperuricemia	Incubated for 4 h at room temperature	28 μM	96.3 (Enzymatic Activity Half Life)	Mice serum protease	Uric acid degradation assay	Mice serum	In Vivo	None	None	N.A.
5286	32803073	2020	GSLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNL-AzF-AITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM	Pal-Rb	169	Free	Free	Linear	L	Conjugation of palmitic acid, biotinylated labelling, , (AzF) was incorporated into the position 126 on the repebody followed by lipid conjugation	Synthetic	Antitumor	Blood was collected in predetermined time points postinjection (n = 5; 0.05, 0.5, 1, 2, 4, 6, 12 and 24 h)	10 mg/kg	4.2 (Distribution Half-Life)	Mice plasma protease	Sandwich ELISA	mice plasma	In Vivo	None	None	The tumor size remained around 200 mm3 until 27 days when Pal-Rb was administered (p < 0.01), whereas tumor continued to grow over 600 mm3 when WT-Rb and PBS were injected.
5287	31845578	2020	N.A.	Man25	449	Free	Free	Linear	L	None	β-mannanase from Thermoanaerobacterium aotearoense	Role in cellulosic biomass degradation	55 °C	N.A.	40.2 (Activity Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	Man25 retaining more than 50% activity at its optimal pH of 5.5
5288	31845578	2020	N.A.	ManM3-3	449	Free	Free	Linear	L	D143A amino acid substituition	Derived from Man25	Role in cellulosic biomass degradation	55 °C	N.A.	143.4 (Activity Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	Man25 retaining more than 50% activity at its optimal pH of 5.5
5289	31845578	2020	N.A.	ManM5-10	449	Free	Free	Linear	L	E32K, E34S amino acid substituition	Derived from Man25	Role in cellulosic biomass degradation	55 °C	N.A.	74.4 (Activity Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	Man25 retaining more than 50% activity at its optimal pH of 5.5
5290	31840306	2020	RLYMRYYSPTTRRYG	conjugate 1 b	16	2A-Gossypol Conjugate Linked By Thiazolidine Imine Linkage	Free	Linear	L	None	Synthetic	Cancer‐cell‐specific drug delivery	After 10 hours	0.1 mg	52% Cleavage of the peptide	N.A.	HPLC	50 μL of 6M Gn·HCl, 200 mM phosphate buffer at pH 7	In Vitro	None	None	N.A.
5291	33270417	2020	ENGTISRY	Peptide 1a	8	Free	Free	Linear	L	None	From human α-1-acid glycoprotein 1	Used to study glycosylation effects on deamidation	48 hours under 37 C	N.A.	31.08 (Deamidation Half Life)	N.A.	HPLC-MS	N.A.	In Vitro	None	None	N.A.
5292	33270417	2020	SYSRNHTY	Peptide 2a	8	Free	Free	Linear	L	None	From peptidyl-prolyl cis−trans isomerase FKBP10	Used to study glycosylation effects on deamidation	12 days under 37 C	N.A.	6.4 (Deamidation Half Life)	N.A.	HPLC-MS	N.A.	In Vitro	None	None	N.A.
5293	33270417	2020	EPWNSSIT	Peptide 3a	8	Free	Free	Linear	L	None	From deoxyribonuclease-2-alpha	Used to study glycosylation effects on deamidation	15 days under 37 C	N.A.	13 (Deamidation Half Life)	N.A.	HPLC-MS	N.A.	In Vitro	None	None	N.A.
5294	33270417	2020	SEGGNDSR	Peptide 4a	8	Free	Free	Linear	L	None	From protein sidekick-1	Used to study glycosylation effects on deamidation	13 days under 37 C	N.A.	13.2 (Deamidation Half Life)	N.A.	HPLC-MS	N.A.	In Vitro	None	None	N.A.
5295	33270417	2020	ASSGNATG	Peptide 5a	8	Free	Free	Linear	L	None	From the smoothened homologue	Used to study glycosylation effects on deamidation	13 days under 37 C	N.A.	18.78(Deamidation Half Life)	N.A.	HPLC-MS	N.A.	In Vitro	None	None	N.A.
5296	33270417	2020	IGLHDPSHGTLPNGS	INGAP-P	15	Free	Free	Linear	L	None	Synthetic	N.A.	N.A.	N.A.	55.9 (Deamidation Half Life)	N.A.	HPLC	N.A.	In Vitro	None	None	N.A.
5297	33115231	2020	RGDfK	ASL	5	Bodipy Tr-X Ester Linked Via (Peg)12	Free	Linear	Mix	None	Synthetic	Anticancer	N.A.	N.A.	Stable (Release Half Life)	N.A.	Fluorescent assay	PBS containing 0.05% (w/v) Tween 80	In Vitro	None	None	IC50 = 4.908 ± 0.739 μM for dEx
5342	31310433	2019	[(VPGVG)11(VPGKG)1(VPGVG)1]9-DPNYPRGHEAEDLQVGQVELGGGPGAGSLQPLALEGSLQ	K9-C-peptide hydrogel	624	Free	Human C-peptide genetically conjugated at the C-terminus of nine repeats of lysine-containing elastin-like polypeptide	Linear	L	Cy3 conjugation	ELP analogues	Antidiabetes	120 minutes	N.A.	72.3% Degradation	Elastase-2	Confocal microscopy	Reaction buffer + elastase-2	In Vitro	None	None	EC50 values of the four enzymes (collagenase-2, elastase-2, pepsin, and trypsin) were 0.17, 0.23, 510.00, and 124.60 U m/L for K9-C peptide
5343	31310433	2019	[(VPGVG)11(VPGKG)1(VPGVG)1]9-DPNYPRGHEAEDLQVGQVELGGGPGAGSLQPLALEGSLQ	K9-C-peptide hydrogel	624	Free	Human C-peptide genetically conjugated at the C-terminus of nine repeats of lysine-containing elastin-like polypeptide	Linear	L	Cy3 conjugation	ELP analogues	Antidiabetes	N.A.	N.A.	<10% Degradation	N.A.	Confocal microscopy	Reaction buffer	In Vitro	None	None	EC50 values of the four enzymes (collagenase-2, elastase-2, pepsin, and trypsin) were 0.17, 0.23, 510.00, and 124.60 U m/L for K9-C peptide
5344	31310433	2019	[(VPGVG)11(VPGKG)1(VPGVG)1]9-DPNYPRGHEAEDLQVGQVELGGGPGAGSLQPLALEGSLQ	K9-C-peptide hydrogel	624	Free	Human C-peptide genetically conjugated at the C-terminus of nine repeats of lysine-containing elastin-like polypeptide	Linear	L	Cy3 conjugation	ELP analogues	Antidiabetes	Repeated 30-min elastase-2 treatments	N.A.	48.6 ± 0.8% Degradation After First Treatment	Elastase-2	Confocal microscopy	Reaction buffer + elastase-2	In Vitro	None	None	EC50 values of the four enzymes (collagenase-2, elastase-2, pepsin, and trypsin) were 0.17, 0.23, 510.00, and 124.60 U m/L for K9-C peptide
5345	31310433	2019	[(VPGVG)11(VPGKG)1(VPGVG)1]9-DPNYPRGHEAEDLQVGQVELGGGPGAGSLQPLALEGSLQ	K9-C-peptide hydrogel	624	Free	Human C-peptide genetically conjugated at the C-terminus of nine repeats of lysine-containing elastin-like polypeptide	Linear	L	Cy3 conjugation	ELP analogues	Antidiabetes	N.A.	N.A.	89.7 ± 0.2% Degradation After Fifth Elastase Treatment	Elastase-2	Confocal microscopy	Reaction buffer + elastase-2	In Vitro	None	None	EC50 values of the four enzymes (collagenase-2, elastase-2, pepsin, and trypsin) were 0.17, 0.23, 510.00, and 124.60 U m/L for K9-C peptide
5346	31310433	2019	[(VPGVG)11(VPGKG)1(VPGVG)1]9-DPNYPRGHEAEDLQVGQVELGGGPGAGSLQPLALEGSLQ	K9-C-peptide hydrogel	624	Free	Human C-peptide genetically conjugated at the C-terminus of nine repeats of lysine-containing elastin-like polypeptide	Linear	L	Cy3 conjugation	ELP analogues	Antidiabetes	N.A.	N.A.	1.3 ± 0.6% Degradation After 1St Buffer Treatment	N.A.	Confocal microscopy	Reaction buffer	In Vitro	None	None	EC50 values of the four enzymes (collagenase-2, elastase-2, pepsin, and trypsin) were 0.17, 0.23, 510.00, and 124.60 U m/L for K9-C peptide
5347	31310433	2019	[(VPGVG)11(VPGKG)1(VPGVG)1]9-DPNYPRGHEAEDLQVGQVELGGGPGAGSLQPLALEGSLQ	K9-C-peptide hydrogel	624	Free	Human C-peptide genetically conjugated at the C-terminus of nine repeats of lysine-containing elastin-like polypeptide	Linear	L	Cy3 conjugation	ELP analogues	Antidiabetes	N.A.	N.A.	27.9 ± 2.5% Degradation After 5Th Buffer Treatment	N.A.	Confocal microscopy	Reaction buffer	In Vitro	None	None	EC50 values of the four enzymes (collagenase-2, elastase-2, pepsin, and trypsin) were 0.17, 0.23, 510.00, and 124.60 U m/L for K9-C peptide
5359	31235532	2019	LQEHPNARKYKGANKKGLSKGCFGLKLDRIGSMSGLGC	5-kDa PEG-linker CNP-38	38	PEG5KDa through permanent linker	Free	Cyclic (1 Disulfide Bond)	L	None	CNP-38 analog	Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3–related Skeletal Dysplasias	4 days	100 μg/ml	Stable	Recombinant human NEP protease	HPLC-UV	Recombinant human NEP (2.5 mg/ml) + digest buffer (50 mM Tris-HCl, 10 mM NaCl, pH 7.4)	In Vitro	None	None	Ratio IC50 CNP-38/IC50 CNP-38 conjugate = 199 ± 12 (NPR-C Affinity)
5361	31235532	2019	LQEHPNARKYKGANKKGLSKGCFGLKLDRIGSMSGLGC	4x 10-kDa PEG-linker CNP-38	38	Free	Free	Cyclic (1 Disulfide Bond)	L	PEG40KDa modification at Lys26 through permanent linker	CNP-38 analog	Treatment of Comorbidities associated with Fibroblast Growth Factor Receptor 3–Related Skeletal Dysplasias	4 days	100 μg/ml	Stable	Recombinant Human Nep Protease	HPLC-UV	Recombinant human NEP (2.5 mg/ml) + digest buffer (50 mM Tris-HCl, 10 mM NaCl, pH 7.4)	In Vitro	None	None	Ratio IC50 CNP-38/IC50 CNP-38 conjugate < 2 (NPR-C Affinity)
5366	31181805	2019	GCCSHPVCSAMSPIC	TxID	15	Free	Amidation	Cyclic (C2-C8, C3-C15 Disulfide Linkage)	L	None	Cloned from Hainan native Conus textile	Treatment of Neuropathic Pain, Addiction And Small Cell Lung Cancer	At 37 °C for 0, 1, 3, 6, 12, 24, and 48 h, respectively	0.25 mM	Less Stable	Human serum protease	RP-UPLC	Human serum	In Vitro	None	None	DSPE-PEG-TxID was still effective in inhibiting the α3β4 receptor, relative to TxID with slower reversible recovery.
5367	31181805	2019	GCCSHPVCSAMSPIC	DSPE-PEG-TxID	15	DSPE-PEG	Amidation	Cyclic (C2-C8, C3-C15 Disulfide Linkage)	L	None	Derived from TXID	Treatment of Neuropathic Pain, Addiction And Small Cell Lung Cancer	At 37 °C for 0, 1, 3, 6, 12, 24, and 48 h, respectively	0.25 mM	Stable	Human serum protease	RP-UPLC	Human serum	In Vitro	None	None	DSPE-PEG-TxID was still effective in inhibiting the α3β4 receptor, relative to TxID with slower reversible recovery.
5368	31181805	2019	GCCSHPVCSAMSPIC	DSPE-PEG-TxID	15	DSPE-PEG	Amidation	Cyclic (C2-C8, C3-C15 Disulfide Linkage)	L	None	Derived from TXID	Treatment of Neuropathic Pain, Addiction And Small Cell Lung Cancer	Investigations were made at 0, 30, 60, 90, 120, and 180 min (SIF) incubations	N.A.	Stable	Simulated intestinal fluid serum protease	N.A.	Simulated intestinal fluid serum	In Vitro	None	None	DSPE-PEG-TxID was still effective in inhibiting the α3β4 receptor, relative to TxID with slower reversible recovery.
5369	31181805	2019	GCCSHPVCSAMSPIC	TxID	15	Free	Amidation	Cyclic (C2-C8, C3-C15 Disulfide Linkage)	L	None	Cloned from Hainan native Conus textile	Treatment of Neuropathic Pain, Addiction And Small Cell Lung Cancer	Investigations were made at 0, 30, 60, 90, 120, and 180 min (SIF) incubations	N.A.	Less Stable	Simulated intestinal fluid serum protease	N.A.	Simulated intestinal fluid serum	In Vitro	None	None	DSPE-PEG-TxID was still effective in inhibiting the α3β4 receptor, relative to TxID with slower reversible recovery.
5397	31079216	2019	pGlu-LYENKPRRPYIL	NT	13	pGlu = Pyroglutamate	Free	Linear	L	None	Isolated from bovine hypothalamus	Dual function as a neurotransmitter/neuromodulator in the Central Nervous System (CNS) and as a hormone/cellular mediator in peripheral tissues, such as the gastrointestinal tract and adipose tissue	24 h incubation at 37 °C	160 μM	Lower Stability	Human plasma protease	UHPLC	Human plasma	In Vitro	PDB id: 2LNE	None	−LogIC50±SE = 9.54±0.42 in Neurotensin (1–13) for NTS1 receptor
5398	31079216	2019	KPyIL	NT-5	4	AOPC8 = 1‑(2‑(2‑aminophenyl)‑2‑oxoethyl)‑1H‑pyrrole‑2‑ carboxylic acid (AOPC)	Free	Linear	Mix	Lys9, d-Tyr(Et)11 modification in NT(8–13)	NT analogue	Dual function as a neurotransmitter/neuromodulator in the Central Nervous System (CNS) and as a hormone/cellular mediator in peripheral tissues, such as the gastrointestinal tract and adipose tissue	24 h incubation at 37 °C	160 μM	Higher stability than NT	Human plasma protease	UHPLC	Human plasma	In Vitro	None	None	−LogIC50±SE = 5.63±0.15 in Neurotensin (1–13) for NTS1 receptor
5399	31079216	2019	rPyIL	NT-6	5	AOPC8 = 1‑(2‑(2‑aminophenyl)‑2‑oxoethyl)‑1H‑pyrrole‑2‑ carboxylic acid (AOPC), d-Arg9 modification at N terminal	Free	Linear	Mix	d-Tyr(Et)11 modification in NT(8–13)	NT analogue	Dual function as a neurotransmitter/neuromodulator in the Central Nervous System (CNS) and as a hormone/cellular mediator in peripheral tissues, such as the gastrointestinal tract and adipose tissue	24 h incubation at 37 °C	160 μM	Higher stability than NT	Human plasma protease	UHPLC	Human plasma	In Vitro	None	None	−LogIC50±SE = 5.53±0.31 in Neurotensin (1–13) for NTS1 receptor
5400	31079216	2019	KrPyIL	NT-8	6	AOPC8 = 1‑(2‑(2‑aminophenyl)‑2‑oxoethyl)‑1H‑pyrrole‑2‑ carboxylic acid (AOPC)	Free	Linear	Mix	Lys8, d-Arg9, d-Tyr(Et)11] modification in NT(7–13)	NT analogue	Dual function as a neurotransmitter/neuromodulator in the Central Nervous System (CNS) and as a hormone/cellular mediator in peripheral tissues, such as the gastrointestinal tract and adipose tissue	24 h incubation at 37 °C	160 μM	Higher stability than NT	Human plasma protease	UHPLC	Human plasma	In Vitro	None	None	−LogIC50±SE = 5.28±0.20 in Neurotensin (1–13) for NTS1 receptor
5422	30973007	2019	QNSPNI-NMeF-GQWM	GBAP 11	14	Free	Free	Cyclic (Ser3-Met11 bond)	L	N-methylation at Phe7	GBAP analogs	Antibacterial	Time points were taken at 0 min, 30 min, 1 hr, 2 hr, 4 hr, 8 hr, and 24 hr	0.28 mM	Highly Stable	Chymotrypsin	HPLC	PBS buffer + chymotrypsin	In Vitro	None	None	EC50(nM) = 6.3 for GBAP-[N-MeF7]
5462	30690406	2019	KFRRQRPRLSHKGPMPF	Apelin4	17	Free	Free	Linear	L	None	Apelin analogs	Blood Pressure lowering agents	37 C for up to 72 h	N.A.	N.A.	RHNEP	LC-MS	Apelin4	In Vitro	None	None	EC50(nM) = 568 ± 34
5463	30690406	2019	KFRRQRPRLSHKGPMPF	Apelin5	17	Free	Free	Linear	L	R2=Me, Methylation at Gln5	Apelin analogs	Blood Pressure lowering agents	37 C for up to 72 h	N.A.	N.A.	RHNEP	LC-MS	Apelin5	In Vitro	None	None	EC50(nM) = 176 ± 21
5471	30690406	2019	KFRRQRPRLSHKGPMPF	Apelin4	17	Free	Free	Linear	L	None	Apelin analogs	Blood Pressure lowering agents	37 C for up to 72 h	N.A.	N.A.	RhKLKB1	LC-MS	Apelin4	In Vitro	None	None	EC50(nM) = 568 ± 34
5472	30690406	2019	KFRRQRPRLSHKGPMPF	Apelin5	17	Free	Free	Linear	L	R2=Me, Methylation at Glu5	Apelin analogs	Blood Pressure lowering agents	37 C for up to 72 h	N.A.	N.A.	RhKLKB1	LC-MS	Apelin5	In Vitro	None	None	EC50(nM) = 176 ± 21
5480	30690406	2019	KFRRQRPRLSHKGPMPF	Apelin4	17	Free	Free	Linear	L	None	Apelin analogs	Blood Pressure lowering agents	37 C for up to 72 h	N.A.	N.A.	hplasma protease	LC-MS	hplasma	In Vitro	None	None	EC50(nM) = 568 ± 34
5481	30690406	2019	KFRRQRPRLSHKGPMPF	Apelin5	17	Free	Free	Linear	L	R2=Me, Methylation at Glu5	Apelin analogs	Blood Pressure lowering agents	37 C for up to 72 h	N.A.	N.A.	hplasma protease	LC-MS	hplasma	In Vitro	None	None	EC50(nM) = 176 ± 21
5522	30543420	2019	(QLYSALANKCCHVGVOKRSLARFC)-(ASWMEEVIKLCGRELVRAQIAICGMSTWC)	R3-01	53	Free	FA-01	Linear	L	B-S29C,D1A Cys mutation	R3 based relaxin analogs	Role in Hemodynamics and Renal function and has shown preclinical efficacy in multiple disease models, including Acute Heart Failure, Fibrosis, Preeclampsia, and Corneal Wound Healing	N.A.	0.3 mg/kg	N.A.	Mouse plasma protease	LC-MS	Mouse plasma	In Vivo	None	None	EC50(nM) = 4.3 ± 0.005
5525	30543420	2019	(QLYSALANKCCHVGVOKRSLARFC)-(ASWMEEVIKLCGRELVRAQIAICGMSTWC)	R3-08	53	Free	FA-08	Linear	L	B-S29C,D1A Cys mutation	R3 based relaxin analogs	Role In Hemodynamics And Renal Function And Has Shown Preclinical Efficacy In Multiple Disease Models, Including Acute Heart Failure, Fibrosis, Preeclampsia, And Corneal Wound Healing	N.A.	0.3 mg/kg	N.A.	Mouse plasma protease	LC-MS	mouse plasma	In Vivo	None	None	EC50(nM) = 1.5
5526	30543420	2019	(QLYSALANKCCHVGVOKRSLARFC)-(ASWMEEVIKLCGRELVRAQIAICGMSTWC)	R3-09	53	Free	FA-09	Linear	L	B-S29C,D1A Cys mutation	R3 based relaxin analogs	Role In Hemodynamics And Renal Function And Has Shown Preclinical Efficacy In Multiple Disease Models, Including Acute Heart Failure, Fibrosis, Preeclampsia, And Corneal Wound Healing	N.A.	0.3 mg/kg	N.A.	Mouse plasma protease	LC-MS	mouse plasma	In Vivo	None	None	EC50(nM) = 0.8
5555	31615671	2019	NSEIQNAVEVEEVVLPSIESPTENLPNNGSVVQPPSRSSPAGRPAIWIKDFVWGHIRPRRLTNDRLADMPLERRESWARTQEEGG	Free-ADI	85	Free	Free	Linear	L	None	Isolated from Thermophilic Aspergillus nidulans	Anticancer	4°C	N.A.	1445 (Activity Half Life)	Mice plasma protease	Standard assay	Mice plasma	In Vivo	None	None	IC50 = 6.3 ± 0.6(μmol/mg/min) in HepG-2 cells
5556	31615671	2019	NSEIQNAVEVEEVVLPSIESPTENLPNNGSVVQPPSRSSPAGRPAIWIKDFVWGHIRPRRLTNDRLADMPLERRESWARTQEEGG	Dextran-ADI	85	Free	Free	Linear	L	ADI was conjugated to dextran- reactive aldehyde groups via the formation of aldimine linkage	Synthetic	Anticancer	4°C	N.A.	2440 (Activity Half Life)	Mice plasma protease	Standard assay	Mice plasma	In Vivo	None	None	IC50 = 4.7 ± 0.9 (μmol/mg/min) in HepG-2 cells
5557	31615671	2019	NSEIQNAVEVEEVVLPSIESPTENLPNNGSVVQPPSRSSPAGRPAIWIKDFVWGHIRPRRLTNDRLADMPLERRESWARTQEEGG	Free-ADI	85	Free	Free	Linear	L	None	Isolated from Thermophilic Aspergillus nidulans	Anticancer	30 °C	N.A.	23.5 (Activity Half Life)	Mice plasma protease	Standard assay	Mice plasma	In Vivo	None	None	IC50 = 6.3 ± 0.6(μmol/mg/min) in HepG-2 cells
5558	31615671	2019	NSEIQNAVEVEEVVLPSIESPTENLPNNGSVVQPPSRSSPAGRPAIWIKDFVWGHIRPRRLTNDRLADMPLERRESWARTQEEGG	Dextran-ADI	85	Free	Free	Linear	L	ADI was conjugated to dextran- reactive aldehyde groups via the formation of aldimine linkage	Synthetic	Anticancer	30 °C	N.A.	40.2 (Activity Half Life)	Mice plasma protease	Standard assay	Mice plasma	In Vivo	None	None	IC50 = 4.7 ± 0.9 (μmol/mg/min) in HepG-2 cells
5559	31615671	2019	NSEIQNAVEVEEVVLPSIESPTENLPNNGSVVQPPSRSSPAGRPAIWIKDFVWGHIRPRRLTNDRLADMPLERRESWARTQEEGG	Free-ADI	85	Free	Free	Linear	L	None	Isolated from Thermophilic Aspergillus nidulans	Anticancer	37°C	N.A.	17.3 (Activity Half Life)	Mice plasma protease	Standard assay	Mice plasma	In Vivo	None	None	IC50 = 6.3 ± 0.6(μmol/mg/min) in HepG-2 cells
5560	31615671	2019	NSEIQNAVEVEEVVLPSIESPTENLPNNGSVVQPPSRSSPAGRPAIWIKDFVWGHIRPRRLTNDRLADMPLERRESWARTQEEGG	Dextran-ADI	85	Free	Free	Linear	L	ADI was conjugated to dextran- reactive aldehyde groups via the formation of aldimine linkage	Synthetic	Anticancer	37°C	N.A.	34.2 (Activity Half Life)	Mice plasma protease	Standard assay	Mice plasma	In Vivo	None	None	IC50 = 4.7 ± 0.9 (μmol/mg/min) in HepG-2 cells
5561	31615671	2019	NSEIQNAVEVEEVVLPSIESPTENLPNNGSVVQPPSRSSPAGRPAIWIKDFVWGHIRPRRLTNDRLADMPLERRESWARTQEEGG	Free-ADI	85	Free	Free	Linear	L	None	Isolated from Thermophilic Aspergillus nidulans	Anticancer	45°C	N.A.	3.4 (Activity Half Life)	Mice plasma protease	Standard assay	Mice plasma	In Vivo	None	None	IC50 = 6.3 ± 0.6(μmol/mg/min) in HepG-2 cells
5562	31615671	2019	NSEIQNAVEVEEVVLPSIESPTENLPNNGSVVQPPSRSSPAGRPAIWIKDFVWGHIRPRRLTNDRLADMPLERRESWARTQEEGG	Dextran-ADI	85	Free	Free	Linear	L	ADI was conjugated to dextran- reactive aldehyde groups via the formation of aldimine linkage	Synthetic	Anticancer	45°C	N.A.	8.4 (Activity Half Life)	Mice plasma protease	Standard assay	Mice plasma	In Vivo	None	None	IC50 = 4.7 ± 0.9 (μmol/mg/min) in HepG-2 cells
5563	31536939	2019	ALLANHEELFQT-GGGSK	ALL*labeled nanocarriers	12	Free	D-Α-Tocopherol Succinate Linked Via Peg	Linear	L	Peptides are attached via a GGGSK linker to the nanocarrier surface via a thioether-mediated conjugation	Synthetic	Anticancer (therapy of hepatocellular carcinoma)	37 °C for 0, 1, 2, 6, 12, and 24 h	30 μM	22.7 ( Sorafenib Release Half Life)	Mouse serum protease	HPLC	Mouse serum	N.A.	None	None	IC50 = 3.6 μM show greater toxicity to Hep3B cells in vitro
5564	31536939	2019	QLELTFHANLEA-GGGSK	QLE* labeled nanocarriers	12	Free	D-Α-Tocopherol Succinate Linked Via Peg	Linear	L	Peptides are attached via a GGGSK linker to the nanocarrier surface via a thioether-mediated conjugation	Synthetic	Anticancer (therapy of hepatocellular carcinoma)	37 °C for 0, 1, 2, 6, 12, and 24 h	30 μM	19.5 (Sorafenib Release Half Life)	Mouse serum protease	HPLC	Mouse serum	N.A.	None	None	IC50 = 6.0 μM show lesser toxicity to Hep3B cells in vitro
5565	31376486	2019	MRLTWTCLLTLVLVTAACEAPGEEPVPAEEAVPALKEVFADAFLVGAALNPDQFYGRDTLGVALITKHFNTITPENVMKWEQIHPEPDRYDFEAADRFVAFGEERDLFIVGHTLVWHNQTPDWVFEDDRGEPLTREALLERMRDHIQTVVGRYRGRVDGWDVVNEALNEDGTLRPTRWLEIIGEDYLAHAFRFAHEADPQAELYYNDYSLTNPAKREGAVRLVQGLLDAGVPVTGIGMQGHYALTYPTLEELETSITTFAGLGVDVMITELDVAVLPRPSEYWGADVSRREELRAELDPYREAFPDSMQQALADRYAGFFEVFLRQQEALTRVTFWGVTDGDSWLNNWPIRGRTSYPLLFDRAYRPKPAFFAVVATARE	Recombinant XynRA1	379	Free	Free	Linear	L	None	Derived from Rhodothermaceae bacterium RA	Endo-1,4-β-xylanase	60 °C	N.A.	1 (Activity Half Life)	N.A.	BCA Protein Assay	N.A.	In Vitro	Uniprot id: A0A1V0DJ74	None	XynRA1 enzyme retained 80% of its maximal activity for 5 h
5566	31281949	2019	KDQSPLAGESGETEYITEVYGNQQNPVDIDKKLPNETGFSGNMVETEDT	FUD	49	Free	Free	Linear	L	Sulfo-Cy5 fluorophore	Synthetic	Therapeutic candidate for disorders linked with hyperdeposition of fibronectin-modulated ECM proteins	At time points of 30 min and 1, 3, 6, 12, 24, 36, and 48 h	12.5 mg/kg	0.81 (Abosrption Half Life)	N.A.	Fluorescence in vivo imaging	Mice	In Vivo	https://pmc.ncbi.nlm.nih.gov/articles/PMC5705399/	None	N.A.
5567	31281949	2019	KDQSPLAGESGETEYITEVYGNQQNPVDIDKKLPNETGFSGNMVETEDT	10K PEG-FUD	49	10K PEG	Free	Linear	L	Sulfo-Cy5 fluorophore	Synthetic	Therapeutic candidate for disorders linked with hyperdeposition of fibronectin-modulated ECM proteins	At time points of 30 min and 1, 3, 6, 12, 24, 36, and 48 h	12.5 mg/kg	3.28 (Abosrption Half Life)	N.A.	Fluorescence in vivo imaging	Mice	In Vivo	https://pmc.ncbi.nlm.nih.gov/articles/PMC5705399/	None	N.A.
5568	31281949	2019	KDQSPLAGESGETEYITEVYGNQQNPVDIDKKLPNETGFSGNMVETEDT	20K PEG-FUD	49	20K PEG	Free	Linear	L	Sulfo-Cy5 fluorophore	Synthetic	Therapeutic candidate for disorders linked with hyperdeposition of fibronectin-modulated ECM proteins	At time points of 30 min and 1, 3, 6, 12, 24, 36, and 48 h	12.5 mg/kg	6.77 (Abosrption Half Life)	N.A.	Fluorescence in vivo imaging	Mice	In Vivo	https://pmc.ncbi.nlm.nih.gov/articles/PMC5705399/	None	N.A.
5569	31281949	2019	KDQSPLAGESGETEYITEVYGNQQNPVDIDKKLPNETGFSGNMVETEDT	40K PEG-FUD	49	40K PEG	Free	Linear	L	Sulfo-Cy5 fluorophore	Synthetic	Therapeutic candidate for disorders linked with hyperdeposition of fibronectin-modulated ECM proteins	At time points of 30 min and 1, 3, 6, 12, 24, 36, and 48 h	12.5 mg/kg	10.09 (Abosrption Half Life)	N.A.	Fluorescence in vivo imaging	Mice	In Vivo	https://pmc.ncbi.nlm.nih.gov/articles/PMC5705399/	None	N.A.
5570	31281949	2019	KDQSPLAGESGETEYITEVYGNQYNSVDPDKKLINEGGFSTNMVEPEDT	mFUD	49	Free	Free	Linear	L	Sulfo-Cy5 fluorophore	Synthetic	Therapeutic candidate for disorders linked with hyperdeposition of fibronectin-modulated ECM proteins	At time points of 30 min and 1, 3, 6, 12, 24, 36, and 48 h	12.5 mg/kg	0.86 (Abosrption Half Life)	N.A.	Fluorescence in vivo imaging	Mice	In Vivo	https://pmc.ncbi.nlm.nih.gov/articles/PMC5705399/	None	N.A.
5571	31281949	2019	KDQSPLAGESGETEYITEVYGNQQNPVDIDKKLPNETGFSGNMVETEDT	10K PEG-mFUD	49	10K PEG	Free	Linear	L	Sulfo-Cy5 fluorophore	Synthetic	Therapeutic candidate for disorders linked with hyperdeposition of fibronectin-modulated ECM proteins	At time points of 30 min and 1, 3, 6, 12, 24, 36, and 48 h	12.5 mg/kg	3.06 (Abosrption Half Life)	N.A.	Fluorescence in vivo imaging	Mice	In Vivo	https://pmc.ncbi.nlm.nih.gov/articles/PMC5705399/	None	N.A.
5572	31281949	2019	KDQSPLAGESGETEYITEVYGNQQNPVDIDKKLPNETGFSGNMVETEDT	20K PEG-mFUD	49	20K PEG	Free	Linear	L	Sulfo-Cy5 fluorophore	Synthetic	Therapeutic candidate for disorders linked with hyperdeposition of fibronectin-modulated ECM proteins	At time points of 30 min and 1, 3, 6, 12, 24, 36, and 48 h	12.5 mg/kg	5.25 (Abosrption Half Life)	N.A.	Fluorescence in vivo imaging	Mice	In Vivo	https://pmc.ncbi.nlm.nih.gov/articles/PMC5705399/	None	N.A.
5573	31281949	2019	KDQSPLAGESGETEYITEVYGNQQNPVDIDKKLPNETGFSGNMVETEDT	40K PEG-mFUD	49	40K PEG	Free	Linear	L	Sulfo-Cy5 fluorophore	Synthetic	Therapeutic candidate for disorders linked with hyperdeposition of fibronectin-modulated ECM proteins	At time points of 30 min and 1, 3, 6, 12, 24, 36, and 48 h	12.5 mg/kg	8.36 (Abosrption Half Life)	N.A.	Fluorescence in vivo imaging	Mice	In Vivo	https://pmc.ncbi.nlm.nih.gov/articles/PMC5705399/	None	N.A.
5574	31067782	2019	G(VPGVG)96Y	Rhodamine-labeled V96	482	Free	Free	Linear	L	Rhodamine labeling	Synthetic	Increases half life	37°C, Small aliquots of the solution (100 µL) were withdrawn at predetermined intervals (5, 15, 30 min, 1, 2, 4, 8, 24, 48, 72, 96, 120, 168 h)	100 µM	0.2 (T1/2 Fast Release Kinetics)	N.A.	Fluorescence assay	Proclear CompatiblesTM contact lenses	In Vivo	None	None	N.A.
5575	31067782	2019	G(VPGVG)96Y	Rhodamine-labeled V96	482	Free	Free	Linear	L	Rhodamine labeling	Synthetic	Increases half life	37°C, Small aliquots of the solution (100 µL) were withdrawn at predetermined intervals (5, 15, 30 min, 1, 2, 4, 8, 24, 48, 72, 96, 120, 168 h)	100 µM	4615 (T1/2 Slow Release Kinetics)	N.A.	Fluorescence assay	Proclear CompatiblesTM contact lenses	In Vivo	None	None	N.A.
5576	31067782	2019	G(VPGVG)96Y	Rhodamine-labeled V96	482	Free	Free	Linear	L	Rhodamine labeling	Synthetic	Increases half life	4°C, Small aliquots of the solution (100 µL) were withdrawn at predetermined intervals (5, 15, 30 min, 1, 2, 4, 8, 24, 48, 72, 96, 120, 168 h)	100 µM	0.2 (T1/2 Fast Release Kinetics)	N.A.	Fluorescence assay	Proclear CompatiblesTM contact lenses	In Vivo	None	None	N.A.
5577	31067782	2019	G(VPGVG)96Y	Rhodamine-labeled V96	482	Free	Free	Linear	L	Rhodamine labeling	Synthetic	Increases half life	4°C, Small aliquots of the solution (100 µL) were withdrawn at predetermined intervals (5, 15, 30 min, 1, 2, 4, 8, 24, 48, 72, 96, 120, 168 h)	100 µM	96.2 (T1/2 Slow Release Kinetics)	N.A.	Fluorescence assay	Proclear CompatiblesTM contact lenses	In Vivo	None	None	N.A.
5578	31067782	2019	G(VPGSG)96Y	Rhodamine-labeled S96	482	Free	Free	Linear	L	Rhodamine labeling	Synthetic	Increases half life	37°C, Small aliquots of the solution (100 µL) were withdrawn at predetermined intervals (5, 15, 30 min, 1, 2, 4, 8, 24, 48, 72, 96, 120, 168 h)	100 µM	0.2 (T1/2 Fast Release Kinetics)	N.A.	Fluorescence assay	Proclear CompatiblesTM contact lenses	In Vivo	None	None	N.A.
5579	31067782	2019	G(VPGSG)96Y	Rhodamine-labeled S96	482	Free	Free	Linear	L	Rhodamine labeling	Synthetic	Increases half life	37°C, Small aliquots of the solution (100 µL) were withdrawn at predetermined intervals (5, 15, 30 min, 1, 2, 4, 8, 24, 48, 72, 96, 120, 168 h)	100 µM	137.1 (T1/2 Slow Release Kinetics)	N.A.	Fluorescence assay	Proclear CompatiblesTM contact lenses	In Vivo	None	None	N.A.
5580	31067782	2019	G(VPGVG)96Y	V96	482	Free	Free	Linear	L	None	Synthetic	Increases half life	N.A.	N.A.	4 (Retention Half Life)	N.A.	N.A.	Solution	N.A.	None	None	N.A.
5581	30684538	2019	LVIWINGDK	Tryptic peptide	9	Free	Free	Linear	L	N23G24	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	400 ± 100 (Deamidation Half Life)	Trypsin	LC-MS	WT - MBP	In Vitro	None	None	N.A.
5582	30684538	2019	GYNGLAEVGK	Tryptic peptide	10	Free	Free	Linear	L	N29G30	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	1100 ± 700(Deamidation Half Life)	Trypsin	LC-MS	WT - MBP	In Vitro	None	None	N.A.
5583	30684538	2019	LYPFTWDAVRYNGK	Tryptic peptide	14	Free	Free	Linear	L	N111G112	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	18 ± 2 (Deamidation Half Life)	Trypsin	LC-MS	WT - MBP	In Vitro	None	None	N.A.
5584	30684538	2019	YENGKYDIK	Tryptic peptide	9	Free	Free	Linear	L	N184G185	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	12 ± 1 (Deamidation Half Life)	Trypsin	LC-MS	WT - MBP	In Vitro	None	None	N.A.
5585	30684538	2019	GETAMTINGPWAWSNIDTSK	Tryptic peptide	20	Free	Free	Linear	L	N238G239	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	N.A.	Trypsin	LC-MS	WT - MBP	In Vitro	None	None	N.A.
5586	30684538	2019	DVGVDNAGAK	Tryptic peptide	10	Free	Free	Linear	L	N196A197	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	120 ± 10 (Deamidation Half Life)	Trypsin	LC-MS	WT - MBP	In Vitro	None	None	N.A.
5587	30684538	2019	TAVINAASGR	Tryptic peptide	10	Free	Free	Linear	L	N360A361	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	630 ± 30 ( Deamidation Half Life)	Trypsin	LC-MS	WT - MBP	In Vitro	None	None	N.A.
5588	30684538	2019	LVIWINGDK	Peptic peptide	9	Free	Free	Linear	L	N23G24	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	200 ± 40 (Deamidation Half Life)	Pepsin	LC-MS	Mutant MBP	In Vitro	None	None	N.A.
5589	30684538	2019	GYNGLAEVGK	Peptic peptide	10	Free	Free	Linear	L	N29G30	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	500 ± 200 (Deamidation Half Life)	Pepsin	LC-MS	Mutant MBP	In Vitro	None	None	N.A.
5590	30684538	2019	LYPFTWDAVRYNGK	Peptic peptide	14	Free	Free	Linear	L	N111G112	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	12 ± 5 (Deamidation Half Life)	Pepsin	LC-MS	Mutant MBP	In Vitro	None	None	N.A.
5591	30684538	2019	YENGKYDIK	Peptic peptide	9	Free	Free	Linear	L	N184G185	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	2.0 ± 0.5 (Deamidation Half Life)	Pepsin	LC-MS	Mutant MBP	In Vitro	None	None	N.A.
5592	30684538	2019	GETAMTINGPWAWSNIDTSK	Peptic peptide	20	Free	Free	Linear	L	N238G239	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	N.A.	Pepsin	LC-MS	Mutant MBP	In Vitro	None	None	N.A.
5593	30684538	2019	DVGVDNAGAK	Peptic peptide	10	Free	Free	Linear	L	N196A197	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	50 ± 2 (Deamidation Half Life)	Pepsin	LC-MS	Mutant MBP	In Vitro	None	None	N.A.
5594	30684538	2019	TAVINAASGR	Peptic peptide	10	Free	Free	Linear	L	N360A361	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 µM	120 ± 4 (Deamidation Half Life)	Pepsin	LC-MS	Mutant MBP	In Vitro	None	None	N.A.
5595	30676716	2019	IAVEEEE	APA1	7	SATHA-FBA	Free	Linear	L	R=OMe	Synthetic	Increase half life of H2S	N.A.	0.1 mg/mL	31 ± 8 (H2S Release Half Life)	Dilute APA solution protease	Methylene blue method	Dilute APA solution	In Vitro	None	None	N.A.
5596	30676716	2019	IAVEEEE	APA2	7	SATHA-FBA	Free	Linear	L	R=Me	Synthetic	Increase half life of H2S	N.A.	0.1 mg/mL	22±4 (H2S Release Half Life)	Dilute APA solution protease	Methylene blue method	Dilute APA solution	In Vitro	None	None	N.A.
5597	30676716	2019	IAVEEEE	APA3	7	SATHA-FBA	Free	Linear	L	None	Synthetic	Increase half life of H2S	N.A.	0.1 mg/mL	19±8 (H2S Release Half Life)	Dilute APA solution protease	Methylene blue method	Dilute APA solution	In Vitro	None	None	N.A.
5598	30676716	2019	IAVEEEE	APA4	7	SATHA-FBA	Free	Linear	L	R=F	Synthetic	Increase half life of H2S	N.A.	0.1 mg/mL	14±2 (H2S Release Half Life)	Dilute APA solution protease	Methylene blue method	Dilute APA solution	In Vitro	None	None	N.A.
5599	30676716	2019	IAVEEEE	APA5	7	SATHA-FBA	Free	Linear	L	R=Cl	Synthetic	Increase half life of H2S	N.A.	0.1 mg/mL	13±4 (H2S Release Half Life)	Dilute APA solution protease	Methylene blue method	Dilute APA solution	In Vitro	None	None	N.A.
5600	33224505	2019	AREYGTRFSLIGGYR-GGGGKKKK	AR-Bi@SiO2-Gd/DOX NPs	23	Free	C-Terminal End Of The Ar Peptide Was Added With An Nh2-Rich Linker (GGGGKKKK)	Linear	L	None	Synthetic	Antitumor (Tumor homing )	N.A.	N.A.	104.5 (Tumor Retention Half Life)	N.A.	ICP-MS	N.A.	In Vivo	None	None	N.A.
5601	30344018	2019	N.A.	ASN	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	B. cereus BDRD-ST26 (P43-amyE-BcA)	Production of acrylamide-free food	50 C	N.A.	17.35 (Activity Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	Km = 9.38 mM
5602	30344018	2019	N.A.	ASN	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	B. cereus BDRD-ST26 (P43-BcA)	Production of acrylamide-free food	50 C	N.A.	17.57 (Activity Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	km = 9.41 mM
5603	30344018	2019	N.A.	ASN	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	B. subtilis 168	Production of acrylamide-free food	65 C	N.A.	61 (Activity Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	km = 5.3 mM
5604	30344018	2019	N.A.	ASN	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	T. kodakaraensis 1656	Production of acrylamide-free food	85 C	N.A.	130 (Activity Half Life)	N.A.	N.A.	N.A.	N.A.	None	None	km = 5.5 mM
5605	30684538	2019	HMNADTDYSIAEAAFNK	Tryptic peptide	17	Free	Free	Linear	L	N216A217	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	N.A.	Trypsin	LC-MS	WT - MBP	In Vitro	None	None	N.A.
5606	30684538	2019	PFVGVLSAGINAASPNK	Tryptic peptide	17	Free	Free	Linear	L	N278A279	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	N.A.	Trypsin	LC-MS	WT - MBP	In Vitro	None	None	N.A.
5607	30684538	2019	IAATMENAQK	Tryptic peptide	10	Free	Free	Linear	L	N278A279	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	N.A.	Trypsin	LC-MS	WT - MBP	In Vitro	None	None	N.A.
5608	30684538	2019	HMNADTDYSIAEAAFNK	Peptic peptide	17	Free	Free	Linear	L	N216A217	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	N.A.	Pepsin	LC-MS	Mutant MBP	In Vitro	None	None	N.A.
5609	30684538	2019	PFVGVLSAGINAASPNK	Peptic peptide	17	Free	Free	Linear	L	N278A279	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	N.A.	Pepsin	LC-MS	Mutant MBP	In Vitro	None	None	N.A.
5610	30684538	2019	IAATMENAQK	Peptic peptide	10	Free	Free	Linear	L	N278A279	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	N.A.	Pepsin	LC-MS	Mutant MBP	In Vitro	None	None	N.A.
5611	30684538	2019	VIWINGDKGY	Tryptic peptide	10	Free	Free	Linear	L	N23G24	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	980 ± 60 (Hx Half Life)	Trypsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	WT - MBP	In Vitro	None	None	N.A.
5612	30684538	2019	VIWINGDKGYNGL	Tryptic peptide	13	Free	Free	Linear	L	N29G30	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	1300 ± 100 (Hx Half Life)	Trypsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	WT - MBP	In Vitro	None	None	N.A.
5613	30684538	2019	VRYNGKL	Tryptic peptide	7	Free	Free	Linear	L	N111G112	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	150 ± 10 (Hx Half Life)	Trypsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	WT - MBP	In Vitro	None	None	N.A.
5614	30684538	2019	FKYENGKY	Tryptic peptide	8	Free	Free	Linear	L	N184G185	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	<30 (Hx Half Life)	Trypsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	WT - MBP	In Vitro	None	None	N.A.
5615	30684538	2019	TINGPWAWSN	Tryptic peptide	10	Free	Free	Linear	L	N238G239	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	10,900 ± 400 (Hx Half Life)	Trypsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	WT - MBP	In Vitro	None	None	N.A.
5616	30684538	2019	VGVDNAGAKAGLTF	Tryptic peptide	14	Free	Free	Linear	L	N196A197	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	<30 (Hx Half Life)	Trypsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	WT - MBP	In Vitro	None	None	N.A.
5617	30684538	2019	YAVRTAVINAASGRQTVDE	Tryptic peptide	19	Free	Free	Linear	L	N360A361	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	<30 (Hx Half Life)	Trypsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	WT - MBP	In Vitro	None	None	N.A.
5618	30684538	2019	VDLIKNKHMNADTDY	Tryptic peptide	15	Free	Free	Linear	L	N216A217	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	270 ± 30 (Hx Half Life)	Trypsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	WT - MBP	In Vitro	None	None	N.A.
5619	30684538	2019	SAGINAASPNKEL	Tryptic peptide	13	Free	Free	Linear	L	N278A279	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	3800 ± 400 (Hx Half Life)	Trypsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	WT - MBP	In Vitro	None	None	N.A.
5620	30684538	2019	AKDPRIAATMENAQKGEIM	Tryptic peptide	19	Free	Free	Linear	L	N278A279	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	35,000 ± 900 (Hx Half Life)	Trypsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	WT - MBP	In Vitro	None	None	N.A.
5621	30684538	2019	VIWINGDKGY	Peptic peptide	10	Free	Free	Linear	L	N23G24	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	700 ± 60 (Hx Half Life)	Pepsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	Mutant MBP	In Vitro	None	None	N.A.
5622	30684538	2019	VIWINGDKGYNGL	Peptic peptide	13	Free	Free	Linear	L	N29G30	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	600 ± 20 (Hx Half Life)	Pepsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	Mutant MBP	In Vitro	None	None	N.A.
5623	30684538	2019	VRYNGKL	Peptic peptide	7	Free	Free	Linear	L	N111G112	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	130 ± 5 (Hx Half Life)	Pepsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	Mutant MBP	In Vitro	None	None	N.A.
5624	30684538	2019	FKYENGKY	Peptic peptide	8	Free	Free	Linear	L	N184G185	MBP analog	Model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	<30 (Hx Half Life)	Pepsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	Mutant MBP	In Vitro	None	None	N.A.
5625	30684538	2019	TINGPWAWSN	Peptic peptide	10	Free	Free	Linear	L	N238G239	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	7800 ± 100 (Hx Half Life)	Pepsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	Mutant MBP	In Vitro	None	None	N.A.
5626	30684538	2019	VGVDNAGAKAGLTF	Peptic peptide	14	Free	Free	Linear	L	N196A197	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	<30 (Hx Half Life)	Pepsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	Mutant MBP	In Vitro	None	None	N.A.
5627	30684538	2019	YAVRTAVINAASGRQTVDE	Peptic peptide	19	Free	Free	Linear	L	N360A361	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	<30 (Hx Half Life)	Pepsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	Mutant MBP	In Vitro	None	None	N.A.
5628	30684538	2019	VDLIKNKHMNADTDY	Peptic peptide	15	Free	Free	Linear	L	N216A217	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	<30 (Hx Half Life)	Pepsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	Mutant MBP	In Vitro	None	None	N.A.
5629	30684538	2019	SAGINAASPNKEL	Peptic peptide	13	Free	Free	Linear	L	N278A279	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	2600 ± 100 (Hx Half Life)	Pepsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	Mutant MBP	In Vitro	None	None	N.A.
5630	30684538	2019	AKDPRIAATMENAQKGEIM	Peptic peptide	19	Free	Free	Linear	L	N278A279	MBP analog	model protein	Wild-type and mutant MBP samples were collected after 1, 3, 6, 9, and 12 and 1, 3, 5, 7, 9, and 12 calendar months,pH 7.0 at 23 ± 2C	20 μM	16,700 ± 20 (Hx Half Life)	Pepsin	Hydrogen Exchange Mass Spectrometry (HX-MS)	Mutant MBP	In Vitro	None	None	N.A.
5631	30809901	2019	N.A.	FITC-AAR029b	N.A.	Fluorescein isothiocynate labeled	Free	Macrocyclic	L	None	Derived from a class of peptides known as cyclic peptide triazoles (cPTs)	Antiviral	N.A.	0.01 mg/kg	0.029 ± 0.01 (T1/2Α-Distribution Half Life)	Rats plasma protease	Fluorescence assay	Rats plasma	In Vivo	None	None	EC50(nM) = 210±16 for AAR029b in Bal.01 virus
5632	30809901	2019	N.A.	FITC-AAR029b in Liposome	N.A.	Fluorescein isothiocynate labeled	Free	Macrocyclic	L	None	Derived from a class of peptides known as cyclic peptide triazoles (cPTs)	Antiviral	N.A.	0.01 mg/kg	0.032 ± 0.005 (T1/2Α-Distribution Half Life)	Rats plasma protease	Fluorescence assay	Rats plasma	In Vivo	None	None	EC50(nM) = 210±16 for AAR029b in Bal.01 virus
5638	30411073	2018	MVRIKPGSANKPSDD	sPIF	15	Free	Free	Linear	L	None	Human embryo‐derived peptide analogs	Treatment of Autoimmune Hepatitis	Patients’ serum samples were collected and analyzed at five different time points: screening (day ‐28 to day 0), pre‐injection (day 0), and postinjection days 1, 2, and 8	0.1 mg/kg	N.A.	Human serum protease	LC-MS	Human serum	In Vivo	None	None	N.A.
5698	29958697	2018	TLQPPASSRRRHFHHALPPAR	125I-TLQP-21	21	125I labelled	Free	Linear	L	None	Derived from the proteolytic cleavage of the 617-aa VGF	Isoproterenol stimulated lipolysis	At the time points of 0 min, 10 min, 30 min, and 60 min, aliquots of the incubated solutions were withdrawn (15uL)	1 mM	0.97 (T1/2 Initial Phase)	Rats plasma protease	LC-MS	Rats plasma volume reduced to 12.5 ml	In Vitro	None	None	N.A.
5756	29673717	2018	HGEGTFTSDV-X1-SYLEGQAAKEFIAWLVKGR	I-1	30	Free	Amidation	Linear	L	Cys17-Gly8-GLP-1(7-36) modification and fatty acid modification through Mal referred to as X1	GLP-1 analogs	Antidiabetes	At 0, 1, 2, 4, 6, 8, 12, 24, 36, 48 and 72 h time points	1000 ng/mL	More Stable Than Ex-4	Rats plasma protease	LC-MS/MS	Rats plasma	In Vitro	None	None	EC50(pM) = 5.6 ± 1.1
5757	29673717	2018	HGEGTFTSDV-X2-SYLEGQAAKEFIAWLVKGR	I-2	30	Free	Amidation	Linear	L	Cys17-Gly8-GLP-1(7-36) modification and fatty acid modification through Mal referred to as X2	GLP-1 analogs	Antidiabetes	At 0, 1, 2, 4, 6, 8, 12, 24, 36, 48 and 72 h time points	1000 ng/mL	More Stable Than Ex-4	Rats plasma protease	LC-MS/MS	Rats plasma	In Vitro	None	None	EC50(pM) = 14.3 ± 2.0
5758	29673717	2018	HGEGTFTSDV-X3-SYLEGQAAKEFIAWLVKGR	I-3	30	Free	Amidation	Linear	L	Cys17-Gly8-GLP-1(7-36) modification and fatty acid modification through Mal referred to as X3	GLP-1 analogs	Antidiabetes	At 0, 1, 2, 4, 6, 8, 12, 24, 36, 48 and 72 h time points	1000 ng/mL	More Stable Than Ex-4	Rats plasma protease	LC-MS/MS	Rats plasma	In Vitro	None	None	EC50(pM) = 26.3 ± 2.5
5759	29673717	2018	HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR-X1	I-4	31	Free	Amidation	Linear	L	Cys37-Gly8-GLP1(7-36) modification and fatty acid conjugation through Mal at Cys37 referred to as X1	GLP-1 analogs	Antidiabetes	At 0, 1, 2, 4, 6, 8, 12, 24, 36, 48 and 72 h time points	1000 ng/mL	More Stable Than Ex-4	Rats plasma protease	LC-MS/ MS	Rats plasma	In Vitro	None	None	EC50(pM) = 6.1 ± 1.9
5760	29673717	2018	HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR-X2	I-5	31	Free	Amidation	Linear	L	Cys37-Gly8-GLP1(7-36) modification and fatty acid conjugation through Mal at Cys37 referred to as X2	GLP-1 analogs	Antidiabetes	At 0, 1, 2, 4, 6, 8, 12, 24, 36, 48 and 72 h time points	1000 ng/mL	More Stable Than Ex-4	Rats plasma protease	LC-MS/ MS	Rats plasma	In Vitro	None	None	EC50(pM) = 9.3 ± 1.1
5761	29673717	2018	HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR-X3	I-6	31	Free	Amidation	Linear	L	Cys37-Gly8-GLP1(7-36) modification and fatty acid conjugation through Mal at Cys37 referred to as X3	GLP-1 analogs	Antidiabetes	At 0, 1, 2, 4, 6, 8, 12, 24, 36, 48 and 72 h time points	1000 ng/mL	More Stable Than Ex-4	Rats plasma protease	LC-MS/ MS	Rats plasma	In Vitro	None	None	EC50(pM) = 19.8 ± 2.1
5772	29617109	2018	YTIWMPENPRPGTPCDIFTNSRGKRASNGC	RNP-DFO	30	Free	PLGA linked through mPEG	Linear	L	None	Synthetic	Treatment of Parkinson in mice	Blood samples were harvested from the tail vein at 0.08, 0.5, 1, 2, 4, 6, 12, and 24 h post-dosing	50 mg/kg	More Stable	Rats plasma protease	HPLC	Rats plasma	In Vivo	None	None	N.A.
5804	29517911	2018	CSWPARCLHQDLC	2b	13	Free	Free	Bicyclic (Cyclized On C1, C7, C13 By 1,3,5 Trismethylbenzene)	L	None	2a analogue	Antidiabetes (Treatment of Diabetic Macular Edema)	Serial blood samples were taken from each animal via temporary indwelling tail vein cannulae at 5, 10, 20, 30, 60, 120, 180, and 240 min postdose,	10 mg/kg	N.A.	Rats plasma protease	LC-MS/MS	Rats plasma	In Vivo	None	None	Ki Values (nM) = 2.0 ± 0.9 against PKal from Rats
5869	29421564	2018	RPKPQQFFGLM	SP	11	Free	Free	Linear	L	None	Synthetic	Therapeutic Regeneration By Facilitating Mobilization Of Endogenous Stem Cells From Bone Marrow To The Injured Sites	0 to 72 h at 37°C	5 nmol	0.8	Mice serum protease	ELISA	Mice serum	In Vivo	None	None	N.A.
5916	29633613	2018	N.A.	ThXylC	N.A.	Free	Free	Linear	L	None	Obtained from the soluble fractions of the recombinant E. coli BL21(DE3) cells	β-xylosidase	65 °C	N.A.	8.9 (Activity Half Life)	N.A.	N.A.	ThXylC	In Vitro	None	None	N.A.
5917	29633613	2018	N.A.	ThXylC-ELK	N.A.	Free	ELK16 short peptide was introduced to the C-terminus of ThXylC	Linear	L	None	Obtained from the soluble fractions of the recombinant E. coli BL21(DE3) cells	β-xylosidase	65 °C	N.A.	54.8 (Activity Half Life)	N.A.	N.A.	ThXylC-ELK	In Vitro	None	None	N.A.
5918	29316656	2018	DNWWPKPPHQGPRPPRPRPKP	[125I]-Az	21	Free	Free	Linear	L	125I labeld at His9	Derived from Azemiops feae (Fea's viper)	Local muscle relaxant	Animal blood samples were taken from the orbital sinus 5, 15, 30, 60 min and 1, 2, 4 and 24 h after [125I]-Az administration	0.25 mg/kg	0.3 (Excretion Half Life)	ICR mice blood protease	Radioactivity assay	ICR mice blood	In Vivo	None	None	LD50 of Az (0.51 mg/kg)
5919	29316656	2018	DNWWPKPPHQGPRPPRPRPKP	[125I]-Az	21	Free	Free	Linear	L	125I labeld at His9	Derived from Azemiops feae (Fea's viper)	Local muscle relaxant	Animal blood samples were taken from the orbital sinus 5, 15, 30, 60 min and 1, 2, 4 and 24 h after [125I]-Az administration	0.5 mg/kg	0.68 (Excretion Half Life)	ICR mice blood protease	Radioactivity assay	ICR mice blood	In Vivo	None	None	LD50 of Az (0.51 mg/kg)
5920	29316656	2018	DNWWPKPPHQGPRPPRPRPKP	[125I]-Az	21	Free	Free	Linear	L	125I labeld at His9	Derived from Azemiops feae (Fea's viper)	Local Muscle Relaxant	Animal blood samples were taken from the orbital sinus 5, 15, 30, 60 min and 1, 2, 4 and 24 h after [125I]-Az administration	0.25 mg/kg	0.26(Excretion Half Life)	ICR mice blood protease	Radioactivity assay	ICR mice blood	In Vivo	None	None	LD50 of Az (0.51 mg/kg)
5921	29316656	2018	DNWWPKPPHQGPRPPRPRPKP	[125I]-Az	21	Free	Free	Linear	L	125I labeld at His9	Derived from Azemiops feae (Fea's viper)	Local muscle relaxant	Animal blood samples were taken from the orbital sinus 5, 15, 30, 60 min and 1, 2, 4 and 24 h after [125I]-Az administration	0.5 mg/kg	0.29(Excretion Half Life)	ICR mice blood protease	Radioactivity assay	ICR mice blood	In Vivo	None	None	LD50 of Az (0.51 mg/kg)
5922	29373818	2018	N.A.	fibrinolytic enzyme	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	From the marine Serratia marcescens subsp sakuensis	Clot lysis	37 °C	N.A.	19 (Activity Half Life)	N.A.	N.A.	N.A.	In Vitro	None	None	N.A.
5923	29373818	2018	N.A.	fibrinolytic enzyme	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	From the marine Serratia marcescens subsp sakuensis	Clot lysis	50°C	N.A.	29 (Activity Half Life)	N.A.	N.A.	N.A.	In Vitro	None	None	N.A.
5924	29385666	2018	MKGSWWRRVAMIALSAGLLAGSLSMGTGIRKADAAAGNQNYAEALQKAIYFYEAQRSGPLPASNRVEWRGNSGIQDGADVGVDLTGGWYDAGDHVKFGFPMAASATMLAWSVVEYSDGYEQAGQLEEIKDNIRWATDYFMKAHTKPNELWGQVGAGNTDHAWWGPAEVMQMNRPSFKIDASCPGSDLAAETAAALAASSIVFADDDPAYSARLLQHAKELYNFAYTYRGEYTDCITDAAAFYNSWTGYEDELAWGGAWLYLATNDSAYLSKAIAATDRWSSSGGSANWPYTWTQGWDSKHYGAQILLARITSSLNMPEATRFIQSTERNLDYWTVGVNGTRVKYTPGGLAWLDQWGSLRYAANASFISFVYSDWVSDPVKKSRYQDFAVSQMNYILGDNPRQSSYVVGYGQNAPQHPHHRTAHGSWLNNEDIPANHRHILYGAMVGGPDASDGYTDDIGDYVSNEVATDYNAGFTGALAKMNLLFGQNHQPLANFPAPEVKGDEFFVEAAIKSSGANYTEIRAQLNNRSAWPARMGDQLSFKYFLDLSEVYAAGRTVSDVQVTTSYTEGATVSQPVVVNAAQHIYAITANFGNTKIYPGGEGNYRKEVQFRITGPQGAWNASNDHSFQTLTTGTPVKSIYLPVYDAGVKVYGQEPGLTPVTVPGAPAGVQAVAGSSQVNLTWAAVSGAESYTVKRSEVSGGPYTTVATGVNGLTYTNTGLTNGTTYYYVVTAVNSAGESSGSVQVSATPQAASTVPGALTLSGTAGNAQSVLTWTTASGATTYKVQRSVAGGTYADVATGLSVLTYTDTTALNGTTYNYRIAAVNANGQTLSNVLALTPSAPPVTTGTLEVQYRSGGSGNSSNAATPQFNVKNTGTQAIDLSTVKIRYYFTKDGADQMTFWCDYAEMGTANVEGTFVTVNPAKGTADTYLEISFKSGAGSLAAGAETGVIQARFSKNNWSNFDLSNDYSYDASKTAFAAWNKVTGYQGNTKVWGLEP	Cel9K	997	Free	Free	Linear	L	None	Cloned using the shot-gun method from Paenibacillus sp. X4	Endo-β-1,4-glucanase	50°C	N.A.	59.2 (Activity Half Life)	N.A.	N.A.	Cel9K	In Vitro	None	None	N.A.
5925	29464007	2018	((99mTc-HHEDEG-DEG-QWECPYGLCWIQ)-PEG2000)4	99mTc-F4A	72	Free	Free	Cyclic (PEG2000 Linkage)	L	Tetramerization using PEG2000	Fibrin-specific natural peptide analogue	99mTc-F4A is a high-avidity prototype probe for characterizing thrombus in LVADs	serial blood samples were obtained at 0, 2, 5, 10, 15, 20, 30, 60, 120, and 180 min via an indwelling jugular catheter	N.A.	5.0 ± 1.9 (T1/2A Distribution Half Life)	Mice plasma protease	Radioactivity assay	Mice plasma	In Vivo	None	None	N.A.
5926	29464007	2018	QWECPYGLCWIQ	99mTc-F1A	18	99MTC-HHEDEG-DEG	Free	Cyclic (C-C Disulfide Bond In C Terminal)	L	None	Fibrin-specific natural peptide analogue	99mTc-F4A is a high-avidity prototype probe for characterizing thrombus in LVADs	serial blood samples were obtained at 0, 2, 5, 10, 15, 20, 30, 60, 120, and 180 min via an indwelling jugular catheter	N.A.	8.6 ± 1.9(T1/2A Distribution Half Life)	Mice plasma protease	Radioactivity assay	Mice plasma	In Vivo	None	None	N.A.
5927	30063837	2018	DSDDRVTPPAEPLDRMPDP-(3-chloro-Tyr)-RPSYGRAETVVNNYIRKWQQVYSHRDGRKQQMTEEQREWLS-(3-choro-Tyr)-GCVGVTWVNSGQYPTNRLAFASFDEDRFKNELKNGRPRSGETRAEFEGRVAKESFDEEKGFQRAREVASVMNRALENAHDESAYLDNLKKELANGNDALRNEDARSPF-(3-chloro-Tyr)-SALRNTPSFKERNGGNHDPSRMKAVIYSKHFWSGQDRSSSADKRKYGDPDAFRPAPGTGLVDMSRDRNIPRSPTSPGEGFVNFDYGWFGAQTEADADKTVWTHGNHYHAPNGSLGAMHVYESKFRNWSEGYSDFDRGAYVITFIPKSWNTAPDKVKQGWP	MTG variant	331	Free	Free	Linear	L	ClY20/62/171 modifications, ClY = 3-Chloro-Tyrosine	Derived from Streptoverticillium mobaraense	Transglutaminase	60°C for 10 min	N.A.	5.1-Fold Longer Than That Of The Wild-Type Enzyme (Activity Half Life)	N.A.	N.A.	Buffer	In Vitro	pdb id: 1IU4	None	N.A.
6001	28575099	2017	ONNRPVYIPRPRPPHPOL	Api134	18	Gu: N,N,N′,N′-tetramethylguanidine, O denotes L-ornithine	Amidation	Linear	L	Orn=Ornithine	Apidaecin analog	Antibacterial	Aliquots (20 or 40 μL) taken after 0 and 60 min (0, 10 and 30 min for Api88)	31.5 μmol/L	Highly Stable	Mouse blood/plasma/serum protease	RP-HPLC	Mouse blood/plasma/serum	In Vitro	None	None	N.A.
6002	28575099	2017	ONNRPVYIPRPRPPHPRL	Api137	18	Gu: N,N,N′,N′-tetramethylguanidine, O denotes L-ornithine	Free	Linear	L	Orn=Ornithine	Apidaecin analog	Antibacterial	Aliquots (20 or 40 μL) taken after 0 and 60 min (0, 10 and 30 min for Api88)	31.5 μmol/L	Highly Stable	Mouse blood/plasma/serum protease	RP-HPLC	Mouse blood/plasma/serum	In Vitro	None	None	N.A.
6003	28575099	2017	VDKPPYLPRPRPPRrIYNr	Onc112	19	Free	Amidation	Linear	Mix	D-amino acid substituitons	Analog of Oncopeltus	Antibacterial	Aliquots (20 or 40 μL) taken after 0 and 60 min (0, 10 and 30 min for Api88)	31.5 μmol/L	Highly Stable	Mouse blood/plasma/serum protease	RP-HPLC	Mouse blood/plasma/serum	In Vitro	None	None	N.A.
6004	28575099	2017	VDKPPYLPRPRPPRRIYNR	Onc18	19	Free	Amidation	Linear	L	None	Analog of Oncopeltus	Antibacterial	Aliquots (20 or 40 μL) taken after 0 and 60 min (0, 10 and 30 min for Api88)	31.5 μmol/L	Medium Stable	Mouse blood/plasma/serum protease	RP-HPLC	Mouse blood/plasma/serum	In Vitro	None	None	N.A.
6005	28575099	2017	VDKPPYLPRPRPPROIYNO	Onc72	19	Free	Amidation	Linear	L	L-ornithine (Orn)	Analog of Oncopeltus	Antibacterial	Aliquots (20 or 40 μL) taken after 0 and 60 min (0, 10 and 30 min for Api88)	31.5 μmol/L	Medium Stable	Mouse blood/plasma/serum protease	RP-HPLC	Mouse blood/plasma/serum	In Vitro	None	None	N.A.
6006	28575099	2017	ONNRPVYIPRPRPPHPRL	Api88	18	Gu: N,N,N′,N′-tetramethylguanidine, O denotes L-ornithine	Amidation	Linear	L	Orn=Ornithine	Apidaecin analog	Antibacterial	Aliquots (20 or 40 μL) taken after 0 and 60 min (0, 10 and 30 min for Api88)	31.5 μmol/L	Low Stable	Mouse blood/plasma/serum protease	RP-HPLC	Mouse blood/plasma/serum	In Vitro	None	None	N.A.
6007	28575099	2017	AAYRVDKPPYLPRPRPPRrIYNr	AAYR-Onc112	23	AAYR	Amidation	Linear	Mix	None	Analog of Oncopeltus	Antibacterial	Aliquots (20 or 40 μL) taken after 0 and 60 min (0, 10 and 30 min for Api88)	31.5 μmol/L	Low Stable	Mouse blood/plasma/serum protease	RP-HPLC	Mouse blood/plasma/serum	In Vitro	None	None	N.A.
6008	28575099	2017	LVPRVDKPPYLPRPRPPRrIYNr	LVPR-Onc112	23	LVPR	Amidation	Linear	Mix	None	Analog of Oncopeltus	Antibacterial	Aliquots (20 or 40 μL) taken after 0 and 60 min (0, 10 and 30 min for Api88)	31.5 μmol/L	Low Stable	Mouse blood/plasma/serum protease	RP-HPLC	Mouse blood/plasma/serum	In Vitro	None	None	N.A.
6011	28494253	2017	NKVPNLRGDLQVLAQKVART	Peptide 22	20	111In-DTPA = diethylenetriaminepentaacetic acid	Free	Linear	L	X1=Asn at position 1, X2=Leu at position , X3=Lys,X4 = Thr, Biotinylated Lysine	A20FMDV2 analogue	Antitumor	After 24 hrs at 37 ◦C	7.5 MBq	77% Stable	Human blood plasma protease	Radio-HPLC	Human blood plasma	In Vitro	None	None	Affinity for peptide 22 = 1.01 ± 0.21
6012	28494253	2017	GNKVPNLRGDLQVLAQKVART	Peptide 23	21	111In-DTPA-Gly = diethylenetriaminepentaacetic acid	Free	Linear	L	X1=Asn, X2=Leu, X3=Lys,X4 = Thr, Biotinylated Lysine	A20FMDV2 analogue	Antitumor	After 24 hrs at 37 ◦C	7.5 MBq	60% Stable	Human blood plasma protease	Radio-HPLC	Human blood plasma	In Vitro	None	None	Affinity for peptide 23 = 1.28 ± 0.23
6013	28494253	2017	NKVPNLRGDLQVLAQKVART	Peptide 24	20	111In-DTPA = diethylenetriaminepentaacetic acid	Amidation	Linear	L	X1=Asn, X2=Leu, X3=Lys,X4 = Thr, Biotinylated Lysine	A20FMDV2 analogue	Antitumor	After 24 hrs at 37 ◦C	7.5 MBq	52% Stable	Human blood plasma protease	Radio-HPLC	Human blood plasma	In Vitro	None	None	Affinity for peptide 24 = 1.19 ± 0.30
6014	28494253	2017	nKVPNLRGDLQVLAQKVART	Peptide 25	20	111In-DTPA = diethylenetriaminepentaacetic acid	Free	Linear	Mix	X1=D-Asn, X2=Leu, X3=Lys,X4 = Thr, Biotinylated Lysine	A20FMDV2 analogue	Antitumor	After 24 hrs at 37 ◦C	7.5 MBq	80% Stable	Human blood plasma protease	Radio-HPLC	Human blood plasma	In Vitro	None	None	Affinity for peptide 25 = 1.36 ± 0.42
6015	28494253	2017	nKVPNLRGDLQVLAQKVARt	Peptide 26	20	111In-DTPA = diethylenetriaminepentaacetic acid	X4 = D-Thr at C terminal	Linear	Mix	X1=D-Asn, X2=Leu, X3=Lys, Biotinylated Lysine	A20FMDV2 analogue	Antitumor	After 24 hrs at 37 ◦C	7.5 MBq	77% Stable	Human blood plasma protease	Radio-HPLC	Human blood plasma	In Vitro	None	None	Affinity for peptide 26 = 1.19 ± 0.40
6087	28953210	2017	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGP	99mTc-exendin(9-39)	31	99Mtc Radiolabeled	Free	Linear	L	None	Exendin4 analogs	Antidiabetes	Whole-body images from four healthy individuals were acquired at 20 min, 2, 6, and 24 h after 99mTc-exendin(9-39)/octreotide administration	N.A.	1.2 (T1/2 a- Fast ) (Activity Half Life)	Human blood protease	N.A.	Human blood	N.A.	PDB id: 7MLL	None	N.A.
6088	28953210	2017	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGP	99mTc-exendin(9-39)	31	99Mtc Radiolabeled	Free	Linear	L	None	Exendin4 analogs	Antidiabetes	Whole-body images from four healthy individuals were acquired at 20 min, 2, 6, and 24 h after 99mTc-exendin(9-39)/octreotide administration	N.A.	8.7 (T1/2 b- Slow)(Activity Half Life)	Human blood protease	N.A.	Human blood	N.A.	PDB id: 7MLL	None	N.A.
6089	28953210	2017	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGP	99mTc-exendin(9-39)	31	99Mtc Radiolabeled	Free	Linear	L	None	Exendin4 analogs	Antidiabetes	Whole-body images from four healthy individuals were acquired at 20 min, 2, 6, and 24 h after 99mTc-exendin(9-39)/octreotide administration	N.A.	1.7(T1/2 b-Slow)(Activity Half Life)	Human blood protease	N.A.	Human blood	N.A.	PDB id: 7MLL	None	N.A.
6090	28870261	2017	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGOPSSGAPPPS	EXT-Sol	39	Free	Free	Linear	L	Substituition of amino acids G,L,K,Q,M,E,E,V,R,L,E,K,N,O,P,S,S,G,A,P,P,P,S	Exendin4 analogs	Antidiabetes	At specific time 0, 0.25, 0.5, 1,1.5, 2, 3, 4, 6, 8 h after injection	50 μg/kg	0.22 ± 0.03 (T1/2a- Distribution)	SD rats plasma protease	ELISA	SD rats plasma	In Vivo	None	None	EXT-SBA-15 exhibited efficacy that is comparable to EXT-Sol on 5 h
6091	28870261	2017	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGOPSSGAPPPS	EXT-SBA-15	39	Free	Free	Linear	L	Substituition of amino acids G,L,K,Q,M,E,E,V,R,L,E,K,N,O,P,S,S,G,A,P,P,P,S	Exendin4 analogs	Antidiabetes	Collected at 0, 0.5, 1, 1.5, 2, 3, 5, 8, 12, 24, 36, 48, 72, 120 h	50 μg/kg	0.26 ± 0.05(T1/2a- Distribution)	SD rats plasma protease	ELISA	SD rats plasma	In Vivo	None	None	EXT-SBA-15 exhibited efficacy that is comparable to EXT-Sol on 5 h
6092	28870261	2017	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGOPSSGAPPPS	EXT-Sol	39	Free	Free	Linear	L	Substituition of amino acids G,L,K,Q,M,E,E,V,R,L,E,K,N,O,P,S,S,G,A,P,P,P,S	Exendin4 analogs	Antidiabetes	At specific time 0, 0.25, 0.5, 1,1.5, 2, 3, 4, 6, 8 h after injection	50 μg/kg	0.60 ± 0.08(T1/2b-Elimination Half Life)	SD rats plasma protease	ELISA	SD rats plasma	In Vivo	None	None	EXT-SBA-15 exhibited efficacy that is comparable to EXT-Sol on 5 h
6093	28870261	2017	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGOPSSGAPPPS	EXT-SBA-15	39	Free	Free	Linear	L	Substituition of amino acids G,L,K,Q,M,E,E,V,R,L,E,K,N,O,P,S,S,G,A,P,P,P,S	Exendin4 analogs	Antidiabetes	Collected at 0, 0.5, 1, 1.5, 2, 3, 5, 8, 12, 24, 36, 48, 72, 120 h.	50 μg/kg	14.53 ± 0.70(T1/2b-Elimination Half Life)	SD rats plasma protease	ELISA	SD rats plasma	In Vivo	None	None	EXT-SBA-15 exhibited efficacy that is comparable to EXT-Sol on 5 h
6094	28714475	2017	ACRWPARCVHQDLCG	PK128	15	Free	Free	Bicyclic (C2-C8,C8-C14 Disulfide Bond In Pk128)	L	None	Synthetic	Inhibit plasma kallikrein	Probes were taken at different time points (5 min, 0.5, 1, 2, 4, 8, 24 and 48 h) at 37 C , diluted to 3 mM (urokinase inhibitor) or 0.75 mM (plasma kallikrein inhibitor) with assay buffer (10 mM TrisCl, pH 7.4, 150 mM NaCl, 10 mM MgCl2, 1 mM CaCl2, 0.01% v/v Tween-20, and 0.1% (w/v) casein)	20 microM	1.8 ± 0.3 (Activity Half Life)	Human plasma protease	N.A.	Human plasma	In Vitro	None	None	Albumin binding (Kd) (nM) = 720±90 for rat albumin for tagPK128
6095	28714475	2017	EYEKEYEACRWPARCVHQDLCG	tagPK128	22	Tag	Free	Bicyclic (C2-C8,C8-C14 Disulfide Bond In Pk128)	L	Lys4 conjugated with Palm	Synthetic	Inhibit plasma kallikrein	Probes were taken at different time points (5 min, 0.5, 1, 2, 4, 8, 24 and 48 h) at 37 C , diluted to 3 mM (urokinase inhibitor) or 0.75 mM (plasma kallikrein inhibitor) with assay buffer (10 mM TrisCl, pH 7.4, 150 mM NaCl, 10 mM MgCl2, 1 mM CaCl2, 0.01% v/v Tween-20, and 0.1% (w/v) casein)	20 microM	>48 (Activity Half Life)	Human plasma protease	N.A.	Human plasma	In Vitro	None	None	Albumin binding (Kd) (nM) = 720±90 for rat albumin for tagPK128
6096	28416744	2017	RGDyK	cRGD-ZW800-1	5	Free	Zw800-1	Cyclic (RGDyK)	Mix	y = D-Tyr, cyclic peptide linked with ZW800-1	Synthetic	Generic tracer for intraoperative near-infrared fluorescence imaging of solid tumors	time points -5, 1, 6, 10, 20, 30, 40, 50, 60, 90, 120, and 240 min. post injection	10 nmol	14.6 ± 1.7 (Distribution Half Life)	Mice serum protease	Fluorescence assay	Mice serum	In Vivo	None	None	N.A.
6097	27784692	2017	MCGPGVG-(VPGxG)160-VPGWPGSG	ELP	815	Free	Free	Linear	L	x = Val,Gly or Ala	Synthetic	Carrier protein	Whole-animal fluorescence images were collected at regular intervals for 24 hours	100 mg/kg	3.63 (T1/2,Distribution)	Rats plasma protease	whole-body fluorescence imaging	Rats plasma	In Vivo	None	None	N.A.
6098	27784692	2017	MCLPVASCGGPGVG-(VPGxG)160-VPGWPGSGGC	KTP-ELP	822	Conjugation of KTP cyclic peptide at N terminal	Free	Linear	L	x = Val,Gly or Ala	Fusion protein of KTP and ELP	Carrier protein	Whole-animal fluorescence images were collected at regular intervals for 24 hours	100 mg/kg	39.12 (T1/2,Distribution)	Rats plasma protease	whole-body fluorescence imaging	Rats plasma	In Vivo	None	None	N.A.
6099	27784692	2017	MCGPGVG-(VPGxG)160-VPGWPGSG	ELP	815	Free	Free	Linear	L	x = Val,Gly or Ala	Synthetic	Carrier protein	Whole-animal fluorescence images were collected at regular intervals for 24 hours	5 mg/kg	3.8 (T1/2,Distribution)	Swine plasma protease	whole-body fluorescence imaging	Swine plasma	In Vivo	None	None	N.A.
6100	27784692	2017	MCLPVASCGGPGVG-(VPGxG)160-VPGWPGSGGC	KTP-ELP	822	Conjugation of KTP cyclic peptide at N terminal	Free	Linear	L	x = Val,Gly or Ala	Fusion protein of KTP and ELP	carriers	Whole-animal fluorescence images were collected at regular intervals for 24 hours	5 mg/kg	6 (T1/2,Distribution)	Swine plasma protease	whole-body fluorescence imaging	Swine plasma	In Vivo	None	None	N.A.
6101	28717654	2017	N.A.	RT1.14opt-in	561	Free	Free	Linear	L	(D185N, D186N, E478Q) amino acid modifications	Derived from HIV-1 MN	Induce oxidative stress	After 0, 2, 4, and 6 hours of incubation, the cells were harvested, lysed	N.A.	2 (Activity Half Life)	HeLa cells lysate protease, E64 (10 μM),leupeptin (10 μg/ml), aprotinin (10 μg/ml), pepstatin A (7,5 μM), MG132 (5 μM), or epoxomicin (0,1 μM)	Cycloheximide chase assay and Western blot	HeLa cells lysate after treatment with cycloheximide	In Vivo	Transfection route**	None	Lysates of 105 cells expressing RT1.14opt-in retained 0,00012% activity
6102	28717654	2017	RNPTMSMSFLLAGGLVLAMTLGVGA	RT1.14oil	586	N-Terminally fused to a leader signal sequence from the NS1 protein	Rt1.14	Linear	L	(D185N, D186N, E478Q) amino acid modifications	Derived from HIV-1 MN	Induce oxidative stress	After 0, 2, 4, and 6 hours of incubation, the cells were harvested, lysed	N.A.	~15 (Activity Half Life)	HeLa cells lysate protease, E64 (10 μM),leupeptin (10 μg/ml), aprotinin (10 μg/ml), pepstatin A (7,5 μM), MG132 (5 μM), or epoxomicin (0,1 μM)	Cycloheximide chase assay and Western blot	HeLa cells lysate after treatment with cycloheximide	In Vivo	Transfection route**	None	Lysates of 105 cells expressing RT1.14oil retained 0,00005% of the activity
6245	27393654	2016	CDLPQTHSLGSRRTLMLLAQMRKISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE	IFN-α	165	Free	Free	Linear	L	None	Human derived	Antiproliferative, immunoregulatory and antiviral	At desired time points (1, 5, 15, 30 min, 1, 3, 6, 24,48, 72 and 96 h)	1 mg IFN-α equivalent/kg	0.33 (T1/2a- Distribution Half Life)	Mice plasma protease	ELISA	Mice plasma	In Vivo	PDB id: 1ITF	None	IC50 = 10.77 pg/mL
6246	27393654	2016	CDLPQTHSLGSRRTLMLLAQMRKISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE-(PMPC)	IFN-PMPC	165	Free	Poly(2-Methacryloyloxyethyl Phosphorylcholine)	Linear	L	None	Human derived	Antiproliferative, immunoregulatory and antiviral	At desired time points (1, 5, 15, 30 min, 1, 3, 6, 24,48, 72 and 96 h)	1 mg IFN-α equivalent/kg	2 (T1/2a- Distribution Half Life)	Mice plasma protease	ELISA	Mice plasma	In Vivo	PDB id: 1ITF	None	IC50 = 20.02 pg/mL
6247	28989813	2016	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2	Exendin	39	Free	Amidation	Linear	L	Fluorescently labeled with Alexa Fluor	Isolated from the saliva of the Gila monster lizard (Heloderma suspectum)	Antidiabetes	10 μL of blood samples were collected from the tail vein into 100 μL of a heparin solution (1kU/ml in PBS, Sigma Aldrich) at 40 s, 40 min, 2.5 h, 4.5 h, 8 h, 24 h, 48 h, 72 h, 96 h and 120 h after injection	75 nmol/kg	0.7 ± 0.1 (T1/2 Absorption Half Life)	Mice plasma protease	Fluorescence assay	Mice plasma	In Vivo	PDB id: 7MLL	None	EC50(nM) = 0.08 ± 0.01
6248	28989813	2016	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSC	54.6 kDa EG9	40	Free	Poly[Oligo(Ethylene Glycol)9 Methyl Ether Methacrylate] = Poegma(54.6 Kda)	Linear	L	Fluorescently labeled with Alexa Fluor	Exendin-C-POEGMA conjugates	Antidiabetes	10 μL of blood samples were collected from the tail vein into 100 μL of a heparin solution (1kU/ml in PBS, Sigma Aldrich) at 40 s, 40 min, 2.5 h, 4.5 h, 8 h, 24 h, 48 h, 72 h, 96 h and 120 h after injection	75 nmol/kg	6.2 ± 0.5 (T1/2 Absorption Half Life)	Mice plasma protease	Fluorescence assay	Mice plasma	In Vivo	PDB id: 7MLL	None	EC50(nM) = 1.91 ± 0.35
6249	28989813	2016	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSC	55.6 kDa EG3	40	Free	Poly[Oligo(Ethylene Glycol)3 Methyl Ether Methacrylate] = Poegma(55.6Kda)	Linear	L	Fluorescently labeled with Alexa Fluor	Exendin-C-POEGMA conjugates	Antidiabetes	10 μL of blood samples were collected from the tail vein into 100 μL of a heparin solution (1kU/ml in PBS, Sigma Aldrich) at 40 s, 40 min, 2.5 h, 4.5 h, 8 h, 24 h, 48 h, 72 h, 96 h and 120 h after injection	75 nmol/kg	7.6 ± 0.7 (T1/2 Absorption Half Life)	Mice plasma protease	Fluorescence assay	Mice plasma	In Vivo	PDB id: 7MLL	None	EC50(nM) = 4.17 ± 0.13
6250	28989813	2016	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSC	71.6 kDa EG3	40	Free	Poly[Oligo(Ethylene Glycol)3 Methyl Ether Methacrylate] = Poegma(71.6Kda)	Linear	L	Fluorescently labeled with Alexa Fluor	Exendin-C-POEGMA conjugates	Antidiabetes	10 μL of blood samples were collected from the tail vein into 100 μL of a heparin solution (1kU/ml in PBS, Sigma Aldrich) at 40 s, 40 min, 2.5 h, 4.5 h, 8 h, 24 h, 48 h, 72 h, 96 h and 120 h after injection	75 nmol/kg	9.0 ± 1.7 (T1/2 Absorption Half Life)	Mice plasma protease	Fluorescence assay	Mice plasma	In Vivo	PDB id: 7MLL	None	EC50(nM) = 5.11 ± 0.23
6251	26552936	2016	AGLPTREPVRQASTAEPGAERIIVKYRAGTAAAGDRSAKLSTVQSALTRASLSGGTARASTLGPQVVRKLGVGADLIRLQGRLAPAELQRVLKELKADPAVQYAEADVKLRRTELRAGDVQPALAPNDPYYQQYQWHLHNATGGINAPSAWDVSQGEGVVVAVLDTGILPQHPDLVGNLLEGYDFISDAETSRRATNDRVPGAQDYGDWVENDNECYTGSVAEDSSWHGTHVAGTVAEQTNNGVGMAGVAHKAKVLPVRVLGKCGGYLSDIADAITWASGGTVAGVPANANPAEIINMSLGGSGSCDGTYQDAINGAISRGTTVVVAAGNETDNASKYRPASCDGVVTVGATRITGGITYYSNYGTRVDLSGPGGGGSVDGNPGGYVWQSGSDAATTPESGSYSYMGMGGTSMASPHVAAVAALVQSALIAKGKDPLAPAAMRTLLKETARPFPVSIPAATPIGTGIVDAKAALAKALEEPCTESCGPVATPLTNKAAVGGLNGTAGSSRLYSFEAAAGKQLSVITYGGTGNVSVYIAQGREPSASDNDGKSTRPGTSETVRVNKPVAGTYYIKVVGEAAYNGVSILATQH	DDD	591	Free	Free	Linear	L	His-tag	Wild-type KerSMD	Keratinase	60°C	N.A.	41 ± 15 (Activity Half Life)	N.A.	Enzyme activity assay	DDD	In Vitro	None	None	Activity with Casein (U mg−1) = 3779 ± 20
6252	26552936	2016	AGLPTREPVRQASTAEPGAERIIVKYRAGTAAAGDRSAKLSTVQSALTRASLSGGTARASTLGPQVVRKLGVGADLIRLQGRLAPAELQRVLKELKADPAVQYAEADVKLRRTELRAGDVQPALAPNDPYYQQYQWHLHNATGGINAPSAWDVSQGEGVVVAVLDTGILPQHPDLVGNLLEGYDFISDAETSRRATNDRVPGAQDYGDWVENDNECYTGSVAEDSSWHGTHVAGTVAEQTNNGVGMAGVAHKAKVLPVRVLGKCGGYLSDIADAITWASGGTVAGVPANANPAEIINMSLGGSGSCDGTYQDAINGAISRGTTVVVAAGNETDNASKYRPASCDGVVTVGATRITGGITYYSNYGTRVDLSGPGGGGSVDGNPGGYVWQSGSDAATTPESGSYSYMGMGGTSMASPHVAAVAALVQSALIAKGKDPLAPAAMRTLLKETARPFPVSIPAATPIGTGIVDAKAALAKALEEPCTESPGGNVLQNNVPVTGLGAATGAELNYTVAVPAGSSQLRVTISGGSGDADLYVRQGSAPTDTSYTCRPYLSGNSETCTINSPAAGTWYVRVKAYSTFSGVTLNAQYH	DDF	590	Free	T1 From KERsmf	Linear	L	His-tag	KerSMD mutants	Keratinase	60°C	N.A.	105.3 ± 5 (Activity Half Life)	N.A.	Enzyme activity assay	DDF	In Vitro	None	None	Activity with Casein (U mg−1) = 4467 ± 14
6253	26552936	2016	GDVQLSGLQSAPTHQRFIVKYRDGSAPVANTTALASSLKSAAAGLASSQGRALGLQEVRKLAVGPTLVRTDRPLDQAESELLMRKLAADPNVEYVEVDQIMRATLAPNDPYYQQYQWHLHNATGGINAPSAWDVSQGEGVVVAVLDTGILPQHPDLVGNLLEGYDFISDAETSRRATNDRVPGAQDYGDWVENDNECYTGSVAEDSSWHGTHVAGTVAEQTNNGVGMAGVAHKAKVLPVRVLGKCGGYLSDIADAITWASGGTVAGVPANANPAEIINMSLGGSGSCDGTYQDAINGAISRGTTVVVAAGNETDNASKYRPASCDGVVTVGATRITGGITYYSNYGTRVDLSGPGGGGSVDGNPGGYVWQSGSDAATTPESGSYSYMGMGGTSMASPHVAAVAALVQSALIAKGKDPLAPAAMRTLLKETARPFPVSIPAATPIGTGIVDAKAALAKALEEPCTESCGPVATPLTNKAAVGGLNGTAGSSRLYSFEAAAGKQLSVITYGGTGNVSVYIAQGREPSASDNDGKSTRPGTSETVRVNKPVAGTYYIKVVGEAAYNGVSILATQH	FDD	572	P1 Substituitions From Kersmf	Free	Linear	L	His-tag	KerSMD mutants	Keratinase	60°C	N.A.	152.2 ± 2 (Activity Half Life)	N.A.	Enzyme activity assay	FDD	In Vitro	None	None	Activity with Casein (U mg−1) =7844 ± 25
6254	26552936	2016	GDVQLSGLQSAPTHQRFIVKYRDGSAPVANTTALASSLKSAAAGLASSQGRALGLQEVRKLAVGPTLVRTDRPLDQAESELLMRKLAADPNVEYVEVDQIMRATLAPNDPYYQQYQWHLHNATGGINAPSAWDVSQGEGVVVAVLDTGILPQHPDLVGNLLEGYDFISDAETSRRATNDRVPGAQDYGDWVENDNECYTGSVAEDSSWHGTHVAGTVAEQTNNGVGMAGVAHKAKVLPVRVLGKCGGYLSDIADAITWASGGTVAGVPANANPAEIINMSLGGSGSCDGTYQDAINGAISRGTTVVVAAGNETDNASKYRPASCDGVVTVGATRITGGITYYSNYGTRVDLSGPGGGGSVDGNPGGYVWQSGSDAATTPESGSYSYMGMGGTSMASPHVAAVAALVQSALIAKGKDPLAPAAMRTLLKETARPFPVSIPAATPIGTGIVDAKAALAKALEEPCTESPGGNVLQNNVPVTGLGAATGAELNYTVAVPAGSSQLRVTISGGSGDADLYVRQGSAPTDTSYTCRPYLSGNSETCTINSPAAGTWYVRVKAYSTFSGVTLNAQYH	FDF	571	P1 Substituitions From Kersmf	T1 Substituitions From Kersmf	Linear	L	His-tag	KerSMD mutants	Keratinase	60°C	N.A.	244.6 ± 2 (Activity Half Life)	N.A.	Enzyme activity assay	FDF	In Vitro	None	None	Activity with Casein (U mg−1) =8229 ± 50
6255	26552936	2016	AGLPTREPVRQASTAEPGAERIIVKYRAGTAAAGDRSAKLSTVQSALTRASLSGGTARASTLGPQVVRKLGVGADLIRLQGRLAPAELQRVLKELKADPAVQYAEADVKLRRTELRAGDVQPALAPNDPYYQQYQWHLHNATGGINAPSAWDVSQGEGVVVAVLDTGILPQHPDLVGNLLEGYDFISDAETSRRATNDRVPGAQDYGDWVENDNECYTGSVAEDSSWHGTHVAGTVAEQTNNGVGMAGVAHKAKVLPVRVLGKCGGYLSDIADAITWASGGTVAGVPANANPAEIINMSLGGSGSCDGTYQDAINGAISRGTTVVVAAGNETDNASKYRPASCDGVVTVGATRITGGITYYSNYGTRVDLSGPGGGGSVDGNPGGYVWQSGSDAATTPESGSYSYMGMGGTSMASPHVAAVAALVQSALIAKGKDPLAPAAMRTLLKETARPFPVSIPAATPIGTGIVDAKAALAKALEEPCTESH	DD	486	Free	T2 Removed	Linear	L	His-tag	KerSMD mutants	Keratinase	60°C	N.A.	5.6 ± 2 (Activity Half Life)	N.A.	Enzyme activity assay	DD	In Vitro	None	None	Activity with Casein (U mg−1) = 4328 ± 18
6256	26552936	2016	GDVQLSGLQSAPTHQRFIVKYRDGSAPVANTTALASSLKSAAAGLASSQGRALGLQEVRKLAVGPTLVRTDRPLDQAESELLMRKLAADPNVEYVEVDQIMRATLAPNDPYYQQYQWHLHNATGGINAPSAWDVSQGEGVVVAVLDTGILPQHPDLVGNLLEGYDFISDAETSRRATNDRVPGAQDYGDWVENDNECYTGSVAEDSSWHGTHVAGTVAEQTNNGVGMAGVAHKAKVLPVRVLGKCGGYLSDIADAITWASGGTVAGVPANANPAEIINMSLGGSGSCDGTYQDAINGAISRGTTVVVAAGNETDNASKYRPASCDGVVTVGATRITGGITYYSNYGTRVDLSGPGGGGSVDGNPGGYVWQSGSDAATTPESGSYSYMGMGGTSMASPHVAAVAALVQSALIAKGKDPLAPAAMRTLLKETARPFPVSIPAATPIGTGIVDAKAALAKALEEPCTESH	FD	467	P1 From KERsmf	T2 Removed	Linear	L	His-tag	KerSMD mutants	Keratinase	60°C	N.A.	36.5 ± 6 (Activity Half Life)	N.A.	Enzyme activity assay	FD	In Vitro	None	None	Activity with Casein (U mg−1) = 9876 ± 50
6257	26673564	2016	ARTKQTARKSTGGKAPRKQLATKAARKSAP	H3	30	Free	Free	Linear	L	None	Histone 3	Structural role	preincubated for 1 h	3.0 μM	9.63 (Activity Half Life)	N.A.	Resorufin-derived absorbance assay	Assay buffer containing 25 μM peptide substrate, 50 μM Amplex Red, and 1 unit/mL HRP and H3	In Vitro	None	None	IC50(nM) =153
6259	076-262-596-914-468	2016	NA	GLP-1 ELP1-120	NA	His7 of GLP1	Free	Linear	L	Fusion with ELP	preproglucagon	N.A.	N.A.	10mg/kg	12.9	Tev protease	Bioassay	Rat	in vivo	https://www.lens.org/lens/patent/076-262-596-914-468	US 9,458,218 B2	N.A.
6260	076-262-596-914-468	2016	NA	GLP-1 ELP1-120	NA	His7 of GLP1	Free	Linear	L	Fusion with ELP	preproglucagon	N.A.	N.A.	1 mg/kg	20	Tev protease	Bioassay	Rabbit	in vivo	https://www.lens.org/lens/patent/076-262-596-914-468	US 9,458,218 B2	N.A.
6261	107-968-725-190-134	2016	HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS	Ex-4	39	Free	Free	Linear	L	None	NA	N.A.	30 min	25 ŒºM	38	chymotrypsin	ELISA	male C57BL/6 mice serum	in vivo	https://lens.org/107-968-725-190-134	US 9,296,805 B2	N.A.
6262	107-968-725-190-134	2016	HGEGTFTSDX SKQXEEEAVRLFIEWLKNGGPSSGAPPPS	singly stapled SAH-Ex(A)	39	Stapled	Free	Linear	L	None	NA	N.A.	30 min	25 ŒºM	94	chymotrypsin	ELISA	male C57BL/6 mice serum	in vivo	https://lens.org/107-968-725-190-134	US 9,296,805 B2	N.A.
6263	107-968-725-190-134	2016	HGEGTFTSDLSKQXEEEAVRLFIXWLKXGGPSSGAPPPS	singly stapled SAH-Ex(B)	39	Stapled	Free	Linear	L	None	NA	N.A.	30 min	25 ŒºM	128	chymotrypsin	ELISA	male C57BL/6 mice serum	in vivo	https://lens.org/107-968-725-190-134	US 9,296,805 B2	N.A.
6264	107-968-725-190-134	2016	HGEGTFTSDXSKQXEEEAVRLFIXWLKXGGPSSGAPPPS	doubly stapled peptide SAH-Ex(A, B)	39	Stapled	Stapled	Linear	L	None	NA	N.A.	30 min	25 ŒºM	295	chymotrypsin	ELISA	male C57BL/6 mice serum	in vivo	https://lens.org/107-968-725-190-134	US 9,296,805 B2	N.A.
6265	106-160-175-860-210	2016	LSTAADMQGVVTDGMASGLDKDYLKPDD	P28	28	acetylate	amidated	Cyclic	L	enzymatically cyclized	P. aeruginosa azurin	Therapeutic	72 hours	10 Œºl	Increased	NA	MTT	Human Cancer Cells	in vivo	https://lens.org/106-160-175-860-210	US 9,434,770 B2	N.A.
6266	059-320-765-410-102	2016	MGSHHHHHHSSGENLYFQGHPCPDSSPLLQFGGQVRQRYLYTDDAQQTEAHLEIREDGTVGGAADQSPESLLQLKALKPGVIQILGVKTSRFLCQRPDGALYGSLHFDPEACSFRELLLEDGYNVYQSEAHGLPLHLPGNKSPHRDPAPRGPARFLPLPGLPPALPEPPGILAPQPPDVGSSDPLSMVEPSQGRSPSYASP	FGF21	NA	6-his tag, free cysteine	182P	Linear	L	Vitamin D3-PEG-maleimide	E. coli	Therapeutic	NA	0.1 mg/kg	675-fold increase	NA	ELISA	Rats	in vivo	https://www.lens.org/lens/patent/059-320-765-410-102	US 9,289,507 B2	N.A.
6267	059-320-765-410-102	2016	GS(n-octanoyl-S)FLSPEHQKAQQRKESKKPPAKLQPRC	rGhrelin-carrier conjugate	NA	Free	cysteine	Linear	L	Vitamin D3-PEG-maleimide	E. coli	Therapeutic	NA	0.1 mg/kg	8	NA	ELISA	Rats	in vivo	https://www.lens.org/lens/patent/059-320-765-410-102	US 9,289,507 B2	N.A.
6268	043-207-181-799-34X	2016	MVSQALRLLCLLLGLQGCLAAVFVTQEEAHGVLHRRRRANAFLEELRPGSLERECKEEQCSFEEAREIFKDAERTKLFWISYSDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKRNASKPQGRIVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFPSSSSKAPPPSLPSPSRLPGPSDTPILPQSSSSKAPPPSLPSTSRLPGPSDTPILPQSSSSKAPPPSLPSPSRLPGP	Coagulation Factor VII	444	Free	3CTPs	Linear	L	CTP	hepatocytes		60 sec	100 Œºl	4.07	serine protease	ELISA	Blood Stream	in vivo	https://www.lens.org/lens/patent/043-207-181-799-34X	US 9458444 B2	N.A.
6269	136-103-666-814-603	2016	MGWSLILLFLVAVATRVLS	bi-specific fusion protein	19	Free	Free	Linear	L	None	NA	non-immunogenic protein	NA	NA	between 2 hours and 24 hours, greater than 24 hours, or greater than one week	NA	ELISA		in vivo	https://www.lens.org/lens/patent/136-103-666-814-603	US 9238080 B2	N.A.
6270	032-864-902-079-483	2016	HADGSFSDEMNTILDNLAAR DFINWLIQTKITD	glucagon-like peptide-2	33	removing Œ±-carbon of histidine	thiol group	Linear	L	None	NA	NA	NA	NA	Increased	NA	NA	NA	in vivo	https://lens.org/032-864-902-079-483	US 9504757 B2	NA
6271	191-672-090-004-249	2016	DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNE CFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFY APELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKC ASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDL LECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPA DLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLA KTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGE YKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAE DYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPK EFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDD FAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL	human albumin	NA	Free	Free	Linear	L	None	Human	NA	NA	NA	NA	NA	NA	NA	in vivo	https://lens.org/191-672-090-004-249	US 9352016 B2	NA
6272	023-486-744-040-716	2016	ANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQC ETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFC HEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER	Factor Xa variant	NA	Free	Free	Linear	L	None	Human	NA	NA	NA	1	intracellular protease	aPTT-based assay	CHO cells	in vivo	https://lens.org/023-486-744-040-716	US 9371522 B2	NA
6273	130-503-305-403-520	2016	APISSHCRLDKSNFQQPYITNRTFMLAKEASLADNNTDVRLIGEKLFHGV SMSERCYLMKQVLNFTLEEVLFPQSDRFQPYMQEVVPFLARLSNRLSTCH IEGDDLHIQRNVQKLKDTVKKLGESGEIKAIGELDLLFMSLRNACIGSGG GSGGGGSGGGGSAPISSHCRLDKSNFQQPYITNRTFMLAKEASLADNNTD VRLIGEKLFHGVSMSERCYLMKQVLNFTLEEVLFPQSDRFQPYMQEVVPF LARLSNRLSTCHIEGDDLHIQRNVQKLKDTVKKLGESGEIKAIGELDLLF MSLRNACI	IL-22 dimer	308	Free	Free	Linear	L	None	Human	NA	20-30 min	100 Œºg/kg	1.3	NA	MTT	PC12 cells	in vitro	https://lens.org/130-503-305-403-520	US 9352024 B2	NA
6274	033-015-326-560-809	2016	QDSTSDLIPAPPLSKVPLQQNFQDNQFHGKWYVVGLAGNAILREDKDPQK MYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGSQPGEFTLGNIKSY PGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKE NFIRFSKSLGLPENHIVFPVPIDQCIDG	Lipocalin 2 mutein	178	Free	Free	Linear	L	None	Human	antagonist	30 min	NA	NA	serine protease	ELISA	NA	in vivo	https://lens.org/033-015-326-560-809	US 9260492 B2	NA
6275	030-841-916-119-277	2017	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR	GLP-1	30	Free	Fusion with ELP	Linear	L	None	synthetic	agonists	15-60 min	300-500 mg/dl	20	NA	cAMP assay	rabbits	in vivo	https://lens.org/030-841-916-119-277	US 9821036 B2	NA
6276	030-841-916-119-277	2017	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR	GLP-1	30	Free	Fusion with ELP	Linear	L	None	synthetic	agonists	15-60 min	300-500 mg/dl	24	NA	cAMP assay	rabbits	in vivo	https://lens.org/030-841-916-119-277	US 9821036 B2	NA
6277	030-841-916-119-277	2017	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR	GLP1	30	Free	Fusion with ELP	Linear	L	None	synthetic	agonists	15-60 min	300-500 mg/dl	12.9	NA	cAMP assay	rats	in vivo	https://lens.org/030-841-916-119-277	US 9821036 B2	NA
6278	030-841-916-119-277	2017	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR	GLP1	30	Free	Fusion with ELP	Linear	L	None	synthetic	agonists	15-60 min	300-500 mg/dl	8.6	NA	cAMP assay	rats	in vivo	https://lens.org/030-841-916-119-277	US 9821036 B2	NA
6279	179-033-965-606-598	2017	GIVEQCCTSICSLYQLENYCN	insulin	21	Free	Free	Linear	L	None	Human	NA		0.02 mg/kg	Less than 20K-PEG-insulin	NA	enzyme immunoassay	Rat Blood	in vivo	https://lens.org/179-033-965-606-598	US 9616109 B2	EC50 = 7.9ng/ml
6280	179-033-965-606-598	2017	NA	20K-PEG-insulin	NA	20K-PEG	Free	Linear	L	None	Human	NA	15 min	NA	improved	NA	enzyme immunoassay	Rat Blood	in vivo	https://lens.org/179-033-965-606-599	US 9616109 B2	EC50 =26.3ng/ml
6281	179-033-965-606-598	2017	NA	VitD-(25)-PEG2K-insulin	NA	VitD-(25)-PEG2K	Free	Linear	L	None	Human	NA	2-16 hours	NA	improved	NA	enzyme immunoassay	Rat Blood	in vivo	https://lens.org/179-033-965-606-600	US 9616109 B2	EC50 =15.8ng/ml
6282	179-033-965-606-598	2017	NA	VitD-(3)-PEG1.2K-insulin	NA	VitD-(3)-PEG1.2K	Free	Linear	L	None	Human	NA	20 min	NA	Drastically Improved	NA	enzyme immunoassay	Rat Blood	in vivo	https://lens.org/179-033-965-606-601	US 9616109 B2	EC50= 282.2ng/ml
6283	025-814-764-427-267	2017	HSDAVFTDNYTRLRKQMAVKKYLNSILN	PB1120	28	VIP with a Met	ELP(1-120)	linear	L	None	Synthetic	NA	30 min	3 mg/kg	45.8	NA	cell-based bioassay	Monkeys	in vivo/vitro	https://www.lens.org/lens/patent/025-814-764-427-267	US 9,700,598 B2	NA
6284	138-792-131-275-411	2017	MAERAALEELVKLQGERVRGLKQQKASAELIEEEVAKLLKLKAQLGPDESKQKFVLKTPKHHHHHH	HRS (1-60)	67	Free	Free	Linear	L	None	Synthetic	Therapeutic	1.5 hr	8 mg/kg	0.5	NA	ELISA	mice	in vivo	https://lens.org/138-792-131-275-411	US 9587235 B2	NA
6285	138-792-131-275-411	2017	MSDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSH EDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKE YKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCL VKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGKAERAALEELVKLQGERVRGLK QQKASAELIEEEVAKLLKLKAQLGPDESKQKFVLKTPK	Fc-HRS (2-60)	293	Fc	Free	Linear	L	None	Synthetic	Therapeutic	1.5 hr	8 mg/kg	72	NA	ELISA	mice	in vivo	https://lens.org/138-792-131-275-411	US 9587235 B2	NA
6286	138-792-131-275-411	2017	MAERAALEELVKLQGERVRGLKQQKASAELIEEEVAKLLKLKAQLGPDES KQKFVLKTPKSDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEV TCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVL HQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMT KNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSK LTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK	HRS (1-60)-Fc	293	Free	Fc	Linear	L	None	Synthetic	Therapeutic	1.5 hr	8 mg/kg	33	NA	ELISA	mice	in vivo	https://lens.org/138-792-131-275-411	US 9587235 B2	NA
6287	138-792-131-275-411	2017	MAERAALEELVKLQGERVRGLKQQKASAELIEEEVAKLLKLKAQLGPDESKQKFVLKTPKHHHHHH	HRS (1-60)	67	Free	Free	Linear	L	None	Synthetic	Therapeutic	1.5 hr	8 mg/kg	0.7	NA	ELISA	mice	in vivo	https://lens.org/138-792-131-275-411	US 9587235 B2	NA
6288	138-792-131-275-411	2017	MSDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSH EDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKE YKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCL VKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGKAERAALEELVKLQGERVRGLK QQKASAELIEEEVAKLLKLKAQLGPDESKQKFVLKTPK	Fc-HRS (2-60)	293	Fc	Free	Linear	L	None	Synthetic	Therapeutic	1.5 hr	8 mg/kg	71	NA	ELISA	mice	in vivo	https://lens.org/138-792-131-275-411	US 9587235 B2	NA
6289	138-792-131-275-411	2017	MAERAALEELVKLQGERVRGLKQQKASAELIEEEVAKLLKLKAQLGPDES KQKFVLKTPKSDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEV TCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVL HQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMT KNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSK LTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK	HRS (1-60)-Fc	293	Free	Fc	Linear	L	None	Synthetic	Therapeutic	1.5 hr	8 mg/kg	37	NA	ELISA	mice	in vivo	https://lens.org/138-792-131-275-411	US 9587235 B2	NA
6290	159-909-893-044-968	2017	K(mod)GCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY	adrenomedullin	44	lipid	free	Linear	D	None	human adrenomedullin peptide	agonistic	NA	NA	1.5	NA	ELISA	SHR rat	in vivo	https://lens.org/159-909-893-044-968	US 9694051 B2	NA
6291	013-179-165-807-035	2017	MHRPRRRGTRPPPLALLAALLLAARGADARSTGSPGSGDKTHTCPPCPAP ELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGV EVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPI EKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWE SNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEAL HNHYTQKSLSLSPGKGGGGSGGGGSGGGGSQRPRLSHKGPMPF	hFc-Apelin13	298	hFC	free	Linear	L	None	human adrenomedullin peptide	na	2 HRS	10 Œºg/mL	01-Oct	NA	ELISA	C57/Bl6 mice	in vivo	https://lens.org/038-310-729-099-192	US 9789197 B2	NA
6292	013-179-165-807-035	2017	MHRPRRRGTRPPPLALLAALLLAARGADAQRPRLSHKGPMPFGGGGSGGG GSGGGGSDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVV VDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDW LNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQV SLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVD KSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK	Apelin13-hFc	289	free	hFC	Linear	L	None	human adrenomedullin peptide	na	2 HRS	3 Œºg/mL	01-Oct	NA	ELISA	C57/Bl6 mice	in vivo	https://lens.org/038-310-729-099-192	US 9789197 B2	NA
6293	092-334-515-289-964	2017	MHSDAVFTDNYTRLRKQMAVKKYLNSILN	PB1120	29	VIP	ELP (1-120)	Linear	L	None	NA	anti-hypertensive	NA	NA	45.8	NA	NA	Monkeys	in vitro	https://lens.org/092-334-515-289-964	US 9561262 B2	NA
6294	034-343-155-162-302	2017	MKIILWLCVFGLFLATLFPISWQMPVESGLSSEDSASSESFASKIKRHGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSG	Ex4	87	Free	Free	Linear	L	None	NA	NA	NA	NA	38	chymotrypsin	ELISA	NA	in vitro	https://lens.org/034-343-155-162-302	US 9695224 B2	NA
6295	034-343-155-162-302	2017	NA	singly stapled SAH-Ex(A)	NA	SAH	Free	Linear	L	None	NA	NA	NA	NA	94	chymotrypsin	ELISA	NA	in vitro	https://lens.org/034-343-155-162-302	US 9695224 B2	NA
6296	034-343-155-162-302	2017	NA	singly stapled SAH-Ex(B)	NA	SAH	Free	Linear	L	None	NA	NA	NA	NA	128	chymotrypsin	ELISA	NA	in vitro	https://lens.org/034-343-155-162-302	US 9695224 B2	NA
6297	034-343-155-162-302	2017	NA	doubly stapled SAH-Ex(A, B)	NA	SAH	Free	Linear	L	None	NA	NA	NA	NA	295	chymotrypsin	ELISA	NA	in vitro	https://lens.org/034-343-155-162-302	US 9695224 B2	NA
6298	034-343-155-162-302	2017	MKIILWLCVFGLFLATLFPISWQMPVESGLSSEDSASSESFASKIKRHGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSG	exenatide	87	Free	Free	Linear	L	None	NA	NA	NA	NA	13	pepsin	ELISA	NA	in vitro	https://lens.org/034-343-155-162-302	US 9695224 B2	NA
6299	034-343-155-162-302	2017	NA	singly stapled SAH-Ex(A)	NA	Free	SAH	Linear	L	None	NA	NA	NA	NA	81	pepsin	ELISA	NA	in vitro	https://lens.org/034-343-155-162-302	US 9695224 B2	NA
6300	034-343-155-162-302	2017	NA	SAH-Ex(A, B)	NA	Free	SAH	Linear	L	None	NA	NA	NA	NA	172	pepsin	ELISA	NA	in vitro	https://lens.org/034-343-155-162-302	US 9695224 B2	NA